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THESIS ABSTRACT 
 
My field placement for Master of Philosophy in Applied Epidemiology (MAE) program 
was with the Indigenous Health Division of the Australian Government Department of 
Health, and it provided opportunities for epidemiological training in a broad range of 
contexts.  I present four projects to fulfil the core requirements of the MAE.   
 
I participated in a retrospective investigation into cases of carbapenemase-producing 
Enterobacteriaceae (CPE) identified over a four year period in the Australian Capital 
Territory.  In this investigation I collected epidemiological evidence and analysed 
existing environmental and whole-genome sequencing data to identify two small, but 
prolonged, outbreaks at a tertiary hospital.  The investigation revealed that nosocomial 
transmission of CPE is more extensive than previously understood, and is characterised 
by lengthy asymptomatic carriage and persistence of CPE in the hospital environment.  
We used the outbreak data to assess the utility of an interstate CPE prevention and 
control guideline, and to develop infection control recommendations specifically for the 
hospital.    
 
I analysed data from the Longitudinal Study of Indigenous Children (LSIC) to identify 
early life exposures associated with social and emotional wellbeing (SEWB) in 
Aboriginal and Torres Strait Islander children at school commencement.  Large 
household size and frequent exposure to major life events were weakly associated with 
poorer mental health and fewer prosocial behaviours; but conversely predicted a greater 
connection of the child to community, culture and country.  Most importantly, I found 
that mainstream mental health assessment tools do not reflect the positive, holistic 
concept of SEWB, and I was unable to create a more appropriate index using LSIC data.  
This study highlighted the need to develop measures that privilege Indigenous ways of 
being and knowing. 
 
My evaluation of Australia’s Enhanced Invasive Pneumococcal Disease Surveillance 
Program found that this complex system is highly flexible and stable, and is acceptable 
to users and stakeholders.  It has proved very useful for monitoring the national infant 
vaccination program—informing a change to the recommended vaccine in 2011.  The 
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program is less useful for evaluating targeted vaccination in other high-risk groups and 
for surveillance of antimicrobial resistance.  My key recommendations focussed on 
collecting complete data for all cases, ensuring stakeholders can easily access useful 
surveillance data, and improving collection of antimicrobial resistance data.  
 
I conducted the first evaluation of the New Directions: Mothers and Babies Services 
(NDMBS) program, which aims to increase access to maternal and health child services 
for Aboriginal and Torres Strait Islander families.  I assessed the effect of over $224 
million of investment between 2007 and 2015 using data from the Australian Early 
Development Census.  I found that there was little difference in indicators of early child 
development in the first year of school in areas that were serviced by NDMBS-funded 
organisations, compared to areas that did not.  This may have been due to differences in 
geographical remoteness between the two exposure groups, but the equivocal findings 
were more likely due to the evaluation’s ecological design and classification error.  The 
project highlighted the importance of developing a program logic model and evaluation 
plan during the program planning stage, to ensure that data is prospectively collected for 
use in evaluation.   
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CHAPTER 1 – OVERVIEW OF PLACEMENT AT 
AUSTRALIAN GOVERNMENT DEPARTMENT OF 
HEALTH AND SUMMARY OF PROGRAM 
REQUIREMENTS 
 
 
 
Bring us policy approaches that nurture hope and 
optimism rather than entrench despair…In fast thinking 
on Indigenous affairs we often hear things like ‘We’ve 
tried everything and nothing has worked’ when actually 
we haven’t tried everything, and we certainly haven’t 
seriously tried a high expectations relationships policy 
approach. 
Dr Chris Sarra 
 
 
Go to the end of the path until you get to the gate.  Go 
through the gate and head straight out towards the 
horizon.  Keep going towards the horizon. Sit down and 
have a rest every now and then.  But keep on going.  Just 
keep on with it.  Keep on going as far as you can.  That’s 
how you get there. 
Michael Leunig 
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ABBREVIATIONS 
 
ANFPP Australian Nurse Family Partnership Program 
CaFHS Child and Family Health Section 
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About the field placement 
 
I commenced as a Master of Philosophy in Applied Epidemiology (MAE) scholar at the 
Australian Government Department of Health in the Indigenous Health Division (IHD), 
Health Programs and Sector Development Branch, Child and Family Health section 
(CaFHS) on 16 February 2015.  This was an excellent placement for me, as my work 
experience in the last 10 years has been in rural and remote nursing, Aboriginal and 
Torres Strait Islander ear health and diabetes research, and Aboriginal Health 
Practitioner pre-registration training.  As I took two leaves of absence to have babies, 
and worked part time for a period, my MAE program was extended by a year.   
 
The Child and Family Health section (CaFHS) is responsible for a range of programs to 
improve the health and life outcomes for Aboriginal and Torres Strait Islander families, 
and specifically to halve the gap in child mortality by 2018.  These programs include 
the Australian Nurse Family Partnership Program (ANFPP), a nurse-led home visiting 
program for mothers of Aboriginal and Torres Strait Islander babies; and the New 
Directions: Mothers and Babies Services (NDMBS) program, which aims to increase 
access to maternal and child health services.  The section also supports activities that 
increase understanding of Fetal Alcohol Spectrum Disorders, and leads the Connected 
Beginnings program, in partnership with the Department of Education and Training, 
which integrates services for maternal and child health, early childhood and family 
support within school settings in a number of disadvantaged Aboriginal and Torres 
Strait Islander communities.   
 
Although a scholar from the 2014 MAE cohort was placed with the Division, I was the 
first to be placed with CaFHS.  Initially, my field supervisor was Dr Annie Dullow, the 
section Director.  With a background in nursing and midwifery, Annie has worked 
within the Department since 2003 on a range of child and maternal health policies and 
programs including the National Early Childhood Development Strategy and the 
National Framework for Protecting Australia’s Children.  When I returned from 
maternity leave in 2016, the new Director, Nick Pascual, became my field supervisor.  
Nick has an extensive history in management in the Department, and as a senior adviser 
to the Minister for Indigenous Health.  In some ways this was a challenging placement, 
as my colleagues had backgrounds in national policy and programs rather than 
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epidemiological, public health, or data analysis skills.  This meant that I had flexibility 
in choosing projects, but also that I had to seek support on epidemiological and data 
analysis matters outside the placement.   
 
Summary of public health experience and impact 
Two of my field projects contributed directly to the work of my field placement support 
organisation.  I undertook the first evaluation of the NDMBS program, and analysed 
data from the Longitudinal Study of Indigenous Children (LSIC) to identify 
determinants of social and emotional wellbeing for Aboriginal and Torres Strait Islander 
children.   
 
Due to my epidemiological training and previous work experience, I was able to 
contribute to policy discussions, review documents, and provide advice to my section 
colleagues.  For example, I provided comments on the draft National Framework for 
Health Services for Aboriginal and Torres Strait Islander Children and Families; the 
draft child mortality chapter of the Australian Institute of Health and Welfare’s analysis 
of data for the new Closing the Gap targets; and the evaluation strategy for the 
Connected Beginnings program.  During my placement, CaFHS also committed to 
investing in a randomised controlled trial (RCT) to evaluate the effectiveness of the 
ANFPP in Brisbane.  I have experience in two RCTs in Aboriginal and Torres Strait 
Islander health, and wrote a course for Menzies School of Health Research on clinical 
trials, so I provided advice on RCT design and implementation.   
 
In my final weeks on the placement, I prepared and delivered a two hour workshop for 
my section colleagues.  At their request, I presented an overview of the inter-
relationships and lifelong impacts of maternal and child health to Aboriginal and Torres 
Strait Islander health.  I also presented short summaries on diabetes and pregnancy, 
middle ear disease, acute rheumatic fever and rheumatic heart disease, and an 
interactive session on program logic models and evaluation.   
 
Being placed within the Department facilitated my evaluation of Australia’s Enhanced 
Invasive Pneumococcal Disease Surveillance Program evaluation, including easy access 
to relevant staff from the Office of Health Protection (OHP) and gaining access to 
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surveillance data.  I was also able to attend fortnightly meetings of the OHP 
epidemiologists, during which they prepared for their report to Communicable Diseases 
Network Australia.  I drafted and finalised ten International Reports for these meetings.  
I valued the opportunity to assess reports of communicable disease outbreaks and trends 
for their relevance to public health and emergency response in Australia.   
 
One of the most rewarding aspects of my training was participating in the investigation 
of cases of carbapenemase-producing Enterobacteriaceae (CPE) with the Departments 
of Infectious Diseases and Microbiology at the Canberra Hospital.  I enjoyed sitting in 
with the hospital’s Infection Prevention and Control Team, observing the daily 
activities, and learning about these important pathogens and their control.  I was able to 
provide a tangible contribution to the team through the investigation.   
 
It was accepted into the MAE program on my second application.  I am so glad I 
persisted.  The MAE has provided the rigorous training, real-life experience and 
professional network I hoped for.  I am looking forward to putting the skills and 
knowledge I’ve gained to worthy use, and to calling myself an epidemiologist. 
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Fulfilment of program requirements 
 
Table 1 Overview of my Masters of Philosophy in Applied Epidemiology program 
requirements, February 2015 – November 2017 
Requirement Chapter 2 Chapter 3 Chapter 4 Chapter 5 Chapter 6 
Analyse a public 
health dataset 
     
Design and conduct 
an epidemiological 
study 
     
Evaluate a 
surveillance system 
     
Investigate an acute 
public health 
problem 
     
Literature review 
and critical appraisal  
     
Oral conference 
presentation 
 
 
(Appendix) 
   
Advanced draft of a 
paper for peer-
reviewed journal  
 
 
(Appendix) 
 
(Appendix) 
  
Summary for a lay 
person  
     
Teaching 
requirements 
     
Coursework Unit  Grade 
 Outbreak Investigation High Distinction 
 Public Health Surveillance High Distinction 
 Analysis of Public Health Data High Distinction 
 Methods in Applied Epidemiological 
Research 
Course requirement satisfied 
 Issues in Applied Epidemiology Course requirement satisfied 
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CHAPTER 2 – CARBAPENEMASE-PRODUCING 
ENTEROBACTERIACEAE IN THE AUSTRALIAN 
CAPITAL TERRITORY: OUTBREAK 
INVESTIGATION AND ASSESSMENT OF 
INFECTION CONTROL GUIDELINES  
 
 
 
 
 
 
 
 
When you have eliminated the impossible, whatever remains, 
however improbable, must be the truth. 
 
Arthur Conan Doyle 
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Prologue 
I had heard that there was an opportunity to investigate transmission of multi-resistant 
organisms at the Canberra Hospital (TCH), so I approached the Director of Infectious 
Diseases, Dr Nick Coatsworth.  Nick was kind enough to facilitate my involvement in 
the investigation of cases of carbapenemase-producing Enterobacteriaceae (CPE).  I 
met with Nick, Dr Karina Kennedy (Director of Microbiology), Dr Kathryn Daveson 
(Infectious Diseases physician), and Wendy Beckingham (Assistant Director of Nursing, 
Infection Prevention and Control) to discuss the investigation.  They wanted to 
determine if there was transmission of CPE within Canberra hospitals, and also to 
assess the utility of the Victorian CPE control guideline.  This was an exciting project, 
as the Department of Microbiology had just received the results of whole-genome 
sequencing (WGS) for four years’ worth of stored CPE isolates from patient and 
environmental samples.  The WGS was performed at the Doherty Centre in Melbourne, 
and I was grateful for Karina and Kathryn’s assistance in understanding the sequencing 
data.   
 
In this chapter, the findings from the projects are presented as two articles that have 
been prepared for submission to peer-reviewed journals (Infection Control & Hospital 
Epidemiology and The Medical Journal of Australia, respectively).  They were co-
authored with Karina, Kathryn and my academic supervisor, David Harley.    
 
MY ROLE 
For this project I  
 developed the case definition 
 identified cases 
 collected clinical and admissions data for cases 
 analysed the WGS and admissions data 
 developed the transmission maps 
 drafted the articles and incorporated edits from co-authors, including the 
recommendations for CPE infection prevention and control at TCH 
 submitted a conference abstract for the outbreak investigation 
 presented the findings of the two studies to the TCH Infection Prevention and 
Control Unit team. 
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LESSONS LEARNT 
It was on this project that I wore out my proverbial epidemiologist’s shoe-leather, and 
learnt about the hard graft of outbreak investigation.  Trawling through years’ worth of 
admissions data and hand-written clinical notes for each case took weeks, and looking 
for patients who could plausibly have been undetected carriers was also very time-
consuming.   
 
My understanding of antimicrobial resistance mechanisms and WGS were limited, so I 
undertook two Massive Open Online Courses (MOOCs) through the Technical 
University of Denmark and Health Education England.  This provided me with the basic 
knowledge to undertake targeted literature reviews and participate in discussions with 
my co-investigators.   
 
PUBLIC HEALTH IMPACT 
This project provided the TCH Infection Prevention and Control Unit with evidence of 
significant local transmission of CPE.  It also provided the Unit with guidelines for CPE 
prevention and control that have been tailored to the local context.   
 
The findings will be presented at the Australasian College for Infection Prevention and 
Control conference in late November 2017.    
 
ACKNOWLEDGEMENTS 
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Two carbapenemase-producing Enterobacteriaceae 
outbreaks at an Australian tertiary hospital 
ABSTRACT 
OBJECTIVES 
Carbapenemase-producing Enterobacteriaceae (CPE) pose a serious threat to the 
effectiveness of last-line antimicrobial agents in Australia.  In 2014, two genetically 
linked cases of CPE were detected at the Canberra Hospital (TCH), prompting an 
investigation and response that appeared to contain transmission.  We report a 2017 
retrospective investigation that aimed to identify clusters and transmission mechanisms. 
 
METHODS 
Cases of CPE between 2012 and 2016 were identified from the Australian Capital 
Territory (ACT) Pathology laboratory information system.  Whole-genome sequencing 
was performed retrospectively on 83% of isolates.  We investigated two multilocus 
sequence type clusters using epidemiological, molecular and environmental evidence. 
 
RESULTS 
Seventy-two cases were identified, with 90% of isolates containing blaIMP genes.  
Enterobacter cloacae complex and Citrobacter freundii were most frequently detected 
and, based on multi-locus sequence types (STs), were implicated in two outbreaks each 
spanning over three years.  The E. cloacae complex ST24 (blaIMP-4) outbreak consisted 
of seven cases, including the two linked cases identified in 2014.  The C. freundii ST8 
(blaIMP-4) outbreak consisted of ten cases.  Both outbreaks most likely originated in the 
haematology ward and spread via environmental reservoirs and undetected carriers there, 
in the intensive care unit, and in five other wards.  
 
CONCLUSIONS 
Epidemiological and molecular evidence indicate CPE transmission at TCH is more 
extensive than previously understood.  Prevention and control measures must address 
asymptomatic carriage and persistence in the hospital environment.  The value of WGS 
in CPE outbreak investigation would be increased by using methods that account for 
gene transfer between Enterobacteriaceae species.   
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INTRODUCTION 
Carbapenemases are enzymes capable of hydrolysing the majority of β-lactam 
antibiotics and most resist inhibition by available β-lactamase inhibitors (1).  Since the 
appearance in the 1990s of carbapenemase genes transferred between gram-negative 
bacteria (both inter- and intra-species) on mobile plasmids (1), β-lactam antibiotic 
resistance and nosocomial carbapenemase-producing Enterobacteriaceae (CPE) 
outbreaks are increasingly detected in Australia (2-4).  These bacteria are usually 
resistant to multiple antimicrobial classes, leaving few if any treatment options for CPE 
infections (5).  In Australia, carbapenemases are the most frequently reported 
antimicrobial resistance mechanism posing a serious threat to the effectiveness of last-
line antimicrobial agents (6).  Bacteria are predominantly Enterobacter cloacae 
complex, Escherichia coli and Klebsiella pneumoniae, contain the metallo-β-lactamase 
gene blaIMP, and are mostly detected in hospitalised patients.   
 
In 2009, the first case of CPE—a returned medical tourist whose urinary catheter 
specimen grew Providencia rettgeri containing blaNDM-1—was identified at The 
Canberra Hospital (TCH) (7).  A handful of apparently sporadic cases were recognised 
over the next four years.  In February 2014, incidental molecular typing and genetic 
analysis by a research laboratory identified two Intensive Care Unit (ICU) patients with 
genetically similar isolates of carbapenem-resistant E. cloacae complex, highly 
suggestive of local transmission.  This finding prompted an investigation and response 
from the TCH Infection Prevention and Control Unit team.  Carbapenemase-producing 
E. cloacae complex was isolated from the hand hygiene sink in the single room 
occupied by both patients.  The assumption at this time was that local transmission was 
occurring within the ICU in associated with an environmental reservoir.  The room was 
terminally cleaned, the tap aerator was replaced, and the pipes and sink flushed with 
sodium hypochlorite.  Hand hygiene sinks in the rooms subsequently occupied by the 
two cases on the haematology and surgical wards were also sampled but no CPE were 
identified.  Investigations showed that nursing staff in ICU had been disposing of body 
fluids, such as gastric aspirate, and unused liquid antibiotics in the hand hygiene sinks.  
Staff were educated on the infection control risks and single-use syringes were used for 
gastric aspiration.  All remaining hospitalised patients who had occupied the room in 
the month before the first case were identified and screened, but no CPE was detected.  
Environmental screening was extended to all 26 hand hygiene sinks in the ICU, with a 
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variety of CPE species identified in eight of these.  All sinks were cleaned and bleached 
weekly and then sampled until cleared.  An enhanced surveillance program including 
routine CPE screening (mainly via perianal swabs) of all patients on admission, weekly 
and at discharge from ICU was introduced and continued for six months.  
Approximately 70% of patients were screened.  During this period, five ICU patients 
were identified via screening, of whom three were identified on admission to ICU and 
two on discharge without an admission screen.  These were considered sporadic cases 
without definitive evidence of ongoing local transmission. 
 
PURPOSE OF THIS STUDY AND RESEARCH OBJECTIVES 
We aimed to provide evidence to assist in the prevention of transmission of CPE at 
TCH.  Our research objectives were to: describe cases of CPE detected through routine 
testing from 2012 to 2016; identify past outbreaks based on epidemiological and 
molecular evidence; and investigate possible transmission mechanisms using 
environmental evidence where available. 
 
SETTING 
The Canberra Hospital (TCH) is a 600-bed tertiary referral hospital for the Australian 
Capital Territory (ACT) and surrounding Capital Region of New South Wales (NSW), 
comprising a population of approximately 600,000.  Most subspecialty services are 
provided at TCH, including adult and neonatal intensive care, with the exception of 
solid organ and allogeneic stem transplantation, and paediatric cancer and intensive care 
services.  ACT Pathology provides all microbiological services to the two ACT public 
hospitals (TCH and Calvary Hospital), and some community and private hospital 
services.  Two private pathology laboratories provide the remaining, predominantly 
community, services in the ACT   
 
METHODS 
LABORATORY METHODS 
A case was defined as a person identified from the ACT Pathology laboratory 
information system with an Enterobacteriaceae spp. possessing a carbapenemase gene 
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isolated from a clinical or surveillance specimen between 1 January 2012 and 31 
December 2016.  Methods for identification and genetic characterisation of CPE varied 
over this time period.  Enterobacteriaceae spp. from clinical specimens were identified 
by MALDI-TOF (Bruker Daltronics, Bremen, Germany), followed by susceptibility 
testing using Vitek® 2 (bioMérieux, Marcy l’Etoile, France).  Isolates with a 
meropenem minimum inhibitory concentration (MIC) greater than 0.25µg/ml were 
screened for carbapenemase production by either double disk diffusion test, Carba NP 
or Carbapenem Inactivation Method (8).  The genotypes of isolates with a positive 
carbapenemase screening test and/or those with an MIC>4µg/ml were characterised by 
one of two commercial assays (AusDiagnostics Easy-Plex
TM
 CRE Panel, Sydney; 
Australia and Cepheid Xpert
® 
Carba-R, Sunnyvale, USA).  Surveillance specimens 
were perianal or rectal swabs directly inoculated onto chromogenic agar (bioMérieux 
Brilliance), and any organisms grown were identified by MALDI-TOF, with 
Enterobacteriaceae tested as per the clinical specimens. 
 
In October 2016, whole-genome sequencing (WGS) was performed on fifty-nine stored 
CPE isolates.  The analysis was conducted by the Doherty Institute, Melbourne, using 
Illumina paired-end sequencing on a NextSeq platform.  This analysis provided 
multilocus sequence type (ST), resistance profiles, pairwise core single nucleotide 
polymorphism (SNP) distances and phylogenetic trees, generated using the Nullarbor 
pipeline (9). 
 
INVESTIGATION OF CLUSTERS 
We investigated two clusters of the same multilocus sequence types to identify 
epidemiological and environmental links.  The first was of seven cases of E. cloacae 
complex with sequence type 24 (ST24) containing blaIMP -4.  The second was a cluster of 
10 cases of Citrobacter freundii ST8, also harbouring blaIMP -4.  Clinical data were 
collected from the ACT Health clinical records information system.  We recorded bed 
locations of patients admitted to TCH in Microsoft Excel (2007) using information from 
the ACT Health patient administration system.  We included all admissions and 
emergency department presentations at least 12 months before CPE specimen collection, 
or from January 2012, whichever was earlier.   
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The most parsimonious transmission map was constructed by following the approach 
reported by Snitkin and others (10).  We also accounted for a number of features of CPE 
epidemiology, which are listed in Box 1.  We considered a link between cases most 
likely if cases overlapped on the same ward, or if the time between their admissions to 
the same ward was the shortest, and if the source case was confirmed CPE-positive 
before isolation of CPE from the putative recipient.  Weight was also given to 
relationships where the pairwise genetic distance between the bacteria isolated from the 
source and recipient was small.  We assumed that bacteria separated by small SNPs 
were more closely related to each other than to others in the cluster, because their 
sequences diverged from a common ancestor to the same extent (11).  Where a direct 
epidemiological link between cases could not be found, we looked for potential carriers 
who shared wards with the source and the recipient.   
 
Box 1 Features of hospital-acquired CPE epidemiology considered in construction of the 
transmission map.  
 
 Duration of CPE carriage following hospital discharge may be at 
least 12 months (12) 
 Colonisation may be detected well after the transmission event 
(10) 
 Because of undetected colonisation, CPE can be detected in the 
source case after another case who they infected (10) 
 CPE can persist for long periods in ward infrastructure (such as 
sinks) (3, 13, 14), permitting epidemiological links between 
sources and recipients whose ward admissions do not overlap 
 As targeted CPE surveillance was undertaken in only one ward at 
TCH in 2014, the possibility of multiple unsampled transmission 
chains cannot be excluded (15). 
 
 
ETHICAL REVIEW 
The ethical aspects of this research were approved by the ACT Health Human Research 
Ethics Committee Low Risk Sub-committee (Protocol No. ETHLR.17.042) and by the 
Australian National University Human Research Ethics Committee (Protocol No. 
2017/108).  
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RESULTS 
ALL CPE CASES  
Sixty-three people met the case definition.  As two or more species containing a 
carbapenemase-producing gene were isolated from nine of these people, seventy-two 
isolates were included in the study.  The largest number of cases over a three month 
period was observed from January to March 2015 (Figure 1). Eighty-eight percent of 
cases were hospital inpatients (Table 2), and most (72%) were detected through clinical 
isolates—mainly from urine specimens.  Case and bacterial characteristics are shown in 
Table 3.   
 
Figure 1 Cases of carbapenemase-producing Enterobacteriaceae (CPE) detected by ACT 
Pathology via surveillance and clinical isolates, 2012-2016. 
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Table 2 Specimens and admission status of cases of carbapenemase-producing 
Enterobacteriaceae (CPE) detected by ACT Pathology, 2012-2016. 
Characteristic  Frequency (n=72) 
Specimen type 
urine 25 (35%) 
wound swabs 12 (15%) 
blood 7 (8%) 
sputum 3 (4%) 
other clinical specimens* 5 (8%) 
perianal/rectal surveillance swabs 20 (28%) 
Admission status 
of case at time of 
specimen 
collection   
TCH inpatient 53 (74%) 
Calvary Public or Calvary Private Hospital inpatient  10 (14%) 
Outpatient of any ACT hospital 7 (10%) 
General practice patient 1 (1%) 
* suprapubic catheter site [1], peritoneal swab [1], scrotal wall/groin swab [1], low vaginal swab[1], 
abdominal drain insertion site[1]. 
 
Ninety percent of isolates contained blaIMP genes.  Ten species were detected, 
comprising at least 23 multilocus sequence types—most of which appear only once 
amongst the sequenced isolates.  The most frequently-identified species were E. cloacae 
complex (29%), C. freundii (19%), K. pneumoniae (13%), E. coli (13%) and Klebsiella 
oxytoca (11%).  Based on multilocus sequence types and genetic distances, WGS 
identified two outbreaks.    
Median case age was 62 years (range 4 months to 92 years), and a majority were male 
(57%).  Most (79%) were residents of the ACT, and seven percent lived in residential 
aged care facilities (RACFs).  Five had recently received health care internationally 
(Egypt: K. pneumoniae ST383 blaOXA-48; Bangladesh: C. freundii blaIMP-4; India: E. coli 
ST33 blaIMP-4; India: E. coli blaNDM; and Vietnam: E. coli blaOXA-48) but no other travel 
histories were recorded.  Another case had multiple admissions to hospitals in NSW in 
the 12 months before her transfer to TCH, where CPE was detected on admission (K. 
pneumoniae blaNDM).   
 
ENVIRONMENTAL INVESTIGATION  
The genomes of fourteen environmental CPE isolates collected in 2014 from the ICU 
were sequenced.  All were collected from hand hygiene sinks.  Four (isolates E1, E2, E3 
and E14) were E. cloacae complex ST24 containing blaIMP-4 detected between March 
2014 and April 2015, and had a similar resistome as seven of the cases.  The remainder 
were C. freundii (5 isolates), K. pneumoniae (3 isolates) and K. oxytoca (2 isolates).  
Although all of these harboured blaIMP-4, none were of the same sequence type as the  
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Table 3 Selected characteristics of people infected or colonised with carbapenemase-producing Enterobacteriaceae (CPE) detected by ACT Pathology, 2012-2016. 
Species 
Isolates 
n (%) 
Median age 
(years)  
Female 
n (%) 
Detected from 
clinical isolate 
n (%) 
MLST sequence types 
detected 
No. (%) of isolates carrying gene   
blaIMP-4  blaIMP-38 blaOXA-48 blaNDM-1 blaNDM-5 blaNDM* 
Enterobacter 
cloacae complex 
21 (29%) 63 
8 
(38%) 
15 
(71%) 
24, 32, 45, 50, 66, 113, 
127, 742, 610 
20 
(95%) 
1 
(5%) 
0 0 0 0 
Citrobacter freundii  14 (19%) 65 
3 
(21%) 
10 
(71%) 
8, 62, 98 
14 
(100%) 
0 0 0 0 0 
Klebsiella 
pneumoniae  
9 (13%) 63 
5 
(56%) 
8 
(89%) 
383, 661, 1308, 1528 
7 
(78%) 
0 
1 
(11%) 
0 0 
1 
(11%) 
Escherichia coli 9 (13%) 54 
6 
(67%) 
5 
(56%) 
33, 221, 410, 687 
6 
(67%) 
0 
1* 
(11%) 
1 
(11%) 
0 
1 
(11%) 
Klebsiella oxytoca  8 (11%) 62 
3 
(38%) 
7 
(88%) 
20, 29, 53 
8  
(100%) 
0 0 0 0 0 
Serratia marcescens  
3  
(4%) 
59 
2 
(67%) 
1 
(33%) 
none detected 
3 
(100%) 
0 0 0 0 0 
Citrobacter 
amalonaticus 
3  
(4%) 
78 
1 
(33%) 
2 
(67%) 
none detected 
3 
(100%) 
0 0 0 0 0 
Morganella 
morganii  
3  
(4%) 
56 
2 
(67%) 
3 
(100%) 
none detected 
2 
(67%) 
0 0 0 
1 
(33%) 
0 
Hafnia alvei 
1  
(1%) 
68 
1 
(100%) 
1 
(100%) 
none detected 0 0 0 0 0 
1 
(100%) 
Enterobacter 
aerogenes 
1  
(1%) 
85 0 
1 
(100%) 
none detected 
1 
(100%) 
0 0 0 0 0 
All cases 72 62.4 years 31 (43%) 
52 
(72%) 
- 
64 
(88%) 
1 
(1%) 
2 
(3%) 
1 
(1%) 
1 
(1%) 
3 
(4%) 
* Whole-genome sequencing was not performed on these isolates 
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CPE detected in any of the cases.  None of the samples collected from the haematology 
or gastroenterology wards yielded CPE.  However, Pseudomonas monteilli harbouring 
blaIMP (not sequenced) was detected from a sink in the haematology ward. 
 
ENTEROBACTER CLOACAE COMPLEX ST24 OUTBREAK  
Seven cases of E. cloacae complex ST24 containing blaIMP-4 were detected between 
March 2012 and May 2015, including the two ICU patients referred to in our 
Introduction (Patients EC3 and EC4) (Table 4).  One (EC7) harboured blaIMP-38, which 
differs from blaIMP-4  by one point mutation (16).  Its detection may be a sequencing 
error, or it may have evolved from blaIMP-4 (16).  All organisms contained genes for β-
lactamases, extended-spectrum β-lactamases, aminoglycoside-modifying enzymes, 
chloramphenicol transferase, and fluoroquinolone resistance proteins.  The mean 
genetic distance between pairs of E. cloacae isolated in these seven cases was 915 SNPs 
(range 323-1535).  As the bacteria in each case were around 185 000 SNPs distant from 
the reference genome used for SNP analysis (E. cloacae subspecies cloacae ATCC 
13047 chromosome, complete genome), it is likely that the SNPs between our cases are 
inflated.  Extended periods of carriage or environmental contamination may also explain 
these large SNPs.  The distances between these and other sequenced E. cloacae ranged 
from 16 000 to 21 000 SNPs. 
 
Results of the epidemiological investigation suggest that E. cloacae complex ST24 
originated with Patient EC1 in the haematology ward, although it is possible that there 
were earlier, undetected cases.  The pathogen was most likely transmitted via 
environmental reservoirs or undetected carriers in ICU and the haematology and renal 
medicine wards (Figure 2, Figure 3).  The E. cloacae complex detected from Patient 
EC1 was between 251 and 425 SNPs distant from the ICU environmental samples (E1, 
E2, E3 and E14) collected from sinks in the ICU.  The organism was possibly 
transmitted from Patient EC1 to Patient EC2 via Patient M (proposed CPE carrier).  
Patient M, who had lymphoma, was admitted to the haematology ward and ICU, before 
admission to the renal medicine ward coincident with Patient EC3 for 17 days before 
collection of Patient EC2’s positive sample.  Both Patients M and EC2 were 
subsequently discharged to RACFs.  Patient EC2 was not cleared of CPE at discharge.  
Patient EC4, a 19-year-old who was treated for road trauma, had no risk factors for CPE 
other than ICU admission.  He was transferred to ICU on hospital admission via the 
operating theatre to a bed within the four-bed bay occupied by Patient EC1 over 20 
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months earlier.  He remained there for 10 days before being transferred to a single room 
after detection of CPE.  Three of the four E. cloacae complex environmental samples 
(EEC1, EEC2 and EEC4) were collected from sinks in this single room after his 
admission.  Patient EC3 also occupied the room.  However, the timing of her CPE 
specimen collection indicates that she arrived in ICU having been infected on the 
haematology ward, probably while occupying the two-bed room also occupied by 
Patient EC1.   
 
Patients EC1 and EC6 were admitted to the same single room in ICU in March 2012 
and July 2014 respectively.  Although more than three years elapsed between their 
detection, their isolates shared an identical resistome and had the smallest pairwise 
genetic distance of the outbreak (323 SNPs).  This suggests that Patient EC6 was 
colonised by the resistant E. cloacae complex nearly 10 months before detection.  
Carbapenemase-producing C. freundii and Serratia marcescens were also detected 
Patient EC6 in July 2014.      
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Table 4 Characteristics of people infected or colonised with carbapenemase-producing E. cloacae complex ST24 detected by ACT Pathology, 2012-2016.  Asterisks 
indicate that antimicrobial therapy continued for over one month. 
ID Sex 
Age 
(yrs) 
Condition/s 
Specimen  
Type 
Selected risk factors in the 12 months prior to detection of CPE 
Days in 
hospital 
ICU 
admission 
Upper or 
lower 
endoscopic 
procedure 
Long term 
vascular 
catheter 
Urinary 
catheter 
Type 2 
diabetes 
Immuno-
compromised
/suppressed 
Antimicrobial therapy 
EC1 male 56 
B-cell lymphoma with multi-organ 
failure, scleroderma 
Oropharyngeal 
issue 
16 Y N Y Y N Y 
Meropenem, piperacillin-
tazobactam, vancomycin, 
 linezolid 
EC2 male 85 Parkinson’s disease, foot cellulitis  
Urine, 
suprapubic 
catheter site 
swab 
59 N N N Y N N 
Ceftriaxone, cephazolin,  
cephalexin 
EC3 male 19 
Motor vehicle accident: traumatic 
arm amputation, flail chest, pelvic & 
clavicle fractures 
sputum 6 Y N N Y N N Cephazolin, vancomycin 
EC4 female 69 
Follicular lymphoma, nephrostomy, 
hospital-acquired pneumonia with 
sepsis 
urine 22 N N N Y Y Y 
Vancomycin, gentamicin, 
ceftriaxone, cephazolin,  
cephalexin 
EC5 female 77 
End-stage renal failure on 
peritoneal dialysis 
surveillance 
swab 
46 Y N Y Y Y N 
Cotrimoxazole*, cephalexin*, 
piperacillin-tazobactam, 
vancomycin, gentamicin, 
ciprofloxacin, clarithromycin, 
ampicillin, amoxycillin-clavulanate, 
cefuroxime 
EC6 female 61 
Severe acquired brain injury,  
tracheostomy, recurrent UTI, 
recurrent aspiration pneumonia 
surveillance 
swab 
365 Y Y N Y N Y 
Erythromycin*, trimethoprim*, 
piperacillin-tazobactam, 
gentamicin, metronidazole  
EC7 female 43 
Hodgkin’s Lymphoma, Crohn's 
Disease 
surveillance 
swab 
61 Y N Y Y N Y 
Meropenem, piperacillin-
tazobactam, vancomycin 
 Median 61 yrs  Median    55 days 71% 14% 43% 100% 29% 57%  
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Case 
 ID 
2012 2013 2014 2015 
M A M J J A S O N D J F M A M J J A S O N D J F M A M J J A S O N D J F M A M 
EC1    x died                                     
M*                                      died            
EC2                  x x x x died                     
EC3                       x x x x x x x x               
EC4               
 
 
                                                                                                                                x x x x x x x x          
EC5
#
                                        x            
EC6
#
                                          x 
EC7
#
                                                   x x x x x x x    
   Environmental Samples                                 
EEC1                           x                
EEC2                           x                
EEC3                           x                
EEC4                                        x   
 
KEY x Known CPE positive   Intensive Care Unit   Haematology   Renal medicine   Orthopaedics 
               
  Hospital in the Home   Other TCH unit   Other hospital   Residential aged care 
 
Figure 2 Hospital admission locations of cases of carbapenemase-producing E. cloacae complex ST24 (blaIMP-4) detected by ACT Pathology, 2012-2016, and 
associated environmental samples. *Patient M is a suspected carrier, his CPE status is unknown. #Patients EC5, EC6 and EC7 were detected via surveillance. 
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Figure 3 Putative transmission map for the E. cloacae ST24 (blaIMP-4) outbreak, the Canberra Hospital, 2012-2016. 
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CITROBACTER FREUNDII ST8 OUTBREAK 
Eight cases of C. freundii ST8 containing the carbapenemase gene blaIMP-4 were 
detected between January 2013 and March 2016.  A further two cases with blaIMP-4 had 
indeterminate sequence types, because of lack of characterisation of one allele.  All 
other alleles in these cases were identical to ST8.  All ten organisms contained genes for 
β-lactamases, cephalosporinases, and dihydrofolate reductases.  The mean genetic 
distance between outbreak pairs was 122 SNPs (range 37-231).  The pairwise distances 
between these and other sequenced C. freundii ranged from 28 000 to 49 000 SNPs.   
 
Cases were mostly male (80%) and had a median age of 69 years (Table 5).  Five died 
in hospital without being cleared of CPE.  In the 12 months before CPE detection, four 
cases had been admitted (on 1 to 5 occasions) to five NSW hospitals, but none had a 
documented history of international travel in that period.  As for the E. cloacae complex 
outbreak, most cases occupied multiple beds and wards during their TCH admissions.   
 
The CPE-positive isolates for the C. freundii outbreak were detected between January 
2013 and March 2016 (Figure 4).  The first, Patient CF1, was admitted to and died in 
the haematology ward.  On epidemiological grounds, we infer that transmission 
occurred through high risk intermediate carriers (probably Patients G, C, and R) and 
environmental reservoirs in the haematology ward and ICU (Figure 5).  Patient CF4 
most likely acquired infection on the orthopaedic ward from Patient CF6, who had been 
transferred there from the haematology ward.  Patient CF3 was briefly admitted to the 
medical assessment unit and Hospital in the Home (HITH) before outpatient collection 
of a positive urine specimen.  Plausibly she might have acquired the infection in HITH 
from Patient T who was admitted to ICU concurrently with CF2.  There were no 
environmental samples of C. freundii ST8 identified, but samples of three ICU sinks 
yielded other sequence types (95, 98, and 101) carrying blaIMP-4, one of which was in a 
room occupied by CF6.   
 
 
 
35 
 
Table 5 Characteristics of people infected with or colonised by carbapenemase-producing C. freundii ST8 or similar (genotype blaIMP-4) detected by ACT Pathology, 
2012-2016.  Asterisks indicate that antimicrobial therapy continued for over one month. 
ID Sex 
Age 
(yrs) 
Condition/s 
Specimen 
Type 
Selected risk factors in the 12 months prior to detection of CPE 
Days in 
hospital 
ICU 
admission 
Upper or 
lower 
endoscopy  
Long term 
vascular 
catheter 
Urinary 
catheter 
Type 2 
diabetes 
Immuno-
compromis-
ed 
Antimicrobial therapy 
CF1 male 72 
Acute myeloid leukaemia, neutropaenic 
sepsis, leg ulcer 
blood 51 N Y Y N Y Y 
Cotrimoxazole*, piperacillin-
tazobactam, flucloxacillin, vancomycin, 
metronidazole, ciprofloxacin 
CF2 male 58 
Oesophageal cancer, tracheostomy, 
percutaneous endoscopic gastrostomy 
urine 138 Y Y N Y N Y Cephazolin, metronidazole 
CF3 female 61 
Extended-spectrum β-lactamase cellulitis, 
morbid obesity, colostomy 
urine 31 N N Y N Y N 
Ticarcillin-clavulanate, amoxycillin, 
cephazolin, norfloxacin, cephalexin 
CF4 male 77 
Hypoplastic myelodysplastic syndrome, 
pressure injuries, pneumonia with sepsis 
wound 
swab 
46 N N N N Y N 
Piperacillin-tazobactam, gentamicin, 
amoxycillin-clavulanate 
CF5 male 70 
Retroperitoneal fibrosis with nephrostomy 
tube, nephrectomy, vancomycin-resistant 
Enterobacter bacteraemia  
urine 93 N N N N Y N 
Linezolid, teicoplanin, vancomycin, 
cotrimoxazole, ciprofloxacin, 
trimethoprim, ceftriaxone, cephazolin, 
cephalexin, azithromycin 
CF6 male 44 Acute myeloid leukaemia 
surveillance 
swab 
138 Y N Y N N Y 
Meropenem (14 days total), 
cotrimoxazole*, teicoplanin, piperacillin-
tazobactam 
CF7 male 72 
Cerebellar infarction, tracheostomy, 
percutaneous endoscopic gastrostomy, 
atrial fibrillation with pacemaker 
urine 123 Y Y N Y Y N 
Piperacillin-tazobactam, cotrimoxazole, 
cephazolin, cefepime, cefotaxime, 
cephalexin, roxithromycin, 
erythromycin, azithromycin, 
clindamycin, ciprofloxacin 
CF8 male 65 Multiple myeloma 
surveillance 
swab 
45 Y N N Y Y Y 
Piperacillin-tazobactam, cotrimoxazole, 
ceftazidime, cephalexin 
CF9 female 68 
Neurogenic bladder, rheumatic heart 
disease, ischaemic heart disease 
urine 0 N Y N Y Y N Possibly nitrofurantoin 
CF10 male 74 
Pneumonia with sepsis, myelodysplastic 
syndrome, upper gastrointestinal bleed, 
subdural haematoma, pulmonary fibrosis  
surveillance 
swab 
23 Y Y N Y Y Y 
Piperacillin-tazobactam, doxycycline, 
ceftriaxone, flucloxacillin, benzyl 
penicillin, azithromycin, amoxycillin- 
clavulanate 
          Median   49 days 50% 50% 30% 50% 80% 50%  
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Case 
ID 
2012 2013 2014 2015 2016 
S O  N D J F M A M J J A S O N D J F M A M J J A S O N D J F M A M J J A S O N D J F M 
CF1         x x x x x  died                                 
G*                       died                                   
C*                                                         
CF2                    x x                                   
R*                                                               
T*                                                               
CF3                x x x x x x x x x x                          
CF4                         x x x  died                    
CF5                                      x x x x x x x x x x x x x     died        
CF6
#
                                                   x x x  died                  
CF7                              x x x x x x x x x x x x x x x x x x x x x x x x x 
CF8
#
                              x  died                
CF9                                     x x x x x x x x x x x 
CF10
#
                                              x 
 
KEY x Known CPE positive   Intensive Care Unit   Haematology   Vascular/Urology   Orthopaedics 
               
  Hospital in the Home   Medical Assessment Unit   Other TCH unit   Other hospital 
   
Figure 4 Hospital admission locations of cases of carbapenemase-producing C. freundii ST8 or similar (blaIMP-4) detected by ACT Pathology, 2012-2016. 
* Patients G, C, R and T are suspected carriers, their CPE status is unknown. 
#
Patients CF6, CF8 and CF10 3 were detected via surveillance. 
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DISCUSSION 
Here we describe the epidemiology of CPE at a tertiary hospital in Canberra, Australia, 
over a four year period.  Based on WGS, local transmission can be inferred in almost 
one quarter of cases, clustered in two outbreaks each spanning over three years.  
Epidemiological and environmental data suggest that transmission occurred via 
persistence of CPE in sinks in the ICU, possibly environmental sources in the 
haematology ward, and undetected carriers or hosts without clinically significant 
disease.  
 
X 
Case CF Haematology ward 
Presumptive host/s 
Key 
Intensive care unit 
Orthopaedics ward 
Urology/Vascular ward 
Hospital in the Home 
Transmission Pathways 
Medical assessment unit 
C or 
G 
CF
1 
CF
2 
CF
3 
CF
4 
CF
7 
CF
8 
CF
9 
CF
10 
R 
CF
6 
CF
5 
T 
Figure 5 Putative transmission map for the C. freundii ST8 or similar (blaIMP-4) outbreak, the 
Canberra Hospital, 2012-2016. 
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The pairwise genetic distances between isolates in the two outbreaks were relatively 
large.  This suggests that genomic variation occurred either in intermediate 
environmental reservoirs or in patients during the often extended period between CPE 
acquisition and detection, possibly driven by antimicrobial exposure.  Sinks have been 
implicated as reservoirs in nosocomial outbreaks in Australia (3, 4) and elsewhere (13, 
17-19).  These reservoirs often persisted despite rigorous cleaning (4, 17-19).  In one 
ICU in the Netherlands, a significant reduction in colonisation with multi-drug resistant 
organisms was observed after the removal of sinks from patient rooms (20).  Recently, 
Kotay et al (21) demonstrated that when nutrients were added to a model sink system, E. 
coli could grow from the water in a sink’s P-trap both up to the sink’s strainer, but also 
to the P-traps of neighbouring sinks.  Once the organism has reached the sink strainer, 
tap water flow can disperse it up to 75cm.  The nutrients used in this experiment 
represent fluids sometimes disposed into hospital hand hygiene sinks, including 
intravenous fluids, enteral feeds, and beverages.  At TCH, the detection of P. monteilli 
containing blaIMP gene in a sink in the haematology ward suggests that Pseudomonas 
spp. in the environment could be reservoirs of CPE genes (22). 
 
Our findings are pertinent to questions of who and how to screen for CPE.  Prolonged 
and undetected carriage was an important feature, consistent with conclusions of other 
CPE outbreak investigations (15, 23).  Zimmerman et al (12) found that most patients 
with a positive CPE blaKPC culture during hospitalisation still carry CPE at least nine 
months after discharge.  Our epidemiological data indicate that concurrent admission of 
cases to the same ward was rare, so routine screening only of patients who shared a 
room or bathroom with a case would be unlikely to assist in outbreak containment.  
Although universal screening of all inpatients may not be economically justified at low 
CPE prevalence as is the case for TCH (24), screening of all ICU patients may be highly 
cost effective (25).  Faeces specimens, or rectal plus inguinal swabs also have a higher 
sensitivity than the specimens (mainly perianal swabs) collected for screening of 
contacts and ICU surveillance at TCH (26).   
 
As the occurrence of genes other than blaIMP in the 72 cases reported here can largely be 
explained by international travel, the local picture is one of a range of 
Enterobacteriaceae species containing the blaIMP-4 gene.  This is consistent with the 
epidemiology of human cases within Australia in the eastern jurisdictions of NSW, 
Queensland, and the ACT (6).  A recent study also found that blaIMP-4 
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Enterobacteriaceae were common in silver gulls (Chroicocephalus novaehollandiae) 
who fed on urban waste dumps in NSW, indicating transmission of CPE outside 
hospitals (27).  A high proportion of our outbreak cases had been admitted to interstate 
hospitals during the outbreaks, and two were discharged to RACFs, one interstate.  
Although only 7% of all cases resided in RACFs at the time of CPE specimen collection, 
it is unknown if further cases were to be discharged to RACFs after isolation.  These 
data indicate that CPE transmission is not a problem solely for tertiary hospitals, but 
also the community, and a cross-jurisdictional approach to prevention and control is 
required.   
 
We did not characterise plasmids or integrons, and therefore could not infer the 
horizontal transfer of carbapenemase-encoding plasmids between species or genera, or 
between different multilocus sequence types in the same species.  Similarly, we have 
not considered transfer beyond the Enterobacteriaceae (eg to Pseudomonas spp).  
Plasmid diffusion is a common mechanism for the spread of carbapenemases (28) and 
the dissemination of blaIMP-4 among multiple gram-negative genera in Australian 
hospitals has been demonstrated (29, 30).  If such transfers have occurred at TCH then 
we have underestimated the degree of local transmission of resistance, and may have 
missed other units of TCH on which transmission has been occurring.  Because active 
surveillance occurred over a few months in 2014 in ICU only, it is likely that 
asymptomatic carriers in other areas of the hospital, and possibly additional outbreaks, 
have been missed.  We were unable to account for cases’ admissions to other hospitals 
unless they were included in their TCH records.  
 
In this study, WGS data were a valuable addition to epidemiological correlation for 
identifying outbreaks of CPE cases.  If we had clustered cases using resistance gene 
data collected via other molecular methods (for example, by assuming all E. cloacae 
harbouring blaIMP-4 were related), our investigation would have been unproductive.  
Multilocus sequence types clarified the picture greatly.  The SNP distances between 
cases were relatively large compared with other CPE outbreaks (10, 31).  However, had 
we given them no weight we would still have reached the same conclusions on mode of 
transmission and hospital reservoirs. 
 
Epidemiological investigation and WGS have identified two prolonged CPE outbreaks, 
potentially involving environmental reservoirs and carriers undetected by routine 
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infection prevention and control investigations.  These features imply a risk of 
escalation of incidence of CPE and clinically significant disease, and increasing demand 
upon hospital infection control resources.  Efforts at TCH will need to focus on 
identifying CPE hosts to allow effective infection control practices, and on eliminating 
environmental contamination.  Achieving this aim will require the development of cost-
effective strategies for highly sensitive screening, and rapid outbreak responses using 
WGS methods that account for CPE gene transfer between Enterobacteriaceae species. 
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Transmission of Carbapenemase-producing 
Enterobacteriaceae (CPE) in a tertiary Australian hospital: 
Assessment of the utility of the Victorian CPE Guideline   
 
ABSTRACT 
OBJECTIVES 
Infection with carbapenemase-producing Enterobacteriaceae (CPE) is relatively 
uncommon in Australia currently, presenting a critical opportunity to prevent the levels 
of endemicity of this important antimicrobial resistance experienced elsewhere.  
Guidance documents have been developed for healthcare-associated CPE prevention 
and control.  We aimed to review the likely impact of guideline implementation on 
control of two retrospectively-identified CPE outbreaks at the Canberra Hospital, 
Australia.   
METHODS 
For two CPE outbreaks that we investigated, we retrospectively determined the effect of 
applying the Victorian guideline on carbapenemase-producing Enterobacteriaceae 
(2015).  The number of cases potentially prevented was estimated from epidemiological 
data.  We assumed 100% sensitivity of screening methods and of control measures.  
RESULTS 
Application of controls specified for facilities with local transmission at first CPE 
detection may have prevented all further transmission.  The controls specified for 
facilities with sporadic cases are inadequate because contact tracing is primarily limited 
to patients who shared a room or bathroom with a case in the month prior to detection.   
CONCLUSIONS 
Retrospective analysis using outbreak data permits evaluation and revision of CPE 
control guidelines.  Prevention and control measures should address prolonged CPE 
carriage, and transmission via environmental reservoirs between patients who were 
admitted to the same room or ward several months apart.  A national surveillance and 
response system to facilitate cross-jurisdictional outbreak detection and contact tracing 
would enhance outbreak detection and control.    
44 
 
INTRODUCTION 
Infection with carbapenemase-producing Enterobacteriaceae (CPE) is relatively 
uncommon in Australia, presenting a critical opportunity to prevent the levels of 
endemicity experienced elsewhere (1).  To prevent increase in incidence, guidance 
documents have been developed for healthcare-associated CPE prevention and control.  
We conducted a retrospective case series investigation of CPE detected in the Australian 
Capital Territory (ACT), using whole-genome sequencing (WGS) and epidemiological 
data [outbreak paper reference].  We found evidence of limited local transmission of 
Enterobacteriaceae carrying the metallo-β-lactamase gene blaIMP at a tertiary facility, 
the Canberra Hospital (TCH).  The two outbreaks were similar to nosocomial CPE 
outbreaks described elsewhere, with persistence of the pathogen in the hospital 
environment (2-5) and prolonged asymptomatic carriage (6, 7).   
 
There is no endorsed guideline for the prevention and control of CPE at TCH.  In late 
2015, the Victorian Government released a CPE guideline for health services, which 
recommends different screening and control measures for settings with no cases in the 
previous 12 months, with sporadic cases, or with local transmission (see Supplementary 
material) (8).  Our objectives were to evaluate whether this guideline is relevant to the 
TCH context and, if necessary, make recommendations for prevention and control of 
CPE at TCH.   
SETTING 
The Canberra Hospital is a 600-bed tertiary referral hospital for the ACT and 
surrounding region of south-east New South Wales (NSW), comprising a population of 
approximately 500,000.  Most subspecialty services are provided at TCH, including 
adult and neonatal intensive care, with the exception of solid organ and allogeneic stem 
transplantation, and paediatric cancer and intensive care services.   
METHODS 
While recognising that the guideline was not extant at the time of the two outbreaks, we 
analysed its utility for TCH in CPE case prevention by applying the requirements for 
Tier 1 (settings with sporadic cases—see the Supplementary material) and Tier 2a 
(settings with local transmission on one ward) to the transmission maps of two 
retrospectively identified outbreaks.  The epidemiological investigation and methods 
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used to create these maps have been described previously [reference to Outbreak paper].  
We assumed that both screening sensitivity and effectiveness of control measures were 
100%.   
 
Seven cases of Enterobacter cloacae complex ST24 containing blaIMP-4 were detected 
between March 2012 and May 2015.  We inferred that the E. cloacae complex ST24 
originated in the haematology ward, and was most likely transmitted to other patients in 
the outbreak via environmental reservoirs or undetected carriers in the intensive care 
unit (ICU) and the haematology and renal medicine wards ( 
Figure 6).  This is supported by four positive samples of E. cloacae complex ST24 
containing blaIMP-4 collected from hand basins in ICU, including basins in the room to 
which Patients EC3, EC4 and EC7 were admitted.  Patients 13 and M were transferred 
from TCH to residential aged care facilities.  Ten cases of Citrobacter freundii ST8 or 
ST8-like containing blaIMP-4 were detected between January 2013 and March 2016.  We 
inferred that transmission occurred primarily through undetected intermediate hosts (for 
example, Patients G, C, and R) and environmental reservoirs in the haematology ward 
and ICU ( 
Figure 7).  No environmental samples collected yielded C. freundii ST8.  Six of the 
patients in this cluster were admitted to interstate hospitals during the period of the 
outbreak.  
 
The ethical aspects of this research were approved by the ACT Health Human Research 
Ethics Committee Low Risk Sub-committee (Protocol No. ETHLR.17.042) and by the 
Australian National University Human Research Ethics Committee (Protocol No. 
2017/108).  
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Figure 6 Locations and putative transmission pathways for the E. cloacae ST24 (blaIMP-4) 
outbreak, the Canberra Hospital, 2012-2015.  Patient M is a suspected host, his CPE status is 
unknown.  Patients EC5, EC6 and EC7 were detected via surveillance. 
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Figure 7 Locations and putative transmission pathways for the C. freundii ST8 or similar (blaIMP-4) 
outbreak, the Canberra Hospital, 2013-2016.  Patients G, C, R and T are suspected hosts, their 
CPE status is unknown.  Patients CF6, CF8 and CF10 were detected via surveillance. 
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RESULTS 
The guidelines provide recommendations on data collection for suspected and 
confirmed cases of CPE.  The quality of our outbreak investigation would have been 
improved if standardised data had been collected from cases or their families at 
detection rather than retrospectively.   
The number of cases in each outbreak that could have been prevented by application of 
Tier 1 or 2a guidelines is presented in Table 6.  If the Tier 1 guidelines (see 
Supplementary material) were implemented when Patient EC1 was detected in March 
2012, environmental reservoirs in the haematology ward and ICU would not have been 
identified, and no other cases in the E. cloacae outbreak would have been detected 
through screening of room contacts.  However, asymptomatic carriers may have been 
identified by the latter, by the one-off screen of ICU patients who were in the unit on 
the night that Patient EC1’s positive specimen was collected, or by six-monthly 
screening of ICU and haematology inpatients.  It is doubtful that Patient M would have 
been identified by the last of these measures.  The Tier 1 guideline would therefore have 
been unlikely to prevent the subsequent six cases.  The identification of Patient EC2 
(405 days after the detection of Patient EC1) would have triggered escalation to Tier 2a 
(or possibly 2b, see Supplementary material) only if an intermediate carrier other than 
Patient M was identified by screening room contacts on the renal ward.  Although 
Patients EC2 and M were admitted to the ward concurrently for 34 days, they did not 
share a room or bathroom.  Identification of a carrier or carriers in addition to Patient M 
would have led to environmental sampling and weekly screening of patients in ICU and 
haematology, which may have prevented transmission to all subsequent cases in the 
outbreak.  Otherwise, Tier 2a would not have been triggered until the detection of case 
EC3 (624 days after the after the detection of Patient EC1).  Applying Tier 2a measures 
at this stage may have prevented transmission to Patients EC5, EC6 and EC7.  
If the Tier 2a guideline had been implemented upon detection of Patient EC1, 
intermediate hosts in ICU may have been detected by weekly inpatient screening and 
contact tracing, but environmental sources would only be identified after the detection 
of a related case.  At most, default application of the Tier 2a guideline could have 
prevented five of the subsequent six cases in the outbreak (all but Patient EC4), plus 
transmission to Patient M.   
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In the context of the C. freundii outbreak, implementing the Tier 1 screening of all 
haematology ward patients admitted on the night of the collection of Patient CF1’s 
CPE-positive specimen may have detected the potential case, Patient R.  However, this 
was unlikely, as Patient R had only recently been admitted to hospital at that time, and 
he may not yet have been detectably colonised.  Patients G and C would not have been 
detected.  The hospital would have escalated to a Tier 2a facility in April 2013, when 
screening of Patient EC2’s ICU contacts would have detected Patients R, C, G and T, 
and prevented the subsequent eight cases.  If the Tier 2a guideline were implemented 
when Patient CF1 was first detected, weekly screens of haematology inpatients would 
have detected Patients R, G, and C, and prevented transmission to Patient T and the 
other nine cases in the outbreak.  
 
Table 6 Maximum number of cases in two outbreaks of CPE detected at TCH that could 
possibly have been prevented by application of the Victorian guideline on CPE for Tier 1 and 
Tier 2a facilities (8). 
Outbreak Status of TCH 
Number of cases 
prevented under Tier 1 
meausres 
Number of cases 
prevented under Tier 
2a measures 
E. cloacae 
ST24 
(7 cases) 
Tier 1  
March 2012 
0 
+ no escalation to Tier 
2a for further 405 days 
5 
+ Patient M 
Tier 2a  
June 2013 (if carrier/s in 
renal ward identified) 
Not recommended 5 
Tier 2a  
December 2013  (if no 
carrier/s in renal ward 
identified) 
Not recommended 3 
C. freundii 
ST8 
(10 cases) 
Tier 1  
January 2013  
0 
+ no escalation to Tier 
2a for a further 87 
days 
9 
+ Patient T 
Tier 2a  
April 2013 
Not recommended 8 
 
DISCUSSION 
For both outbreaks, application of controls from the Victorian CPE guideline specified 
for facilities with local transmission at first CPE detection may have prevented all 
subsequent cases.  It may be prudent to treat an apparently sporadic case of CPE with 
blaIMP-4 as a marker of ongoing transmission and environmental contamination on any 
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of the units the case has been admitted to over the previous 12 months.  The controls for 
sporadic cases are inadequate because contact tracing is primarily limited to co-resident 
room contacts over a maximum period of one month.  This does not address 
transmission between patients admitted to the same room or ward several weeks or 
months apart via prolonged carriage or environmental reservoirs.  We have made a 
number of recommendations for prevention of transmission of CPE at TCH (Table 7).  
These have been adapted from the Victorian guideline and the Australian 
Recommendations for the control of carbapenemase-producing Enterobacteriaceae (1). 
 
By assuming 100% screening sensitivity and effectiveness of control measures, we have 
overestimated the effectiveness of the guideline.  To date, screening at TCH has mainly 
been conducted through perianal swabs, which have a relatively low sensitivity (1).  
Using faeces specimens for screening and surveillance is a key recommendation arising 
from this analysis (Table 7).  As reported previously, our outbreak investigations were 
limited by the WGS method used, which did not characterise the plasmids or integrons 
in the isolated bacteria.  This means we were unable to allow for transfer of 
carbapenemase genes between species, genera, or different multilocus sequence types in 
the same species.  As plasmid diffusion is a common mechanism for the spread of 
carbapenemases (9), and the dissemination of blaIMP-4 among multiple gram-negative 
genera has been demonstrated in Australian hospitals (10, 11), it is also important that a 
useful definition of ‘genetically-linked cases’ is developed for use in the TCH context.   
 
The movement of CPE cases between interstate hospitals and RACFs underscores the 
need for a national surveillance and response network for CPE in Australia.  Since 
March 2016, cases have been reportable through the National Alert System for Critical 
Antimicrobial Resistances (CARAlert), which aims to “enable a timely, responsive 
approach to preventing the spread” of CPE and other critical resistances (12).  However, 
reporting is not mandatory, and de-identification of data before state, territory and 
Australian health departments are alerted of a case limits the system’s utility for cross-
institutional or cross-jurisdictional outbreak detection and contact tracing.  In 2016, 
CPE was made a notifiable condition in Tasmania (13).  Mandatory reporting of cases 
through the National Notifiable Diseases Surveillance System, supported by WGS data, 
would facilitate the identification of outbreaks, screening of contacts and prevention of 
transmission.   
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Using outbreak data to retrospectively analyse CPE control guidelines was a successful 
method for evaluating their utility and informing their adaptation to a local context.  
International experience has demonstrated that in countries such as Australia, where 
carbapenemase resistance is rare, we need “to be alert and prepared for its emergence 
and preemptively to form centralised plans for detection and control” with “coordinated 
responses…from policy makers and public health authorities” (14).  
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Table 7 Recommended bundles for prevention and control of CPE at TCH, 2017. 
Bundle Screening Prevention and Control measures 
1 Once-off actions to 
define the status of 
CPE at TCH 
 Undertake a point prevalence survey of all TCH inpatients via 
faeces specimens. Rectal plus inguinal swabs may be taken if 
faeces specimens cannot be collected.  In addition:  
o if a wound or drain is present, a single wound or drain 
specimen is required 
o if an indwelling or supra-pubic catheter is present or the 
patient is having intermittent urinary catheterisations, a 
urine specimen is required 
o if an endotracheal tube (ETT) is present, an ETT aspirate 
is required. 
 Develop a definition of ‘genetically-linked cases’ 
 Establish a procedure for epidemiological and genetic 
review of cases 
 
2 On-going screening 
and prevention 
measures 
 On admission, screen (as for Bundle 1) and isolate all patients 
at significantly higher risk of CPE colonisation or infection, 
including those who 
o were transferred directly from an overseas hospital 
o had an overnight stay in an overseas hospital in the 
previous 12 months  
o were room contacts of CPE cases who have not achieved 
criteria for being cleared.  Room contacts are patients 
who resided overnight in a shared room (or in a separate 
room but shared a bathroom) with the case during the 
case’s period of  potential infectiousness 
o were ward contacts of CPE cases from a ward with ≥2 
genetically linked cases who have not achieved criteria 
for being cleared 
 Screen all patients in the haematology ward and intensive 
care unit (ICU) every six months 
 Screen patients on re-admission who have ever had CPE 
isolated at any point in the past, unless screening within the 
four weeks of the last admission 
 
 Conduct regular education and reminders to clinical 
staff on all units to only dispose of water and soap 
down hand-hygiene sinks 
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Bundle Screening Prevention and Control measures 
3 For all CPE cases  Screen all ward contacts back to the date of likely acquisition, 
or six months prior to the date of identification of CPE in the 
case, whichever is more recent.  This includes patients who 
have been discharged.  
 Screen all patients who subsequently resided in the room/s 
occupied by the case in the period between the date of likely 
acquisition and detection 
 
 Collect standardised data on the case’s history of travel, 
hospitalisation, medical/surgical procedures and 
antimicrobial use 
 Place in a single room with ensuite bathroom  
 Place under contact precautions 
 Place an alert on the case’s file 
 Limit bed transfers within TCH 
 Cleaning and disinfection (with an agent registered with 
the Therapeutic Goods Administration)  
o daily for the case’s room, medical devices and 
equipment 
o twice daily for the case’s bathroom/sink,  
frequently touched surfaces and equipment 
 If the case is transferred out of TCH, advise the 
receiving health service to place the case under contact 
precautions  
 Notify the receiving health service/CARAlert* 
representative to ensure alerts are placed within that 
health service’s system  
 Upon discharge, clean case’s room using no-touch 
methods (e.g. ultraviolet (UV-C) or hydrogen peroxide 
vapour)  
 
*National Alert System for Critical Antimicrobial Resistances 
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Bundle Screening Prevention and Control measures 
4 
 
 
 
 
 
 
Upon detection of 
≥2 genetically 
linked cases (see 
Bundle 1) 
 
 
 Implement Bundle 3 actions (cohorting may be appropriate) 
 Conduct weekly screens of all patients on wards that each 
case was admitted to for longer than one week in the 
previous 12 months  
 Conduct environmental screening on the wards that the case 
was admitted to in the previous 12 months: 
o all sinks in ICU 
o all bathrooms used by the case on other wards. 
 Continue with this bundle until there are at least four 
consecutive weeks of negative screens 
 
 Conduct weekly audits of infection control processes 
on wards that the cases were admitted to for longer 
than one week in the previous 12 months 
 
5 Upon detection of a 
positive 
environmental 
sample 
 Screen all patients on the ward weekly  
 Screen the contaminated element weekly, after cleaning 
 Continue with this bundle until there are at least four 
consecutive weeks of negative screens 
 Clean the contaminated element daily using no-touch 
methods (e.g. ultraviolet (UV-C) or hydrogen peroxide 
vapour) 
 Conduct weekly audits of infection control processes 
on the ward 
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SUPPLEMENTARY MATERIAL 
Summary of screening and infection control measures from the Victorian guideline on 
carbapenemase-producing Enterobacteriaceae, 2015 (8).  
Facility 
Status 
Screening  Control measures 
Tier 0 
Settings with 
no cases 
 
Screen all patients in all haematology wards, intensive care 
units and transplant wards every six months as a part of a 
point prevalence study 
Screen patients on re-admission who have ever had CPE 
isolated at any point in the past, unless screening within 
the four weeks prior to admission 
On admission, screen and isolate all patients at 
significantly higher risk of CPE colonisation or infection, 
including  
 direct transfer from an overseas hospital 
 overnight stay in an overseas hospital in the previous 12 
months  
 room contacts* of CPE cases who have not achieved 
criteria for being cleared.   
 ward contacts
†
 of CPE cases from a unit with local 
transmission
‡
 who have not achieved criteria for being 
cleared 
No environmental screening is recommended 
All patients at significantly higher risk 
of CPE colonisation or infection 
should be placed in contact 
precautions until cleared 
Tier 1 
Settings with 
sporadic 
cases 
 
As for Tier 0 above 
Screen room contacts* of sporadic cases back to the date 
of likely acquisition, or one month prior to the date of 
identification of CPE in the case, whichever is more recent.  
For cases with an elevated risk of onwards transmission 
(see definition in Tier 0), screen all room contacts back to 
the date of likely acquisition, or six months prior to the 
date of identification of CPE in the case, whichever is more 
recent.   
Undertake a single one-off screen of all patients who 
resided overnight on the ward at the same time of a 
sporadic case being identified who has an elevated risk of 
onwards transmission (including patients admitted to ICU, 
malignant haematology patients; patients with a urinary 
catheter, copious/uncontained wound drainage, 
respiratory secretions or urine; or patients with diarrhoea, 
intestinal stoma or colorectal procedure/surgery) 
Environmental screening is not generally required 
As for Tier 0 
Apply contact precautions to all 
suspected cases until cleared 
Apply contact precautions to all 
room contacts
1
 until cleared 
Daily cleaning and disinfection of 
case’s room and bathroom; twice 
daily disinfection of frequently 
touched surfaces and equipment 
Terminal room cleaning on discharge 
of the case 
Hand hygiene and personal 
protective equipment audits 
Use objective methods for auditing 
cleaning  eg fluorescent gel markers 
* Room contact: a person who resided overnight in a shared room (or in a separate room but shared a bathroom) 
with the case during the case’s period of potential infectiousness. 
†
 Ward contact: a person who resided overnight in a ward with local transmission before that ward has returned 
four consecutive negative point prevalence screens spaced at least a week apart. 
‡
 Criteria for local transmission: two or more confirmed cases of genetically-related CPE; and at least one case is 
locally acquired; and there is a plausible epidemiological connection between the two cases, either through 
geographic proximity or shared staff, equipment or other exposures. 
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Facility 
Status 
Screening  Control measures 
Tier 2a 
Settings with 
local 
transmission
‡
 
in a single 
ward or unit 
in the 
previous 12 
months 
 
As for Tier 0 and Tier 1 above 
Screen all patients in the unit each week until there are at 
least four consecutive weeks of negative screens  
Ensure that all ward contacts
†
 are screened within the seven 
days prior to transfer to another health service and are 
negative, otherwise the health service receiving the patient 
must ensure the patient is placed in contact precautions until 
cleared 
Ensure that all discharged ward contacts have alerts placed 
on their medical record so they are placed into contact 
precautions and screened if readmitted within the next 12 
months 
Environmental screening should be undertaken to identify an 
environmental reservoir of CPE when there is local 
transmission on a ward/setting where cases were not always 
cared for in a shared room or with a shared bathroom 
Endoscopes should be screened / microbiologically tested if 
more than one patient with confirmed CPE is found to have 
had a common exposure to an endoscope 
 
As for Tier 1 
Cohorting of same genotype CPE 
infected or colonised patients can 
be considered 
Cohorting is appropriate while 
room contacts are being screened 
Daily cleaning and disinfection of 
the ward; twice daily disinfection 
of frequently touched surfaces 
and equipment 
Consider the use of no-touch 
methods for terminal disinfection 
(eg hydrogen peroxide vapour) 
Monthly audits of infection 
control measures 
 
Tier 2b 
Settings with 
local 
transmission
‡
 
in two or 
more  wards 
or units in the 
previous 12 
months 
Follow Tier 2a guideline above 
 
Additional control measures should be considered, for example 
 daily or weekly audits of infection control processes 
 wider or more frequent screening measures 
 the establishment of a dedicated ward or wing for suspected 
and confirmed cases 
 
 
* Room contact: a person who resided overnight in a shared room (or in a separate room but shared a bathroom) 
with the case during the case’s period of potential infectiousness. 
†
 Ward contact: a person who resided overnight in a ward with local transmission before that ward has returned 
four consecutive negative point prevalence screens spaced at least a week apart. 
‡
 Criteria for local transmission: two or more confirmed cases of genetically-related CPE; and at least one case is 
locally acquired; and there is a plausible epidemiological connection between the two cases, either through 
geographic proximity or shared staff, equipment or other exposures. 
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CHAPTER 3 – DETERMINANTS OF SOCIAL AND 
EMOTIONAL WELLBEING IN ABORIGINAL AND 
TORRES STRAIT ISLANDER CHILDREN: RESULTS 
FROM THE FOOTPRINTS IN TIME STUDY 
 
 
 
 
 
 
We all need to recognise that children’s sense of themselves as 
Aboriginal people—who they are and where they come from—is of 
both practical and spiritual value.  In bestowing identity we also 
bestow dignity.  It is a good deal more than symbolic—it has 
profound practical effects. 
 
Professor Mick Dodson 
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Prologue 
 
This project was proposed by my first placement supervisor, Dr Annie Dullow, who 
wanted to answer a policy question about determinants of social and emotional 
wellbeing (SEWB) in early childhood.  She wanted to take a social determinants 
perspective and include protective factors, and knew that the Longitudinal Study of 
Indigenous Children (LSIC) was a rich and under-utilised source of data.  We 
participated in two teleconferences with officers from the Department of Social Services 
(DSS, who are the custodians of the LSIC data), the Australian Institute of Health and 
Welfare, and the Department of Prime Minister and Cabinet (PMC) to discuss planned 
departmental projects using the LSIC data and ensure they would be complementary.   
 
MY ROLE 
For this project, I 
 developed the proposal and the data analysis plan 
 applied for access to the LSIC data 
 developed the ethics application 
 cleaned, recoded and analysed the data 
 presented the preliminary results to the Indigenous Health Divisional Forum 
(Department of Health, see Appendix 3.1) and at the Australian Longitudinal 
Data Conference 2016 (Appendix 3.2). 
 drafted the thesis chapter 
 drafted the article for submission to the Family Matters journal (Appendix 3.3)1. 
 
My academic supervisor, David Harley, provided excellent feedback and guidance, 
particularly during the planning and writing stages.  
 
LESSONS LEARNT 
There is a massive amount of data collected by the LSIC: it would be easy to drown in it.  
I’m grateful to Martyn Kirk, who recommended a book at the MAE courseblock called 
                                                 
 
1
 This article has been accepted for publication in Family Matters, Issue 100, 2018.  
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The workflow of data analysis using Stata
2
.  It recommends techniques for planning, 
documenting and organising work that increased my efficiency, and surely saved me 
many hours of pain.  I used these techniques in all my Stata projects.   
 
For this project I used Principal Component Analysis (PCA).  As I spent so long 
working out how to do it, it became the topic for my Lesson from the Field.  I rushed to 
submit a conference abstract not long after completing my first analysis of the data, in 
which the PCA had been unsuccessful.  It was not until after presenting the results to 
my Division and at the conference that I checked my analysis and found an error in the 
Stata code.  Once this was fixed, I could successfully perform PCA on the outcome 
variables.  I learnt a valuable lesson about checking and rechecking my analyses.   
 
PUBLIC HEALTH IMPACT 
The equivocal results of the analysis limited the potential impact of this project.  
However, I have emphasised the main conclusion of the study: that those in policy 
development and program planning and management need to be mindful that using 
flawed measures can adversely affect decision making.  Following my conference 
presentation, my slides were requested by an LSIC officer, who forwarded them to the 
Steering Committee members and policy areas for use in discussions about content 
development. 
 
ACKNOWLEDGEMENTS 
I am grateful to the families who participated in the Longitudinal Study of Indigenous 
Children, and the Indigenous Research Administration Officers who work so hard to 
maintain relationships with the families and collect the data.  I would also like thank 
 Dr Annie Dullow, who posed the policy question that led to this research, and 
gave guidance and encouragement early in the project 
 Kirrily Harrison (PMC), who suggested developing an index of cultural 
connection 
 Professor Tom Calma and Menessia Nagie (Department of Health) with whom I 
discussed the SEWB conceptual model 
                                                 
 
2
 Long, J.S., College Station, Texas: Stata Press; 2009. 
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 Dr Katherine Thurber (National Centre for Epidemiology and Population Health, 
NCEPH), who gave advice about using LSIC data 
 Dr Alice Richardson (NCEPH), who gave statistical advice 
 Dr Liana Leach (NCEPH), who gave advice about the study design 
 Fiona Skelton, Laura Bennetts-Kneebone and Debora Kikkawa (DSS), who gave 
helpful feedback on the data analysis plan 
 my colleagues at my field placement, Sam Siripol and Amy Burroughs (MAE 
scholars), who gave feedback on my conference presentation. 
 
 
DISCLAIMER 
This chapter uses unit record data from the LSIC.  The Longitudinal Study of 
Indigenous Children was initiated and is funded and managed by the Australian 
Government Department of Social Services.  The findings and views reported in this 
paper, however, are those of the author and should not be attributed to DSS or the 
Indigenous people and their communities involved in the study. 
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Abstract 
BACKGROUND 
Social and emotional development is an important factor in a child’s readiness to 
participate in school-based learning.  Understanding the determinants of social and 
emotional wellbeing (SEWB) in Aboriginal and Torres Strait Islander children will help 
to direct policy and investment in child and maternal health.  Social and emotional 
wellbeing is a positive, holistic and culturally-specific concept that is not captured by 
Western mental health instruments.  I aimed to identify factors antenatally and in the 
first two years of life associated with SEWB in children at the time of starting school.  
A secondary purpose was to develop a more useful indicator of SEWB. 
 
METHODS 
I selected a sample of children from the Longitudinal Study of Indigenous Children 
(LSIC) who were aged two years or under at Wave 1, or who entered in Wave 2 aged 
three years or under.  I developed a conceptual framework to represent SEWB in 
Aboriginal and Torres Strait Islander children and guide the selection of outcome 
measures from Waves 5 and 6, around the time of starting school.  Children’s prosocial 
behaviour and mental health were measured using the two Strengths and Difficulties 
Questionnaire (SDQ) subscale scores.  I used Principal Component Analysis (PCA) to 
reduce a number of outcome measures (SDQ Prosocial Behaviours score, a measure of 
the primary carer’s SEW; and questions about connection of the child and family to 
community, culture, ancestry, spirituality and country) to a new index of SEWB.  I 
selected early life exposure variables from Waves 1 or 2 based upon factors found by 
previous studies to be associated with SDQ scores, factors that have a biologically or 
socially plausible link to SDQ scores, and factors that reflect the activities or intended 
outcomes of maternal and child health services.  I used PCA to reduce the number of 
exposure variables.  I incorporated exposures with a p value of 0.25 or less from the 
univariable analyses into linear and ordinal regression models, as appropriate. 
 
RESULTS  
There were 726 children included in the analysis.  Children of eligible age who were 
excluded because they did not have a SDQ Prosocial Score at Wave 5 or 6 were more 
likely to be low birthweight, have a young, unemployed primary carer, to have a mother 
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who smoked while pregnant, and to live in a remote or very remote area.  Exposure 
variable data were not suitable for reduction by PCA.  Three principal components 
(“Child’s connection”, “Child’s helping, sharing and mental health”, and “Primary 
carer’s SEWB factors”) were generated from the outcome measures.  Higher household 
occupancy and exposure to fewer major life events were associated with a poorer 
“Child’s helping, sharing and mental health” score (adjusted effect size coefficients -
0.33, 95% CI -0.63–-0.03, p= 0.03; -0.29, -0.54–-0.04, 0.02, respectively), and a poorer 
score for “Primary carer’s SEWB factors” (-0.26, -0.47– -0.53, 0.02; -0.28, -0.47–-0.10, 
0.003, respectively).  However, more people in the household and exposure to more 
events were weakly associated with greater “Child’s connection” to community, culture 
and country (0.09, 0.01–0.16, 0.03; 0.06, 0.001–0.12, 0.05, respectively).  None of the 
early life exposures was associated with prosocial behaviours.  Greater social, emotional 
and behavioural competence as an infant or toddler predicted better outcomes at school 
commencement.   
 
CONCLUSIONS 
The prominence of life events and household occupancy in this analysis lends weight to 
social determinants theory and holistic, trans-portfolio approaches for promoting SEWB 
in Aboriginal and Torres Strait Islander children.  I could not create a single index for 
SEWB using variables from the LSIC.  Those seeking evidence to support SEWB 
policy development, program planning and evaluation must be cautious in applying 
Western biomedical health and wellbeing measures to Indigenous concepts and states.  
Communities should be supported to develop their own measures of wellbeing that 
privilege Indigenous ways of knowing and being.   
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Background 
 
SOCIAL AND EMOTIONAL DEVELOPMENT AND SCHOOL READINESS 
Optimising the mental health and wellbeing of all Aboriginal and Torres Strait Islander 
people is a key priority in the National Aboriginal and Torres Strait Islander Health Plan 
2013-2023 (1).  In this plan, social and emotional wellbeing (SEWB) is seen as a 
“central platform for prevention and clinical care”.  Furthermore, social and emotional 
development—together with cognition and general knowledge, language development, 
and physical wellbeing—is an important factor in children’s readiness to participate in 
school-based learning experiences (2).  Parents’ most commonly reported hope for their 
children in the Longitudinal Study of Indigenous Children (LSIC—also known as 
Footprints in Time) is a good education (3), meaning at least school completion to Year 
12, the final year of high school (4).  Although the Year 12 retention rate for Aboriginal 
and Torres Strait Islander students has nearly doubled since the late 1990s, it was still 
only at 60% in 2014 (5).  As a smooth transition to school predicts school completion 
(6), optimising SEWB in early childhood could contribute to improving the rate of 
school completion and its attendant benefits.    
 
Through the Indigenous Australians’ Health Programme, the Australian Government 
invests in the Better Start to Life (BSTL) approach.  This approach involves the 
expansion of maternal, child and family health programs that support Aboriginal and 
Torres Strait Islander families and early childhood development to ensure children are 
ready to learn when they start school.  Currently, there are two programs under the 
BSTL approach: the New Directions Mothers and Babies Services, and the Australian 
Nurse-Family Partnership program (Figure 1).  To guide programs such as these, it is 
important to understand the nature and determinants of social and emotional wellbeing 
(SEWB) of Aboriginal and Torres Strait Islander children.  
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Figure 8  Program logic for the Better Start to Life approach.
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SOCIAL AND EMOTIONAL WELLBEING IN ABORIGINAL AND TORRES STRAIT ISLANDER 
CHILDREN 
Social and emotional wellbeing is central to the holistic view of health held by 
Aboriginal and Torres Strait Islander people (7).  Social and emotional wellbeing is a 
much broader concept than Western understandings of mental health and resilience.  
Rather, the wellbeing of the individual is  
…intimately associated with collective wellbeing, It involves harmony 
in social relationships, in spiritual relationships and in the 
fundamental relationship with the land and other aspects of the 
physical environment (8).   
Social and emotional wellbeing is a positive concept which recognises these 
relationships as strengths, and goes beyond the absence of mental ill-health (9).  The 
individual wellbeing of a child is nested within family and community wellbeing; with 
deep connections to ancestry, culture, spirituality and country; and with mental health 
part of, but not central to, the individual SEWB of the child (Figure 9). 
 
Limited quantitative studies indicate that Aboriginal and Torres Strait Islander children 
have significantly higher rates of social and emotional difficulties, mental health 
problems and psychological distress than non-Indigenous children (10-12).  This 
disparity is apparent by three years of age (13).  However, as discussed below, the 
measurement of these health states is not straightforward, 
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Figure 9 Conceptual framework for social and emotional wellbeing (SEWB) of Aboriginal and 
Torres Strait Islander children. 
 
MEASURING CHILDREN’S SOCIAL AND EMOTIONAL WELLBEING 
Mental health assessment tools used in non-Indigenous Australians do not reflect the 
broader concept of social and emotional wellbeing (9).  Normal behaviour is culturally 
constructed, and tools may not account for Aboriginal and Torres Strait Islander societal 
norms or language (14).  In recognition of this, a SEWB module was developed to 
collect national data for adults in the 2004–05 National Aboriginal and Torres Strait 
Islander Health Survey (15).  The module consists of eight domains reflecting a holistic 
view of social and emotional wellbeing, but it is not designed for use in children.  
Strong Souls is a 25-item tool developed for a longitudinal study of Aboriginal and 
Torres Strait Islander adolescents “with the help of these young people themselves” (16). 
It assesses four aspects of SEWB, anxiety, depression, suicide risk, and resilience.  The 
tool was found to be valid, reliable and culturally-appropriate for SEWB screening in 
people aged 16 to 19 years in over 70 urban, rural, and remote communities across the 
Northern Territory (16).  However, its usefulness in other Aboriginal and Torres Strait 
Islander communities and age groups has not been assessed.   
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All children in the Footprints in Time study are assessed using the standard version of 
the Strengths and Difficulties Questionnaire (SDQ).  This 25-item questionnaire was 
designed to assess the “psychological adjustment” of children aged three to 16 years, 
and can be completed by parents, carers, teachers, or the child or adolescent (17).  The 
SDQ consists of five scales which score emotional symptoms, conduct problems, 
hyperactivity-inattention, peer problems, and prosocial behaviour (Table 8).  The first 
four scales are summed to generate a Total Difficulties Score, with a higher score 
indicating more difficulty.  The fifth scale is summed to generate a Prosocial 
Behaviours score, with a higher score indicating better behaviours.  The items and their 
groupings were selected based on their relationship to categories of mental disorders 
(17).  Risk groupings for emotional or behavioural problems based on Total Difficulties 
scores are defined as “close to average” (0-13), “slightly raised” (14-16), “high” (17-19) 
and “very high”(above 19) (18).  Hawes and Dadds (19) confirmed that the SDQ, when 
administered using the parent-report form, has sound psychometric properties for 
Australian children aged four to nine years.   
 
  
 73 
 
Table 8 The Strengths and Difficulties Questionnaire (SDQ) items, with scoring, for completion 
by the child’s parent, carer or teacher (20). 
 Score  
 
Not True 
Somewhat 
True 
Certainly 
True 
Emotional Symptoms Scale    
 Often complains of headaches, stomach aches or sickness  0 1 2 
 Many worries or often seems worried  0 1 2 
 Often unhappy, depressed or tearful 0 1 2 
 Nervous or clingy in new situations, easily loses confidence 0 1 2 
 Many fears, easily scared  0 1 2 
Conduct problems Scale    
 Often loses temper  0 1 2 
 Generally well behaved, usually does what adults request 2 1 0 
 Often fights with other children or bullies them 0 1 2 
 Often lies or cheats 0 1 2 
 Steals from home, school or elsewhere  0 1 2 
Hyperactivity scale    
 Restless, overactive, cannot stay still for long  0 1 2 
 Constantly fidgeting or squirming  0 1 2 
 Easily distracted, concentration wanders 0 1 2 
 Thinks things out before acting 2 1 0 
 Good attention span, sees chores or homework through to 
the end  
2 1 0 
Peer Problems Scale    
 Rather solitary, prefers to play alone 0 1 2 
 Has at least one good friend 2 1 0 
 Generally liked by other children  2 1 0 
 Picked on or bullied by other children  0 1 2 
 Gets on better with adults than with other children  0 1 2 
Summed to generate the Total Difficulties Score*: ___ / 40 
    
Prosocial Scale     
 Considerate of other people’s feelings  0 1 2 
 Shares readily with other children, for example, toys, treats, 
pencils 
0 1 2 
 Helpful if someone is hurt, upset or feeling ill  0 1 2 
 Kind to younger children  0 1 2 
 Often volunteers to help others (parents, teachers, other 
children) 
0 1 2 
Summed to generate the Prosocial Behaviours Score†: ___ / 10 
*A higher score indicates greater difficulties 
† A higher score indicates greater prosocial behaviours 
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Zubrick and others (21) tested the reliability of a modified SDQ for Aboriginal children 
across Western Australia and concluded that, with some changes to the wording of 
response categories, it was “a reasonable measure of mental health and well-being” in 
this population.  However, the SDQ does not reflect the importance of relationships 
inherent in the concept of SEWB.  Parents, researchers, youth workers and health 
workers in a study based in Aboriginal communities in Sydney indicated that the 
standard SDQ was acceptable as a measure of mental health, but it does not assess 
“connection to or relationship with extended family, Aboriginal identity, feeling that 
you are accepted by and belong to an Aboriginal community, and the impact and 
experience of racism” (20).  The Total Difficulties score of the SDQ has been used as a 
measure of SEWB in several studies of Aboriginal and Torres Strait Islander children, 
including studies using LSIC data (10, 12, 22-24), but includes only deficit-focused 
subscales.  However, work by Williamson et al. (20) indicates that the Prosocial 
Behaviours scale of the SDQ, which has not been explored by these previous studies, 
provides information about an Aboriginal child’s relationship with their family that is 
central to SEWB. 
 
Using data from the Australian Early Development Census, Goldfield et al. (25) 
developed a measure of “mental health competence” that has a strong positive 
association with the SDQ Prosocial Behaviours scale, and an inverse relationship with 
the Peer Problems scale.  Although it has been used to investigate the epidemiology of 
positive mental health for all Australian children at school entry, the extent to which this 
competence measure reflects values and norms of child mental health held by 
Indigenous communities is uncertain (26). The Brief Infant Toddler Social Emotional 
Assessment (BITSEA) tool is designed for use in screening children aged 12 to 36 
months for social-emotional and behavioural problems and delays in competence (27).  
Whilst it has been used to assess social and emotional wellbeing in Aboriginal and 
Torres Strait Islander children (13), including the younger cohort of LSIC children (28), 
it has not been validated for this population and does not prima facie encompass the full 
breadth of the concept of SEWB.   
 
PURPOSE OF THIS STUDY AND RESEARCH QUESTIONS 
My principal purpose was to provide guidance to policy makers and program 
managers—particularly those working in the area of maternal and child health—
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regarding interventions and approaches that will promote SEWB and thus school 
readiness for Aboriginal and Torres Strait Islander children.  A secondary purpose was 
to attempt to develop a new indicator of SEWB for Aboriginal and Torres Strait 
Islander children. 
 
My research question was, which factors, antenatal to age two years, are associated with 
SEWB and prosocial behaviours and protect against social and emotional difficulties in 
Aboriginal and Torres Strait Islander children at the time of starting school?  Families 
generally have the most contact with maternal and child health services antenatally and 
in the first two years of life when the majority of childhood immunisations and health 
and development checks are delivered.  To answer this question, I undertook an 
exploratory analysis of data from the LSIC.  Previous analyses of the LSIC dataset have 
aimed to identify the risk factors for poor mental health from cross-sectional analyses.  
Instead, I analysed these data longitudinally to identify factors potentially protective for 
SEWB. 
 
ACKNOWLEDGING MY RESEARCH STANDPOINT 
Licensed users of the LSIC data are required to openly acknowledge their research 
standpoint in reports or publications (29).  I am a non-Indigenous Australian with a 
privileged, middle-class background.  I was educated at a private school and studied 
environmental science and nursing.  It was while nursing in rural and remote emergency 
and primary care that I became interested in Aboriginal and Torres Strait Islander health.  
I felt that many of the illnesses and injuries I assessed and managed were preventable 
and I worried about sending people home to the same conditions that made them unwell.  
I felt ashamed that there was such inequity in my own country.  Undertaking a Master in 
Public Health opened my eyes to the social determinants of health and the structural 
inequities creating and sustaining poor health.  Following Pyett, Waples-Crowe and van 
der Sterren (30), in this study I have attempted to interpret the data through a strengths-
based lens and challenge the deficit model of Aboriginal and Torres Strait Islander 
health.  Also, by recognising and favouring Indigenous understandings of SEWB, I have 
used a decolonising approach. 
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Methods 
STUDY DESIGN 
The Longitudinal Study of Indigenous Children is a prospective cohort study. 
DATA SOURCE 
I obtained a Deed of Licence to access LSIC data.  The Department of Families, 
Housing, Community Services and Indigenous Affairs (now the  Department of Social 
Services) initiated the LSIC in 2003, with the aim of improving “the understanding of, 
and policy response to, the diverse circumstances faced by Aboriginal and Torres Strait 
Islander children, their families and communities” (1).  The LSIC team has collected 
data yearly since 2008 (Wave 1).  Important features of the LSIC include extensive and 
ongoing community engagement and consultation, and leadership from a steering 
committee with a majority of Aboriginal and Torres Strait Islander members (31). 
 
SAMPLE 
The study employed a non-random purposive sampling technique, in which Centrelink 
and Medicare records were used to identify Aboriginal and Torres Strait Islander 
children and their families living in areas clustered around 11 sampling sites (Figure 10) 
(31).  These sites were chosen to broadly represent the range of urban, regional and 
remote settings in which Aboriginal and Torres Strait Islander children live.  Families 
were approached to participate by Indigenous Research Administration Officers (RAOs), 
who also identified eligible children through word-of-mouth and local knowledge.  
Children targeted for selection were in two age groups at baseline in 2008: between six 
months and two and a half years of age; and between three and a half and five years of 
age.  In Wave 2 in 2009, additional children were enrolled in order to “maintain the 
viability of the sample in remote regions and meet the requests of a small number of 
families who expressed a strong wish to be part of the study” (32). 
 
For this analysis eligibility criteria were (Figure 10): 
 children who were aged two years or under at Wave 1;  
 children who entered in Wave 2 aged three years or under; and  
 children for whom a SDQ Prosocial Behaviours score could be calculated at 
Wave 6 (or at Wave 5 if there was no score available for Wave 6). 
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LSIC cohort 
selection 
 
Study sample selection 
 
Figure 10 Procedure for selecting the LSIC cohort (31) and the sample for this study. 
 
MEASURES 
OUTCOMES 
Children’s prosocial behaviour and emotional and behavioural difficulties were 
measured using SDQ subscale scores, as assessed by the primary carer at Wave 6.  If 
these scores were missing, scores obtained from the child’s teacher assessment in Wave 
5 were used.  I analysed the Prosocial Behaviours score and the Total Difficulties score 
as categorical and continuous variables, respectively. 
 
To answer the secondary research question, I selected variables from the LSIC dataset 
that most closely reflected other facets of SEWB, as identified in the conceptual 
framework.  As a surrogate measure of family wellbeing, I summed the raw values for 
seven questions which were used to assess the primary carer’s SEWB in interviews with 
Sampling 
sites 
selected 
•  11 sites, based on 
communities' interest 
in participating 
•  urban, regional & 
remote locations  
Children 
identified 
•  Children aged 0.5-2.5 years & 
3.5-5 years 
•  Purposive sampling: 
•   Centrelink & Medicare 
records 
•   word-of-mouth 
•   local knowledge 
Families 
approached 
& consented 
•  recruitment by 
Indigenous 
Research 
Administration 
Officers 
Study 
sample 
selected 
• aged ≤2 years 
at Wave 1 
• aged ≤3 years 
at Wave 2  
• with SDQ 
scores 
collected at 
Wave 5 or 6 
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RAOs in Wave 6, as described by Kikkawa (33).  These were adapted by the LSIC team 
from questions developed for the Strong Souls tool (16), and for this analysis, a higher 
total primary carer’s SEWB score indicates better SEWB.  I chose five additional 
variables to indicate the connection of child and family to community, culture, ancestry, 
spirituality and country.  These variables were primary carers’ answers to questions 
(‘connection questions’) asked in interviews with RAOs in Waves 4, 5 and 6 (Table 9). 
These questions have not been assessed for validity or reliability.  Therefore, aspects of 
SEWB beyond individual wellbeing are not well captured.  There was no available 
variable that assessed spirituality, for example, and although primary carers were asked 
about the child’s connection to country no assessment was made of the child’s access to 
or health of that country.  The relationship between the outcome measures and the 
SEWB conceptual framework is shown in Figure 11.   
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Table 9 List of Primary carer SEWB and Connection Questions, with response options and data 
collection wave included in this analysis.  
Group Question wording Values Wave 
SEWB of 
primary carer 
(‘Strong Souls 
questions’) 
In the last three months, have you stopped liking 
things that used to be fun? (Don’t want to go 
fishing; don’t want to hang out with your 
mates?) 
Lots ; Fair bit;  
Little bit; Never 
 
6 
In the last three months, have you felt like 
everything is hard work (even little jobs are too 
much)? Felt too lazy to do anything? 
In the last three months, have you felt so 
worried your stomach (tummy) has got upset? 
Big worries make you sick. 
In the last three months, have you felt so 
worried that you had trouble breathing? 
In the last three months, do you get angry or 
wild real quick? 
Lots of times; Fair 
bit; Sometimes; Not 
much (or never) 
 
In the last three months, have you felt so sad 
that nothing could cheer you up? Not even your 
friends make you feel better. 
In the last three months, do you do silly things 
without thinking that you feel shame about the 
next day? 
‘Connection 
questions’ 
asked of 
primary carer 
How many days per week does [child’s name] 
spend time with Aboriginal/Torres Strait 
Islander/Aboriginal and Torres Strait Islander 
leaders or elders in your community? 
Every day; 5 to 6 
days per week; 2 to 4 
days per week; Once 
per week; Less than 
once per week; 
Never 
5 
What sort of activities does [child’s name] do 
with you or other family members to learn 
about Aboriginal/Torres Strait Islander/ 
Aboriginal and Torres Strait Islander culture? 
Please specify; None 
 
5 
I want you to pick a number between zero and 
ten that indicates your level of satisfaction 
with…feeling part of your local community?  
0-10 
Higher number 
indicates greater 
satisfaction 
5 
Do you identify [child’s name] with a tribal 
group, a language group or a clan? 
Yes; No 4 
Does [child’s name] have a connection to 
country or place? 
Yes; No 4 
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Figure 11 The relationship between the outcome measures and the SEWB conceptual 
framework. 
 
 
EXPOSURES 
I selected exposure variables based upon factors found by previous studies to be 
associated with SDQ scores, factors that have a biologically or socially plausible link to 
SDQ scores, and factors that reflect the activities or intended outcomes of maternal and 
child health services.  These are broadly categorised as: 
 child characteristics (including intrauterine risk factors) 
 characteristics of the primary carer 
 parenting and care  
 home life and events 
 intergenerational trauma and racism 
 macro-level socio-economic indicators. 
Most of these exposure data were obtained by the LSIC team through interviews with 
primary carers at Wave 1.  Other than checking the family-held birth record for 
birthweight, the LSIC does not directly collect any clinical measures or conduct clinical 
record review. 
 
The two macro-level socio-economic indicators I included in the analysis were derived 
from the child’s home address by the LSIC team.  The Index of Relative Indigenous 
Socio-Economic Outcomes (IRISEO) is a relative ranking of Indigenous Areas based on 
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nine measures of employment, education and housing, calculated from 2001 and 2006 
Census data (34).  The Level of Relative Isolation (LORI) measure was developed for 
the Western Australian Aboriginal Child Health Survey (WAACHS) to represent 
geographic isolation from basic services (35), and in the LSIC has been grouped into 
four categories (none; low; moderate; and high or extreme isolation) (28). 
 
I used data from Wave 2 for children who entered at Wave 2, and for children who 
entered in Wave 1 but were missing data.  Data regarding family experience of racism 
was only collected in Wave 3.  I recoded variables to emphasise the positive behaviour 
or favourable circumstance, in line with the strengths-based approach of this study.  
Details of the exposure variables are presented in Table 10.  Figure 12 shows an 
overview of the temporal relationship between the exposure and outcome variables for 
the children in the sample. 
 
 
 
 
Figure 12 Temporal relationship between the exposure and outcome variables for the children in the 
sample. 
2007 2008  2009 2010 2011 2012 2013 2014 2015 
Exposures 
Wave 1 
Outcomes 
Wave 6 
Birth 
Starting 
School 
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Table 10 Description and coding details for LSIC variables included as exposures in the Principal Component Analysis (PCA) and univariable analysis. 
Variable Description/ LSIC Interview question wording (28) Values and recoding details Wave/s‡ PCA? Univariable 
analysis? 
Mother received 
first antenatal visit 
< 20 weeks 
gestation 
How far along [in weeks] [were you/was she] in 
[your/her] pregnancy when [you/she] had [your/her] 
first check-up? 
Yes= <20 weeks 
No=≥ 20 weeks 
 
1 or 2 
  
Mother did not 
drink alcohol 
during pregnancy 
After finding out you were pregnant with [child’s name] 
did you drink any alcohol during the pregnancy? 
Yes/No 
[coding reversed to positive] 
1 or 2 
  
Mother did not 
smoke during 
pregnancy 
After finding out you were pregnant with [child’s name] 
did you smoke any cigarettes during the pregnancy? 
Yes/No 
[coding reversed to positive] 
1 or 2 
  
Mother did not use 
any substances 
during pregnancy 
We aren't after any details here, but after finding out 
you were pregnant with [child’s name] did you use any 
other substances like smoking marijuana, drinking 
kava, sniffing petrol, or taking any illicit drugs during 
the pregnancy? 
Yes/No 
[coding reversed to positive] 
1 and 2 
  
Child born at full 
term gestation 
How many weeks pregnant [were you/was the birth 
mother] when [child’s name] was born? 
IF RESPONDENT CAN’T REMEMBER, ASK: Do you 
remember how many weeks early or late you were 
when [child’s name] was born? 
Yes = 37-42 weeks 
No=<37 or >42 weeks 
1 or 2 
  
Low birth weight Can you read out the birth weight from the record 
book? How much did [child’s name] weigh at birth? 
If the baby health book is available they are asked to read 
the weight, otherwise they are asked to recall the weight. 
Yes=  <2500g  
No = ≥ 2500g 
 
1 or 2 
  
                                                 
 
‡
 Wave 1 data used unless missing or not collected in that wave 
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Variable Description/ LSIC Interview question wording (28) Values and recoding details Wave/s‡ PCA? Univariable 
analysis? 
Child was ever 
breastfed 
Was [child’s name] ever breastfed? Yes/No 1 and 2 
  
Mother probably 
did not have post-
natal depression 
After [child’s name]'s birth, did [you/the child’s mother] 
suffer from baby blues or post-natal depression for at 
least a month? 
Yes/No 
[recoded from: Yes; Probably; No] 
1 
  
Global health 
measure  
In general, would you say [child’s name]’s health is 
excellent, very good, good, fair or poor? 
Poor; Fair; Good; Very good: excellent 1 or 2 
  
Not hospitalised in 
last 12 months 
In the last 12 months, did [child’s name] stay in hospital 
because (he/she) was sick, injured, or required surgery? 
Yes/No 
[coding reversed to positive] 
1 or 2 
  
Child never had 
any ear problems 
Has [child’s name] ever had runny ears/perforated 
eardrum/ hearing loss (total/partial/one ear) /other ear 
problem? 
Yes/No 
[coding reversed to positive] 
1 or 2 
  
Attends childcare, 
daycare or family 
daycare 
Does [child’s name] go to childcare, day-care or family 
day care? 
Yes/No 1 and 2 
  
Attends playgroup   In the past month, has [child’s name] gone to 
playgroup, mother’s group, father’s group, early 
learning circles or any other baby group/class? 
Yes/No 1 and 2 
  
Primary carer has a 
partner 
Derived from household data Yes/No 1 and 2 
  
Primary carer is 
employed 
Do you have a job? Yes/No 1 or 2 
  
Highest 
qualification of the 
primary carer   
What was the highest qualification that you have 
completed? 
Year 9 or less; Year 10 or 11; Year 12; 
Vocational Education and Training (VET) 
qualification;  Bachelor degree or higher 
2 
  
Parental warmth 
measure (primary 
carer) 
When answering, please say whether you Always, 
Often, Sometimes, Rarely, or Never do each thing I ask 
about:  
Mean score for the six questions  
(min=0; max=5) 
[coding reversed to positive] 
2 
  
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Variable Description/ LSIC Interview question wording (28) Values and recoding details Wave/s‡ PCA? Univariable 
analysis? 
 How often do you hug or hold [child] for no 
particular reason? 
 How often do you enjoy listening to [child]? 
 How often do you enjoy doing things together with 
[child]? 
 How often do you feel close to ([child] when 
[he/she] is happy? 
 How often do you feel close to ([child] when 
[he/she] is upset? 
 When [child] does something really well, how often 
do you go out of your way to say how pleased you 
are? 
A higher score indicates greater parental 
warmth  
 
Score not calculated if > 2 responses 
missing 
Stolen generations Were you or any of your (or your partner's) relatives 
removed from your family by welfare or the 
government or taken away to a mission? 
Yes/No 2 
  
Frequency with 
which family 
experiences racism 
How often does your family experience racism, 
discrimination or prejudice? 
Every day; Every week; Sometimes; Only 
occasionally; Never or hardly ever 
3 
  
Total number of 
people living in 
household 
Derived from household survey question: 
What are the first and last names of all the people who 
live in this household, starting with you? 
continuous variable 1 or 2 
  
Number of major 
life events in 
previous year 
I’d like to ask you about any big things that have 
happened to you, your family or [child] in the last year: 
Pregnancy/close family member been badly hurt or 
sick/close family member or friend passed away/carer 
got a job or returned to study/carer lost their 
job/family had serious worries about money/you or 
your family humbugged (harassed for money)/ felt too 
continuous variable 1 or 2 
  
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Variable Description/ LSIC Interview question wording (28) Values and recoding details Wave/s‡ PCA? Univariable 
analysis? 
crowded where you live, moved house, or had housing 
problems/you or a close family member had an alcohol 
or drug problem/ you or a close family member been 
mugged, robbed or assaulted/you or a close family 
member been arrested, been in jail/prison, or had 
problems with the police/ [child] or any other child of 
yours been involved in or upset by family 
arguments/any of [child]’s parents or carers left 
because of a family split-up/ [child] or any other child of 
yours had to be cared for by someone else for a while 
(at least a week)/ any other major events or stressful 
situations happened to you, your family or [child] in the 
last year 
Number of homes 
child has lived in 
since birth 
How many homes has [child’s name] lived in since 
he/she was born? 
continuous variable 1 or 2 
  
Family financial 
stress 
Which words best describe your family’s money 
situation? 
 
We run out of money before payday; We 
are spending more money than we get; 
We have just enough money to get us 
through to the next payday; There's some 
money left over each week but we just 
spend it; We can save a bit every now and 
then; We can save a lot 
1 or 3 
  
Index of Relative 
Indigenous Socio-
economic 
Outcomes (IRISEO) 
Based on Indigenous Area of child’s residential address Decile 
1=most favourable outcome; 10=least 
favourable outcome 
1 or 2 
  
Level of Relative 
Isolation (LORI) 
Based on geocoding of child’s residential address None; Low; Moderate; High/Extreme 1 or 2 
  
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STATISTICAL ANALYSIS  
Version 13 of Stata was used (36).  To describe the sample I calculated means and 
standard deviations (continuous variables), or frequencies and percentages (categorical 
variables).  I used Pearson’s chi square and t-tests to assess the differences between 
children who were included and excluded from the sample based on having an SDQ 
Prosocial Behaviours score at Waves 5 or 6.  All tests of significance were two-sided, 
and I considered p values of less than 0.05 to be statistically significant. 
 
PRINCIPAL COMPONENT ANALYSIS 
Because of the large number of outcome and exposure variables, I sought to limit the 
number of tests for association using Principal Component Analysis (PCA).  Principal 
Component Analysis is a data reduction technique that creates new variables (called 
components) that express the patterns of correlation between variables and the 
underlying constructs that they measure (37).  It is a method often used to build indices 
or proxy measures (38, 39): 
 
The components are ordered so that the first component explains 
the largest possible amount of variation in the original data…The 
second component is completely uncorrelated with the first 
component, and explains additional but less variation than the first 
component …Subsequent components are uncorrelated with 
previous components; therefore, each component captures an 
additional dimension in the data, while explaining smaller and 
smaller proportions of the variation of the original variables.  The 
higher the degree of correlation among the original variables in the 
data, the fewer components required to capture common 
information.  
 
A successful PCA results in a handful of components to which “common sense 
meanings” can be assigned (37).  Principal components are continuous variables that 
can be used in analyses in place of the many variables that were used to create them.  I 
used PCA to reduce the number of exposure variables.  I performed a second PCA of 
SDQ Prosocial Behaviours score, the primary carer’s SEWB score and the ‘connection 
questions’, with the aim of constructing a new index of SEWB for Aboriginal and 
Torres Strait Islander children. 
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I began by constructing a correlation matrix of the exposure variables listed in Table 10.  
As these variables consisted of a mixture of binary, ordinal and continuous data types, I 
used the user-written Stata command -polychoric- to calculate the appropriate 
coefficients for these relationships (38).  The command assumes that binary and ordinal 
variables were obtained by categorising an underlying normally-distributed continuous 
variable, and treats ordinal variables with more than 10 categories as continuous.   
 
To determine if it was feasible to perform PCA on the matrix, I used Bartlett’s test of 
sphericity (Stata user-written command –factortest-) (40) to check that the matrix 
was significantly different from a matrix of non-correlated variables.  I performed PCA 
using the matrix with Stata’s –pcamat- command.  I selected principal components 
with eigenvalues greater than one (39), and rotated the loading matrix of these for ease 
of interpretation.  Orthogonal rotations result in uncorrelated components, while oblique 
rotations allow for some correlation, which would be expected given the nature of the 
data (41).  I used both orthogonal (varimax) and oblique (promax) rotation methods and 
compared the output.  I calculated scores for each of the principal components, which 
represent the weighted sums of the variables which load most heavily onto the 
component.  I calculated Kaiser-Meyer-Olkin measures of sampling adequacy to assess 
the suitability of the data for PCA and hence the usefulness of the resulting components 
(42).  I repeated this procedure for the outcome measures and intended to use the 
resulting component scores in univariable and multivariable analyses. 
 
UNIVARIABLE ANALYSIS 
I performed three sets of univariable analyses.  I analysed the associations between a 
smaller number of exposure variables (as shown in in Table 10 [above]) and outcome 
principal components, and the two SDQ subscale scores.  I estimated the effect of 
binary exposure variables by calculating Harrell’s C and 95% confidence intervals.  
Harrell’s C estimates the probability that a child in the exposed group has a higher score 
than a child in the unexposed group (43).  This estimate is equivalent to the probability 
output from the Wilcoxon rank-sum test (44), which I used to calculate p values for 
these estimates.  To estimate the effect of ordinal and continuous exposure variables I 
calculated Spearman’s rank correlation coefficients (ρ), together with confidence 
intervals and p values.   
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MULTIVARIABLE ANALYSIS 
For all outcome measures, I incorporated exposures with a p value of 0.25 or less from 
the univariable analysis into regression models.  I also included the potentially 
confounding factors that had a statistically significant association with the outcomes in 
univariable analyses.  I adjusted for the geographic clustering in the LSIC sample using 
the ‘rcluster’ variable.  This variable is provided with the LSIC data and is derived from 
the Indigenous Area in which the child lived (28).  Hypothesis test statistics from 
analyses of unadjusted clustered data may be underestimated, increasing the likelihood 
of Type I error (45).  
 
I used linear regression to identify exposures associated with the Principal Components 
scores and SDQ Total Difficulties score.  I checked for goodness-of-fit by assessing the 
R-squared value and plotting scores against scores predicted by the models.  I tested for 
normality of the residuals by graphing histograms, standardised normal probability plots, 
and quantiles of residuals against the quantiles of a normal distribution.  I assessed the 
homoscedasticity
4
 of the residuals by plotting them against the predicted scores. 
 
For the Prosocial Behaviours outcome, I incorporated exposures into an ordinal logistic 
regression model.  Ordinal logistic regression is based on the proportional odds 
assumption, under which the relationship between any one of the 11 Prosocial 
Behaviours categories and all the other 10 categories is the same (46).  I tested whether 
this assumption had been violated by performing a likelihood ratio test (using the user-
written omodel command) and the Brant test.  As the regression coefficients from the 
ologit output are not interpretable, I predicted the probability of a Prosocial 
Behaviours score of 10 for categories of variables with a p value of less than 0.05 using 
the margins command.  
 
 
ETHICAL REVIEW 
This research was approved by the Australian National University Human Research 
Ethics Committee (Protocol 2016/583).  I discussed the ethical aspects of the research 
                                                 
 
4
 Homogeneity of variance  
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questions and the validity of the SEWB conceptual framework with Professor Tom 
Calma, Co-Chair of Reconciliation Australia and former Aboriginal and Torres Strait 
Islander Social Justice Commissioner and Race Discrimination Commissioner.  He 
confirmed both to be sound. 
 
 
Results 
CHARACTERISTICS OF CHILDREN IN THE STUDY SAMPLE 
Nine hundred and fifty children met the age eligibility criteria, but only 726 of these 
(76%) had a SDQ Prosocial Behaviours score at endpoint and were included in the 
sample (Table 11). Children of eligible age who were excluded were more likely to be 
low birthweight, have a younger and unemployed primary carer, to have a mother who 
smoked while pregnant, and to live in a remote or very remote area (Table 12).  
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Table 11 Selected baseline characteristics of children in the study sample. 
Variable Class or statistic n %* 
Sex Female 360 50% 
Age at Wave 1  
(Wave 1 entrants, months) 
Mean (SD) 14.9 (4.5) 
Age at Wave 2  
(Wave 2 entrants, months) 
Mean (SD) 26.8 (4.6) 
Age of primary carer (years) Mean (SD) 28.4 (7.0) 
Relationship of primary carer 
to child 
Mother 692 95.0% 
Grandparent 16 2.3% 
 Father 12 2.0% 
 Aunty 3 0.4% 
 Adoptive/foster mother 3 0.4% 
Indigenous status of primary 
carer 
Aboriginal and/or Torres Strait Islander 606 83% 
Primary carer had a partner Yes 416 57% 
Child spoke an Indigenous 
language 
Yes 
155 22%† 
Low birthweight Yes 46 8%‡ 
BITSEA Problem Score, Wave 2 Mean (SD) 11.7 (6.1) 
BITSEA Competency Score, 
Wave 2 
Mean (SD) 
16.8 (2.5) 
Number of children reporting 
major life events in previous 
12 months  
 
Pregnancy/new baby in family 469 65% 
Someone close to them passed away 350 48% 
Household crowding, moved house, or 
had housing problems 
282 39% 
Carer got a job or returned to study 236 33% 
Family member badly hurt or sick 232 32% 
Location  Major cities 207 29% 
 Inner regional 177 24% 
 Outer regional 99 14% 
 Remote 92 13% 
 Very remote 150 21% 
IRISEO Deciles 1 & 2 88 20% 
 Deciles 3 & 4 123 17% 
 Deciles 5 & 6 288 40% 
 Deciles 7 & 8 105 15% 
 Deciles 9 & 10 122 17% 
*Due to rounding, percentages may not sum to 100; †4 missing observations; ‡149 missing 
observations; SD - Standard deviation 
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Table 12 Comparison of selected baseline characteristics of children included in and excluded 
from the study sample.  Characteristics with a statistically significant difference (p<0.05) 
between groups are shown in bold. 
Characteristic at baseline 
Included in sample 
% 
Excluded from 
sample* 
% 
p value for 
difference 
Female 49.6 49.1 0.90 
Low birthweight 8.0 15.1 0.01 
Mother did not smoke after 
discovering she was pregnant 
50.9 41.1 0.02 
Mother did not drink alcohol after 
discovering she was pregnant 
78.7 74.1 0.17 
BITSEA Problems score  
(mean, 95% CI) 
11.7 (11.1 – 12.1) 11.4 (10.4 – 12.4) 0.66 
BITSEA Competency score 
(mean, 95% CI) 
16.8 (16.6 – 17.0) 16.5 (16.1 – 16.9) 0.24 
Very good or excellent general health 79.5 76.2 0.30 
Primary carer aged <20 years 7.1 13.1 <0.01 
Primary carer completed Year 12 41.1 33.1 0.74 
Primary carer employed 30.2 17.9 0.00 
Primary carer parental warmth score 
(mean, 95% CI) 
4.8 4.7 0.18 
Lived in remote or very remote area 33.4 49.1 0.00 
 
* Children of eligible age at baseline were excluded if SDQ Prosocial Behaviours score was missing for 
Waves 5 and 6.   
 
Table 13 shows key statistics for the sample children’s SDQ subscale scores at around 
the time of starting school, which are also illustrated in Figure 13 and Figure 14.  The 
mean age of SDQ assessment was 6.0 years (standard deviation 0.5 years).  Only 15 
(2.2%) children had not commenced school by Wave 6.  Primary carer’s SEWB scores 
ranged from seven to 28, with most carers scoring 26 or higher (Table 13).  
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Table 13 Key statistics for children’s Strengths and Difficulties subscale scores and primary 
carer’s SEWB scores, at around the time of starting school, for the study sample.  
 Mean 95% CI Median IQR 
Prosocial Behaviours score 
n=726 
8.5 8.4 – 8.6 9 8 - 10 
Total Difficulties Score 
n=725 
11.5 11.0 – 12.0 11 7 – 16 
Primary carer SEWB score 
* 
n=695 
24.4 24.1 – 24.7 26 23 - 27 
CI – confidence interval; IQR – interquartile range; * A higher score indicates better SEWB, possible 
range 0-28 
 
Figure 13  Distribution of SDQ Prosocial Behaviours scores at the time of starting school for 
children in the sample.  A higher score indicates better prosocial behaviours. 
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Figure 14 Distribution of SDQ Total Difficulties scores at the time of starting school for children 
in the sample.  A higher score indicates greater difficulties. The red line (at 17) indicates the 
threshold above which children are considered at high or very high risk of emotional or 
behavioural problems. 
 
PRINCIPAL COMPONENT ANALYSIS RESULTS 
The Bartlett’s test for sphericity of the exposure variables indicated that these data could 
be reduced using PCA (chi-squared=894, p=0.00).  The principal component analysis of 
the exposure variables would only run using data for 269 children, or 37% of the sample.  
When I excluded the ‘stolen generations’ variable, which was missing data for 42% of 
children, the analysis ran with data for 402 children.  Nine principal components had 
eigenvalues greater than one, explaining 68% of data variance.  Variable loadings for 
both varimax and promax rotations did not lend themselves to easy interpretation.  The 
Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy was unacceptably low 
(0.24), indicating the data were not suitable for reduction by PCA (42).  The results of 
the PCA of the exposure variables were not used in further analyses and are therefore 
not presented here.  
 
The Bartlett’s test for sphericity of the outcome variables indicated that these data could 
be reduced using PCA (chi-squared=468, p=0.00).  The PCA of the outcome variables 
included data for 444 children (Table 14, Figure 15).  Three principal components had 
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eigenvalues greater than one and explained 66% of data variance.  The loadings for 
varimax or promax rotations of these components were very similar.  Around one third 
of the data variance was explained by the first principal component (which I have 
named “Child’s connection”) comprising variables measuring the child’s connection to 
community and country.  The second component (“Child’s helping, sharing and mental 
health”) comprised the child’s two SDQ scores; while the third (“Primary carer’s 
SEWB factors”) comprised mainly the primary carer’s SEWB score and connection to 
community.  A higher component score indicates, respectively: a stronger connection; 
greater helping, sharing and mental health; and greater connection and SEWB of the 
carer.  The KMO measure for this analysis was 0.64, indicating adequate–but not 
optimal–sampling adequacy (42). 
 
 
Table 14 Rotated components and loadings from Principal Component Analysis of outcome 
measures, using oblique promax rotation (n=444).  Only loadings greater than 0.2, or less than 
-0.2, are shown. 
 Component 1 Component 2 Component 3 
Assigned Component Name  
“Child’s 
connection” 
“Child’s helping, 
sharing and 
mental health” 
“Primary carer’s 
SEWB factors” 
Eigenvalue 2.62 1.64 1.04 
Proportion of variance explained 32% 18% 16% 
Variable Loadings    
SDQ Prosocial behaviours score  0.73  
SDQ Total Difficulties Score  -0.64  
Child has a connection to country or 
place 
0.55   
Child identifies with a tribal group, a 
language group or a clan 
0.53   
Child does activities with family 
members to learn about culture 
0.46   
Number of days per week child spends 
time with leaders or elders in 
community 
0.39   
Degree to which primary carer feels 
part of his/her local community 
  0.70 
SEWB of primary carer   0.65 
Component Scores    
Minimum – maximum -4.0 – 2.2 -13.7 – 11.6 0.6 – 17.9 
Mean (Standard deviation) -1.5 (1.1) 2.7 (5.0) 13.3 (3.3) 
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Figure 15 Distributions of the three principal components from analysis of the outcome 
variables: (A) “Child’s connection” component; (B) “Child’s helping, sharing and mental health”; 
and (C) “Primary carer’s SEWB factors”.  For each of these components, a higher score 
indicates a more favourable outcome. 
 
 
ASSOCIATIONS BETWEEN PRINCIPAL COMPONENTS AND EXPOSURE VARIABLES 
PRINCIPAL COMPONENT 1 – “CHILD’S CONNECTION” 
In univariable analyses, there were negligible but statistically significant positive 
associations between the “Child’s connection” component score and several early life 
exposures, including: the primary carer or any of his/her (or his/her partner's) relatives 
being removed from their family or taken away to a mission; and experiencing more 
major life events (Table 15).  Abstaining from alcohol during pregnancy and living in 
an area of greater relative socio-economic disadvantage were associated with a poorer 
score. 
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Table 15 Results of univariable analyses of factors (antenatal to two years) associated with a 
higher “Child’s connection” component score at the time of starting school, Footprints in Time 
cohort 2008-2013.  Results with p<0.05 are shown in bold. 
Exposure 
n in 
analysis 
effect size 
p value 
Harrell’s C* 95% CI 
Mother had antenatal visit <20 weeks  379 0.49 0.38 – 0.61 0.90 
Mother did not drink alcohol during 
pregnancy 
405 0.39 0.33 – 0.46 <0.01 
Mother did not smoke during pregnancy 407 0.45 0.40 – 0.51 0.10 
Mother did not use other substances 
during pregnancy 
407 0.45 0.33 – 0.57 0.42 
Low birthweight 362 0.49 0.39 – 0.59 0.90 
Child not hospitalised in the past 12 
months 
444 0.47 0.41 – 0.53 0.36 
Child never had any ear problems 444 0.46 0.39 – 0.52 0.25 
Attends childcare, daycare or family 
daycare 
444 0.46 0.40 – 0.52 0.19 
Excellent, very good or good global 
health  
444 0.49 0.35 – 0.64 0.92 
Primary carer is employed 444 0.46 0.40 – 0.51 0.16 
Stolen generations 278 0.58 0.50 – 0.64 0.03 
Excellent,  very good or good global 
health at time of SDQ assessment † 
444 0.39 0.24 – 0.54 0.20 
Female† 444 0.48 0.42 – 0.54 0.56 
  ρ  95% CI p value 
Highest qualification of the primary 
carer   
444 -0.10 -0.19 – -0.01  0.03 
Parental warmth measure (primary 
carer) 
414 -0.06 -0.15 – 0.04 0.23 
Frequency with which family 
experiences racism 
404 -0.21 -0.31 – -0.12 <0.01 
Number of people living in household 444 0.17 0.08 – 0.26 <0.01 
Number of life events in previous year 444 0.20 0.11 – 0.29 <0.01 
Number of homes child lived in since 
birth 
436 0.07 -0.01 – 0.18 0.07 
Family financial stress 441 -0.10 -0.19 – -0.00 <0.05 
IRISEO 444 -0.23 -0.32 – -0.14 <0.01 
Level of Relative Isolation  443 0.21 0.11 – 0.29 <0.01 
BITSEA Competency score† 414 -0.16 -0.19 – -0.00 0.04 
BITSEA Problem score† 413 0.26 0.17 – 0.35 <0.01 
Age at time of SDQ assessment† 444 0.05 -0.05 – 0.14 0.35 
CI - Confidence Interval; * Harrell’s C - Probability that an exposed child has a higher score than an 
unexposed child; ρ - Spearman’s rank correlation coefficient; †Potential confounding factor  
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However, most of these factors were no longer significant in the linear regression model 
(Table 16).  The model predicted a “Child’s connection” component score of -1.83 (95% 
CI -2.08 to -1.58) for children in two person households, and a slightly better score of -
1.06 (95% CI -1.55 to -0.59) for those with 11 people (Figure 16A).  The highest 
qualification of the primary carer had a non-linear relationship with this component, 
with only Year 12 completion being a statistically significant predictor (Figure 16B).  
For children of families with different levels of exposure to racism, predicted scores 
differed only between those whose experience was daily and those who never or hardly 
ever experienced racism (Figure 16C).  Although the association with the number of 
major life events was statistically significant, the effect was mild.  The child’s BITSEA 
Problem score at Wave 2, which was included in the model as a confounder, also had a 
modest, positive, dose-response correlation with the score for this component (Figure 
16D).    
 
Table 16 Results of linear regression of factors (antenatal to two years) associated with 
“Child’s connection” component score at the time of starting school, Footprints in Time cohort 
2008-2013.  Variables with p≤0.25 from univariable analysis were included in the regression 
model.  Results with p<0.05 are shown in bold. 
Exposure 
Adjusted effect size (n=230)* 
p value 
coefficient 95% CI 
Mother did not drink alcohol during pregnancy -0.22 -0.55 – 0.11 0.19 
Mother did not smoke during pregnancy -0.06 -0.39 – 0.27 0.71 
Mother did not use other substances during pregnancy 0.19 -0.35 – 0.72 0.49 
Child never had any ear problems -0.14 -0.44 – 0.15 0.33 
Attends childcare, daycare or family daycare 0.08 -0.26 – 0.42 0.66 
Primary carer is employed 0.18 -0.19 – 0.55 0.34 
Stolen generations 0.09 -0.18 – 0.35 0.51 
Highest  Less than Year 10 ref - - 
qualification Year 10/11 -0.27 -0.61 – 0.07 0.12 
of the primary  Year 12 -0.56 -1.02 – -0.10 0.02 
carer   VET qualification 0.16 -0.30 – 0.60 0.50 
 Bachelor degree or higher 0.06 -0.53 – 0.66 0.83 
Parental warmth measure (primary carer) -0.05 -0.61 – 0.52 0.87 
Number of people in the household 0.09 0.01 – 0.16 0.03 
Number of major life events in previous year 0.06 0.00 – 0.12 0.05 
Number of homes child has lived in since birth 0.03 -0.11 – 0.16 0.71 
CI - Confidence Interval; ref – reference group; *Adjusted for 95 clusters 
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Exposure 
Adjusted effect size (n=230)* 
p value 
coefficient 95% CI 
Frequency with 
which family 
experiences 
racism 
Every day ref - - 
Every week -0.03 -0.96 – 0.90 0.95 
Sometimes -0.62 -1.25 – 0.00 0.05 
Only occasionally -0.55 -1.29 – 0.20 0.15 
Never or hardly ever -0.86 -1.53 – -0.18 0.01 
Family financial  
stress 
Run out of money before payday ref - - 
Spending more money than we get 0.25 -0.29 – 1.19 0.59 
Have just enough money to get us 
through to next pay day   
0.27  -0.18 – 0.73 0.24 
 
Some money left over each week 
but we just spend it 
0.10 -0.64 – 0.84 0.79 
 Can save a bit every now and then 0.02 -0.55 – 0.57 0.96 
 Can save a lot 0.22 -0.60 – 1.03 0.60 
IRISEO  -0.04 -0.11 – 0.02 0.19 
Level of Relative 
Isolation  
None ref - - 
Low 0.12 -0.18 – 0.43 0.43 
 Moderate 0.51 -0.05 – 1.07 0.07 
 
High/Extreme 
 
 
0.70 -0.67 – 2.07 0.31 
BITSEA Competency score† -0.03 -0.11 – 0.05 0.50 
BITSEA Problem score† 0.04 0.02 – 0.06 <0.01 
Global health measure at  Poor/Fair ref - - 
time of SDQ assessment† Good/ Very good/ Excellent -0.25 -0.96 – 0.46 0.49 
CI - Confidence Interval; ref – reference group; *Adjusted for 95 clusters; †Potential confounding factor 
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Figure 16 Predicted “Child’s connection” component scores (with 95% CIs) from linear 
regression for (A) number of people in the household; (B) highest qualification of the primary 
carer; (C) frequency with which the family experiences racism; and (D) BITSEA problem score 
at Wave 2.  A higher component score indicates a greater degree of connection.  
 
 
Overall, this linear model was statistically significant (F-statistic=7.5, p=0.00), and 
explained 20% of the variability in the “Child’s connection” component scores 
(Appendix 3.4, Figure A).  The histogram of the residuals, standardised normal 
probability plot, and residual quantile plot indicated that the residuals have a close to 
normal distribution (Appendix 3.4, Figure Bi-iii).  The trend towards smaller residuals 
at extreme predicted values suggests mild heteroscedasticity of the residuals (Appendix 
3.4, Figure Biv). 
 
 
PRINCIPAL COMPONENT 2 – “CHILD’S HELPING, SHARING AND MENTAL HEALTH” 
In univariable analyses, there were small but statistically significant associations 
between a better score for the “Child’s helping, sharing and mental health” component 
and the child’s mother not smoking during pregnancy, the primary carer having a higher 
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level of qualification, and living in a more socio-economically disadvantaged area 
(Table 17).  Experiencing a greater number of major life events and living in a more 
isolated area were associated with poorer scores for this component. 
 
Table 17 Results of univariable analyses of factors (antenatal to two years) associated with a 
higher “Child’s helping, sharing and mental health” component score at the time of starting 
school, Footprints in Time cohort 2008-2013.  Results with p<0.05 are shown in bold. 
Exposure 
n in 
analysis* 
effect size 
p value Harrell’s 
C† 
95% CI 
Mother received first antenatal 
visit < 20 weeks gestation 
379 0.44 0.34 – 0.55 0.34 
Mother did not drink alcohol 
during pregnancy 
405 0.56 0.49 – 0.63 0.09 
Mother did not smoke during 
pregnancy 
407 0.59 0.54 – 0.65 <0.01 
Mother did not use other 
substances during pregnancy 
407 0.58 0.46 – 0.70 0.20 
Low birthweight 362 0.43 0.34 – 0.53 0.21 
Child not hospitalised in the past 
12 months 
444 0.55 0.49 – 0.62 0.11 
Child never had any ear problems 444 0.53 0.46 – 0.60 0.40 
Attends childcare, daycare or 
family daycare 
444 0.54 0.48 – 0.60 0.24 
Excellent, very good or good global 
health  
444 0.60 0.45 – 0.77 0.20 
Primary carer is employed 444 0.55 0.50 – 0.61 0.07 
Stolen generations 278 0.44 0.37 – 0.51 0.07 
Excellent,  very good or good 
global health at time of SDQ 
assessment ‡ 
444 0.65 0.48 – 0.83 0.07 
Female‡ 444 0.54 0.48 – 0.59 0.18 
CI - Confidence Interval; * n differs between variables due to missing data; † Harrell’s C - 
Probability that an exposed child has a higher score than an unexposed child 
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Exposure 
n in 
analysis* 
effect size 
p value 
ρ  95% CI 
Highest qualification of the 
primary carer   
444 0.17 0.08 – 0.26 0.003 
Parental warmth measure 
(primary carer) 
414 0.09 -0.003 – 0.19 0.06 
Frequency with which family 
experiences racism 
404 0.82 -0.11 – 0.09 0.82 
Number of people living in 
household 
444 -0.09 -0.18 – 0.01 0.06 
Number of major life events in 
previous year 
444 -0.20 -0.29 – -0.11 0.00 
Number of homes child has lived in 
since birth 
436 -0.08 -0.18 – 0.01 0.09 
Family financial stress 441 0.33 -0.05 – 0.14 0.33 
IRISEO 444 0.16 0.07 – 0.25 <0.01 
Level of Relative Isolation  443 -0.11 -0.2 – -0.02 0.02 
BITSEA Competency score‡ 414 0.11 0.01 – 0.20 0.03 
BITSEA Problem score‡ 413 -0.32 -0.41 – -0.26 0.00 
Age at time of SDQ assessment‡ 444 -0.06 -0.15 – 0.03 0.19 
CI - Confidence Interval; * n differs between variables due to missing data; ρ - Spearman’s rank 
correlation coefficient; ‡Potential confounding factor  
 
 
In the linear regression model, only the number of people in the household and the 
number of major life events retained statistical significance (Table 18).  The model 
predicted a “Child’s helping, sharing and mental health” component score of 4.39 (95% 
CI 3.30 to 5.46) for children with two people in the household, and a poorer score of 
1.40 (95% CI -0.57 to 3.37) for those with 11 people (Figure 17A).  Children who 
experienced no major life events had a predicted component score of 4.70 (95% CI 3.41 
to 5.99), compared with 1.79 (95% CI 0.26 to 3.32) for those with 10 events (Figure 
17B).  The child’s BITSEA Problem score at Wave 2, which was included in the model 
as a confounder, also had a modest negative correlation with the score for this 
component (Figure 17C).   
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Table 18 Results of linear regression of factors (antenatal to two years) associated with 
“Child’s helping, sharing and mental health” component score at the time of starting school, 
Footprints in Time cohort 2008-2013.  Variables with p≤0.25 from univariable analysis were 
included in the regression model.  Results with p<0.05 are shown in bold. 
Exposure 
Adjusted effect size (n=230)* 
p value 
coefficient 95% CI 
Mother did not drink alcohol during pregnancy 0.03 -1.66 – 1.71 0.98 
Mother did not smoke during pregnancy 1.20 -0.46 – 2.86 0.15 
Mother did not use other substances during pregnancy -0.59 -0.43 – 1.24 0.52 
Low birthweight -0.90 -3.08 – 1.28 0.41 
Child not hospitalised in the past 12 months -0.20 -1.77 – 1.37 0.80 
Attends childcare, daycare or family daycare -0.15 -1.65 – 1.36 0.85 
Excellent,  very good or good global health -1.00 -6.93 – 4.92 0.74 
Primary carer is employed -0.27 -1.87 – 1.33 0.74 
Stolen generations  -0.11 -1.56 – 1.34 0.88 
Highest qualification  Less than Year 10 ref - - 
of the primary carer   Year 10/11 1.00 -1.45 – 3.45 0.42 
 Year 12 1.81 -0.55 – 4.18 0.13 
 VET qualification 0.72 -1.77 – 0.28 0.57 
 Bachelor degree or higher 1.02 -2.72 – 4.75 0.59 
Parental warmth measure (primary carer) -0.40 -2.37 – 1.58 0.69 
Number of people in household -0.33 -0.63 – -0.03 0.03 
Number of major life events in previous year -0.29 -0.54 – -0.04 0.02 
Number of homes child has lived in since birth -0.24 -0.87 – 0.35 0.45 
IRISEO  -0.16 -0.45 – 0.14 0.29 
Level of Relative Isolation  None ref - - 
 Low 0.04 -1.48 – 0.56 0.96 
 Moderate -0.53 -2.02 – 1.84 0.66 
 High/Extreme -2.27 -4.71 – 0.17 0.07 
BITSEA Competency score† 0.12 -0.20 – 0.44 0.47 
BITSEA Problem score† -0.22 -0.34 – -0.10 <0.01 
Female† 0.44 -0.94 – 1.81 0.53 
Age at time of SDQ assessment† 0.03 -0.11 – 0.16 0.81 
Global health measure at  Poor/Fair ref - - 
time of SDQ assessment† Good/ Very good/ 
Excellent 
6.7 -0.71 – 13.25 0.08 
CI - Confidence Interval; ref – reference group; *Adjusted for 95 clusters; †Potential confounding factor 
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Figure 17 Predicted “Child’s helping, sharing and mental health” component scores from linear 
regression for (A) number of people in the household; (B) number of major life events in 
previous year; and (C) BITSEA problem score at Wave 2. 
 
Overall, this linear model was statistically significant (F-statistic=6.0, p=0.00), and 
explained 12% of the variability in the component scores (Appendix 3.4, Figure C).  
The histogram of the residuals, standardised normal probability plot, and residual 
quantile plot indicated that the residuals deviate from a normal distribution slightly 
(Appendix 3.4, Figure Di-iii).  The funnel-shaped graph of residuals plotted against 
predicted values suggests mild heteroscedasticity of the residuals (Appendix 3.4, Figure 
Div). 
 
 
PRINCIPAL COMPONENT 3 – “PRIMARY CARER’S SEWB FACTORS” 
In univariable analyses, there were modest associations between a better “Primary 
carer’s SEWB factors” component score and the child’s mother not drinking alcohol 
during pregnancy, and the child experiencing fewer major life events.  Negligible 
positive effects were also detected for: the mother not smoking during pregnancy; the 
primary carer being employed; having a higher level of qualification and greater 
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parental warmth; the family not being affected by the stolen generations; suffering less 
financial stress; and the child living in fewer homes in the first two years of life (Table 
19).    
Table 19 Results of univariable analyses of factors the first years of life associated with a higher 
“Primary carer’s SEWB factors” component score at the time of starting school, Footprints in 
Time cohort 2008-2013.  Results with p<0.05 are shown in bold. 
Exposure 
n in 
analysis 
effect size 
p value 
Harrell’s C* 95% CI 
Mother received first antenatal visit < 20 
weeks gestation 
379 0.48 0.36 – 0.59 0.68 
Mother did not drink alcohol while pregnant 405 0.62 0.56 – 0.69 <0.01 
Mother did not smoke during pregnancy 407 0.59 0.54 – 0.65 <0.01 
Mother did not use other substances during 
pregnancy 
407 0.56 0.43 – 0.69 0.32 
Low birthweight 362 0.44 0.35 – 0.52 0.26 
Child not hospitalised in the past 12 months 444 0.55 0.49 – 0.62 0.11 
Child never had any ear problems 444 0.52 0.46 – 0.59 0.53 
Attends childcare, daycare or family daycare 444 0.53 0.47 – 0.60 0.32 
Excellent,  very good or good global health  444 0.56 0.41 – 0.70 0.43 
Primary carer is employed 444 0.58  0.52 – 0.63 0.01 
Stolen generations  278 0.42 0.35 – 0.49 0.03 
Excellent, very good or good global health at 
time of SDQ assessment † 
444 0.67 0.53 – 0.82 0.04 
Female† 444 0.51 0.45 – 0.56 0.85 
  ρ  95% CI p value 
Highest qualification of the primary carer   444 0.17 0.08 – 0.26 <0.01 
Parental warmth measure (primary carer) 414 0.10 0.00 – 0.19 0.04 
Frequency of family’s experience of racism 404 0.07 -0.03 – 0.17 0.17 
Number of people living in household 444 -0.08 -0.17 – 0.02 0.10 
Number of life events in previous year 444 -0.25 -0.34 – -0.16 <0.01 
Number of homes child lived in since birth 436 -0.10 -0.19 – 0.00 0.04 
Family financial stress 441 0.11 0.01 – 0.20 0.03 
IRISEO 444 0.09 -0.01 – 0.08 0.07 
Level of Relative Isolation  443 -0.03 -0.21 – 0.07 0.56 
BITSEA Competency score† 414 0.04 0.08 – 0.26 <0.01 
BITSEA Problem score† 413 -0.30 -0.38 – -0.21 <0.01 
Age at time of SDQ assessment† 444 -0.08 -0.17 – 0.01 0.09 
CI - Confidence Interval; * Harrell’s C - Probability that an exposed child has a higher score than an 
unexposed child; ρ - Spearman’s rank correlation coefficient; †Potential confounding factor  
 
 105 
 
In the linear regression model, only the number of people in the household and the 
number of major life events had statistically significant coefficients (Table 20).  The 
model predicted a “Primary carer’s SEWB factors” component score of 14.13 (95% CI 
13.40 to 14.86) for children with two people in the household, and a poorer score of 
11.79 (95% CI 10.40 to 13.19) for those with 11 people (Figure 18A).  Children who 
experienced no major life events had a predicted component score of 14.60 (95% CI 
13.74 to 15.47), compared with 13.18 (95% CI 12.72 to 13.64) for those with five 
events (Figure 18B).  The highest qualification of the primary carer had a non-linear 
relationship with this component, with only Year 12 qualification being a statistically 
significant predictor (Figure 18C).  The child’s BITSEA Problem score at Wave 2, 
which was included in the model as a confounder, also had a negligible negative 
correlation with the score (Figure 18D).   
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Table 20 Results of linear regression of factors (antenatal to two years) associated with 
“Primary carer’s SEWB factors” component score at the time of starting school, Footprints in 
Time cohort 2008-2013.  Variables with p≤0.25 from univariable analysis were included in the 
regression model.  Results with p<0.05 are shown in bold. 
Exposure 
Adjusted effect size (n=230)* 
p value 
coefficient 95% CI 
Mother did not drink alcohol during pregnancy 0.71 -0.41 – 1.81 0.21 
Mother did not smoke during pregnancy 0.68 -0.34 – 1.70 0.19 
Child not hospitalised in the past 12 months 0.31 -0.77 – 1.39 0.57 
Primary carer is employed -0.50 -1.60 – 0.59 0.36 
Stolen generations  -0.29 -1.07 – 0.49 0.46 
Highest qualification  Less than Year 10 ref - - 
of the primary carer   Year 10/11 0.48 -0.53 – 1.49 0.35 
 Year 12 1.68 0.39 – 2.97 0.01 
 VET qualification -0.31 -1.59 – 0.98 0.64 
 Bachelor degree or higher 1.04 -0.67 – 2.75 0.23 
Parental warmth measure (primary carer) 0.31 -1.11 – 1.74 0.66 
Frequency with which family  
experiences racism 
Every day ref - - 
Every week -1.77 -3.71 – 3.35 0.92 
 Sometimes 1.40 -1.22 – 4.02 0.29 
 Only occasionally 0.41 -2.34 – 3.16 0.77 
 Never or hardly ever 0.70 -1.96 – 3.35 0.60 
Number of people in household -0.26 -0.47 – -0.05 0.02 
Number of major life events in previous year -0.28 -0.47 – -0.10 <0.01 
Number of homes child has lived in since birth 0.00 -0.40 – 0.40 0.99 
Family financial  Run out of money before payday ref - - 
stress Spending more money than we get -1.20 -3.71 – 1.31 0.35 
 
Have just enough money to get us 
through to next pay day   
-0.50 -1.73 – 0.73 0.42 
 
Some money left over each week 
but we just spend it 
-0.41 -2.38 – 1.55 0.68 
 Can save a bit every now and then -0.23 -1.70 – 1.25 0.76 
 Can save a lot -1.16 -3.58 – 1.25 0.34 
IRISEO  0.04 -0.13 – 0.21 0.64 
BITSEA Competency score† 0.01 -0.23 – 0.25 0.93 
BITSEA Problem score† -0.09 -0.17 – -0.02 0.01 
Age at time of SDQ assessment† -0.05 -0.14 – 0.04 0.24 
Global health measure at  Poor/Fair ref  -  - 
time of SDQ assessment† Good/ Very good/ 
Excellent 
2.09 0.03 – 4.15 0.05 
CI - Confidence Interval; ref – reference group; *Adjusted for 95 clusters; †Potential confounding factor 
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Figure 18 Predicted “Primary carer’s SEWB factors” component scores from linear regression 
for (A) number of people in the household; (B) number of major life events in previous 12 
months; (C) highest qualification of the primary carer; and (D) BITSEA problem score at Wave 2. 
 
Overall, this linear model was statistically significant (F-statistic=5.3, p=0.00), and 
explained 18% of the variability in the component scores (Appendix 3.4, Figure E).  
The histogram of the residuals, standardised normal probability plot, and residual 
quantile plot indicated that the residuals have a skewed distribution (Appendix 3.4, 
Figure Fi-iii).  The funnel-shaped graph of residuals plotted against predicted values, 
and greater spread of the negative residuals suggests moderate heteroscedasticity 
(Appendix 3.4, Figure Fiv). 
 
ASSOCIATIONS BETWEEN SDQ SCORES AND EXPOSURE VARIABLES 
Factors with a statistically significant association with higher SDQ Prosocial 
Behaviours scores in univariable analyses (Table 21) were the child’s mother not 
smoking during pregnancy, the family experiencing racism and discrimination less 
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frequently, the child experiencing fewer major life events in the previous 12 months, 
and living in a less isolated area. 
In the ordinal logistic regression model, none of these negligible effects remained 
statistically significant (Table 22).  Although the occasional experience of racism and 
discrimination had a statistically significant association in the model, contrasting the 
marginal linear predicted probabilities of this variable’s categories revealed that it had 
no overall effect (chi-square=6.3, p=0.18).  The only factors that were statistically 
significant in this model were the global health of the child at the time of starting school, 
and the child’s BITSEA competency score at Wave 2, both of which were included in 
the model as potential confounding factors.  Children with good, very good or excellent 
global health at the time of starting school had a five-fold probability of a perfect 
prosocial score, compared with children with fair or poor health (Figure 19).  The 
predicted probability of a SDQ Prosocial Behaviours score for children with a BITSEA 
Competency score of two at Wave 2 was 0.14 (95% CI -0.03 to 0.31) (Figure 20).  In 
contrast, children with a BITSEA Competency score of 20 at Wave 2 had a predicted 
probability of 0.47 (95% CI 0.39 to 0.55) of a perfect Prosocial Behaviours score. 
The log likelihood-ratio test of proportionality of odds across the response categories 
was not significant (p=0.15), indicating that the model did not violate the proportional 
odds assumption.  The Brant test could not be performed because there were too many 
empty cells in the cross-tabulation of exposures and Prosocial Behaviours scores.  
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Table 21  Results of univariable analysis of factors in first years of life associated with higher 
SDQ Prosocial Behaviours Score at the time of starting school, Footprints in Time cohort 2008-
2013.  Results with p<0.05 are shown in bold. 
Exposure 
n in 
analysis 
effect size 
p value 
Harrell’s C* 95% CI 
Mother received first antenatal visit <20 
weeks gestation 
604 0.50 0.43 – 0.58 0.94 
Mother did not drink alcohol during 
pregnancy 
658 0.55 0.49 – 0.60 0.09 
Mother did not smoke during 
pregnancy 
660 0.56 0.52 – 0.60 0.01 
Mother did not use other substances 
during pregnancy 
660 0.52 0.43 – 0.62 0.58 
Low birthweight 577 0.47 0.39 – 0.55 0.46 
Child not hospitalised in the past 12 
months 
725 0.50 0.45 – 0.55 0.99 
Child never had any ear problems 726 0.52 0.47 – 0.57 0.49 
Attends childcare, daycare or family 
daycare 
725 0.50 0.46 – 0.55 0.95 
Excellent,  very good or good global 
health  
726 0.49 0.36 – 0.61 0.83 
Primary carer is employed 725 0.49 0.45 – 0.53 0.62 
Stolen generations 419 0.53 0.49 – 0.59 0.22 
Excellent, very good or good global 
health at time of SDQ assessment† 
726 0.12 0.04 – 0.19 <0.01 
Female† 726 0.58 0.54 – 0.62 <0.01 
  ρ  95% CI p value 
Highest qualification of the primary 
carer   
726 0.04 -0.03 – 0.13 0.28 
Parental warmth measure (primary 
carer) 
657 0.03 -0.05 – 0.11 0.42 
Frequency with which family 
experiences racism 
639 -0.08 -0.16 – -0.01 0.04 
Number of people living in household 726 -0.05 -0.13 – 0.02 0.15 
Number of major life events in previous 
year 
726 -0.08 -0.16 – -0.01 0.03 
Number of homes child has lived in since 
birth 
711 -0.01 -0.09 – 0.06 0.75 
Family financial stress 720 -0.004 -0.08 – 0.07 0.91 
IRISEO 726 0.05 -0.02 – 0.12  0.17 
Level of Relative Isolation  725 -0.10 -0.17 – -0.02 0.01 
BITSEA Competency score† 657 0.13 0.05 – 0.20 <0.01 
CI - Confidence Interval; * Harrell’s C - Probability that an exposed child has a higher score than an 
unexposed child; ρ - Spearman’s rank correlation coefficient; †Potential confounding factor  
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Table 22 Results of ordinal logistic regression of factors in first years of life associated with 
higher SDQ Prosocial Behaviours Score at the time of starting school, Footprints in Time cohort 
2008-2013.  Variables with p≤0.25 from univariable analysis were included in the regression 
model.  Results with p<0.05 are shown in bold. 
Exposure 
Adjusted effect size (n=341)* 
p value 
coefficient 95% CI 
Mother did not drink alcohol during pregnancy -0.83 -0.65 – 0.48 0.08 
Mother did not smoke during pregnancy 0.42 -0.03 – 0.86 0.07 
Stolen generations 0.23 -0.19 – 0.66 0.28 
Frequency with which Every day ref  - - 
family experiences racism                                                               Every week 0.62 -1.01 – 2.26 0.46 
 Sometimes 0.99 -0.24 – 2.22 0.11 
 Occasionally 1.13 0.09 – 2.54 0.04 
 Never/hardly ever 0.68 -0.37 – 1.73 0.20 
Number of people living in household -0.06 -0.15 – 0.04 0.23 
Number of major life events in previous year -0.05 -0.14 – 0.04 0.25 
IRISEO -0.07 -0.17 - 0.04 0.21 
Level of Relative Isolation  None ref -  - 
 Low -0.27 -0.72 – 0.19 0.26 
 Moderate -0.29 -1.10 – 0.50 0.47 
 High/Extreme -0.84 -1.76 – 0.08 0.07 
Female† 0.39 -0.02 – 0.79 0.06 
BITSEA Competency score† 0.10 0.00 – 0.19 0.04 
Global health measure at Poor /Fair ref - - 
time of SDQ assessment† Good/ Very good/ 
Excellent 
2.16 0.80 – 3.52 <0.01 
CI - Confidence Interval; ref – reference group; * Adjusted for 120 clusters; †Potential confounding factor 
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Figure 19 Probability of a SDQ Prosocial Behaviours Score of 10, by health of the child at the 
time of SDQ assessment, with 95% confidence intervals. 
 
 
Figure 20 Probability of a SDQ Prosocial Behaviours Score of 10, by BITSEA Competency score 
at Wave 2, with 95% confidence intervals. 
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Six early life exposures had statistically significant association with higher SDQ Total 
Difficulties scores in univariable analyses (Table 23), including the child’s mother 
smoking during pregnancy, and the child experiencing fewer major life events in the 
previous 12 months.  However, after linear regression, only the number of major life 
events remained significant (Table 24), as well as the child’s BITSEA problem score at 
Wave 2, which was included in the model as a potential confounding factor.  Higher 
values for both of these exposures were associated with poorer scores on this outcome.  
Predicted SDQ total difficulties score for children with one event was 9.53 (95% CI 
8.54 to 10.52) while predicted score for children with 8 events was a poorer 11.70 (95% 
CI 10.62 to 12.78) (Figure 21).  Predicted scores for children with BITSEA problem 
score of five was 8.81 (95% CI 8.00 to 9.63), while a BITSEA score of 25 predicted a 
poorer SDQ Total Difficulties score of 14.67 (95% CI 13.14 to 16.19) (Figure 22).  As 
these two factors were shared with the “Child’s connection” component, I conducted a 
post hoc analysis to check the relationship between this component and SDQ Total 
Difficulties score.  There was a moderate positive correlation between these two 
variables (ρ=0.55, 95% CI 0.48 to 0.61, p=0.00). 
 
Overall, the linear model was statistically significant (F-statistic=7.5, p=0.00), but 
explained only 12% of the variability of SDQ Total Difficulties Scores (Appendix 3.4, 
Figure G).  The histogram of the residuals, standardised normal probability plot, and 
residual quantile plot indicated that the residuals have a near normal distribution 
(Appendix 3.4, Figure Hi-iii).  The slight funnel shapes of the graphs of residuals 
against predicted values, for both the overall model and the two statistically significant 
exposure variables, suggest mild heteroscedasticity of the residuals (Appendix 3.4, 
Figure Hiv).   
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Table 23 Results of univariable analysis of factors in first years of life associated with higher 
SDQ Total Difficulties score at the time of starting school, Footprints in Time cohort 2008-2013. 
Results with p<0.05 are shown in bold. 
Exposure 
n in 
analysis 
effect size 
p value 
Harrell’s C* 95% CI 
Mother received first antenatal visit < 20 
weeks gestation 
602 0.50 0.43 – 0.58 0.91 
Mother did not drink alcohol during 
pregnancy 
656 0.45 0.39 – 0.51 0.07 
Mother did not smoke during pregnancy 658 0.43 0.38 – 0.47 <0.01 
Mother did not use other substances 
during pregnancy 
658 0.42 0.33 – 0.52 0.09 
Low birthweight 576 0.56 0.48 – 0.65 0.15 
Child not hospitalised in the past 12 
months 
723 0.46 0.40 – 0.51 0.08 
Child never had any ear problems 724 0.48 0.43 – 0.54 0.57 
Attends childcare, daycare or family 
daycare 
723 0.47 0.42 – 0.52 0.28 
Excellent,  very good or good global 
health 
724 0.42 0.28 – 0.56 0.26 
Primary carer is employed 723 0.44 0.40 – 0.49 0.01 
Stolen generations 419 0.56 0.51 – 0.62 0.03 
Excellent,  very good or good global 
health at time of SDQ assessment † 
724 0.37 0.26 – 0.49 0.05 
Female† 724 0.45 0.41 – 0.49 0.03 
  ρ  95% CI p value 
Highest qualification of the primary 
carer   
724 -0.14 -0.21 – -0.06 <0.01 
Parental warmth measure (primary 
carer) 
656 -0.13 -0.20 – -0.05 <0.01 
Frequency of family’s racism experience  638 0.02 -0.06 – 0.10 0.56 
Number of people living in household 724 0.04 -0.03 – 0.11 0.30 
Number of major life events in previous 
year 
724 0.15 0.07 – 0.22 <0.01 
Number of homes child lived in since 
birth 
709 0.07 0.00 – 0.14 0.06 
Family financial stress 718 -0.05 -0.12 – 0.02 0.18 
IRISEO 724 -0.10 -0.24 – -0.10 0.00 
Level of Relative Isolation  723 0.10 0.03 – 0.18 0.01 
BITSEA Problem score† 654 0.32 0.25 – 0.39 0.00 
Age at time of SDQ assessment† 724 0.07 -0.01 – 0.14 0.08 
CI - Confidence Interval; * Harrell’s C - Probability that an exposed child has a higher score;    ρ - 
Spearman’s rank correlation coefficient; †Potential confounding factor 
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Table 24 Results of linear regression of factors in first years of life associated with lower SDQ 
Total Difficulties score at the time of starting school, Footprints in Time cohort 2008-2013.  
Variables with p≤0.25 from univariable analysis were included in the regression model.  Results 
with p<0.05 are shown in bold. 
Exposure 
Adjusted effect size (n=321)* 
p value 
coefficient 95% CI 
Mother did not drink alcohol during pregnancy -0.30 -0.19 – 1.32 0.71 
Mother did not smoke during pregnancy -0.56 -2.16 – 1.04 0.49 
Mother did not use other substances during pregnancy 0.29 -1.95 – 2.53 0.80 
Low birthweight 1.43 -0.74 – 3.60 0.19 
Child not hospitalised in the past 12 months 0.13 -1.40 – 1.67 0.86 
Primary carer is employed -0.51 -2.06 – 1.05 0.52 
Stolen generations  0.39 -0.85 – 1.63 0.53 
Highest qualification  Less than Year 10 ref - - 
of the primary carer   Year 10/11 -1.72 -4.12 – 0.68 0.16 
 Year 12 -1.44 -4.01 – 1.14 0.27 
 VET qualification -1.29  -3.69 – 1.12 0.29 
 Bachelor degree or higher -0.53 -3.78 – 2.73 0.75 
Parental warmth measure (primary carer) -0.04 -2.25 – 2.18 0.98 
Number of major life events in previous year 0.31 0.08 – 0.54 0.01 
Number of homes child has lived in since birth 0.45 -0.22 – 1.12 0.19 
Family financial  Run out of money before payday ref - - 
stress Spending more money than we get 1.25 -2.41 – 4.90 0.50 
 
Have just enough money to get us 
through to next pay day   
2.21 -0.09 – 4.52 0.06 
 
Some money left over each week 
but we just spend it 
2.36 -0.55 – 5.27 0.11 
 Can save a bit every now and then 1.67 -0.67 – 4.02 0.16 
 Can save a lot 2.80 -0.82 – 6.42 0.13 
IRISEO  -0.14 -0.49 – 0.20 0.42 
Level of Relative Isolation  None ref - - 
 Low -0.23 -2.11 – 1.17 0.57 
 Moderate -0.23 -2.71 – 2.25 0.86 
 High/Extreme 1.51 -1.22 – 4.25 0.28 
BITSEA Problem score† 0.29 0.20 – 0.39 0.00 
Female† -1.17 -2.59 – 0.21 0.10 
Age at time of SDQ assessment† 0.01 -0.12 – 0.14 0.92 
Global health measure at  Poor/Fair ref - - 
time of SDQ assessment† Good/ Very good/ Excellent -5.34 -10.78 – 0.10 0.05 
CI - Confidence Interval; ref – reference group; VET – vocational education and training; * Adjusted for 
120 clusters; †Potential confounding factor  
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Figure 21 SDQ Total Difficulties scores at the time of starting school, predicted by linear 
regression of number of major life events in the previous 12 months reported at Waves 1 or 2, 
with 95% confidence intervals.  A higher score indicates greater social and emotional 
difficulties.  The red line (at 17) indicates the threshold above which children are considered at 
high or very high risk of emotional or behavioural problems. 
 
Figure 22 SDQ Total Difficulties scores at the time of starting school, predicted by linear 
regression of BITSEA score at Wave 2, with 95% confidence intervals.  A higher score indicates 
greater social and emotional difficulties.  The red line (at 17) indicates the threshold above 
which children are considered at high or very high risk of emotional or behavioural problems. 
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Discussion 
MAIN FINDINGS 
The early life exposures associated with surrogate measures of SEWB at the time of 
starting school were the number of people living in the household and major life events 
experienced by the child.  While larger households and more events were associated 
with reduced sharing, helping and mental health in the child and poorer wellbeing in the 
primary carer; more people in the household and exposure to more events was weakly 
associated with greater connection of the child to community, culture and country.  As a 
stand-alone measure, prosocial behaviours at school commencement was not associated 
with any of the early life exposures analysed in this study (including intrauterine risk 
factors; characteristics of the primary carer; parenting and care arrangements; home life 
and events; exposure to intergenerational trauma and racism; and macro-level socio-
economic indicators).   
 
Consistent with previous research (47), better social, emotional and behavioural 
competence as an infant or toddler weakly predicted better scores for most outcomes at 
the time of starting school.  However, greater difficulties as an infant or toddler 
predicted greater connection of the child to community, culture and country, although 
this effect was negligible.  Children with good, very good or excellent global health at 
the time of starting school had markedly increased probability of a perfect prosocial 
score, compared with children with fair or poor health. 
 
The most salient finding is that the SDQ screening tool does not capture the culturally-
specific, multi-faceted and positive concept of SEWB.  I was unable to create an index 
of SEWB using PCA and, surprisingly, post hoc analysis revealed that measures of 
connectedness and relationship were positively correlated with SDQ Total Difficulties 
scores.  Those seeking evidence to support SEWB policy development, program 
planning and evaluation must be cautious in applying Western biomedical health and 
wellbeing measures to Indigenous concepts and states. 
 
I could not use PCA to reduce the exposure data.  This may have been due to missing 
data and use of categorical variables, which have smaller correlations than the 
(unobserved) continuous variables from which they derive (48).  An alternative, but less 
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likely, explanation is that the variables were unrelated, and there were no patterns in the 
population to detect with respect to these factors.  
 
COMPARISON WITH OTHER STUDIES – WHAT DOES THIS STUDY ADD? 
MENTAL HEALTH OF ABORIGINAL AND TORRES STRAIT ISLANDER CHILDREN 
The distributions of SDQ scores for the sample were comparable with other studies of 
Aboriginal children of this age.  Scores were similar to those for the LSIC older cohort 
at around age six years at Wave 3 (49), for six year olds in the WAACHS study (12), 
and for children aged four to 17 years in the Study of Environment of Aboriginal 
Resilience and Child Health (SEARCH) study in urban New South Wales (NSW) 
(which examined Total Difficulties scores only) (50).  While the WAACHS study found 
no difference in SDQ Prosocial Behaviours scores for Aboriginal and non-Aboriginal 
children, both these and the scores from the present study were higher than scores for 
children participating in a validation study of the SDQ involving a sample of mostly 
non-Indigenous children in Brisbane (19).  Mean Total Difficulties scores were higher 
in the present study than for six-year-old non-Aboriginal children in a survey conducted 
to provide comparison data for the WAACHS (12).  These results suggest that 
Aboriginal and Torres Strait Islander children exhibit better prosocial behaviours but 
have poorer mental health, compared with non-Indigenous children.  Using data from 
the Australian Early Development Census, Goldfield (26) also found that Aboriginal 
and Torres Strait Islander children had markedly poorer mental health competence than 
non-Indigenous children at school entry. 
 
 
DETERMINANTS OF SEWB AND MENTAL HEALTH 
Exposure to a greater number of major life events in the early years appeared to be 
mildly detrimental to SDQ scores.  In a study of the older LSIC cohort at Wave 4, when 
the children were aged around seven years, Skelton and Kikkawa (51) found a similar 
strength of association between SDQ Total Difficulties score and exposure to major life 
events in the previous 12 months.  In a cross-sectional analysis of WAACHS data for 
children aged four to 17 years, Zubrick et al. (12) found that exposure to more than 
seven major life events in the preceding year increased by over fivefold the likelihood 
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of a child being at high risk of clinically significant difficulties (SDQ Total 
Difficulties >17), compared with children who experienced two or fewer events.    
 
In the present study, however, experiencing a greater number of events was also 
associated with greater connectedness to elders, culture and country.  It is important to 
note that, unlike in the WAACHS, not all of the events reported in LSIC are inherently 
negative.  Two of the four most commonly reported events in this sample were 
pregnancy or a new baby in the household, and one of the child’s carers returning to 
work or study (Table 11).  Exposure to more life events, including death of someone 
close, is to some extent a result of larger and stronger family and community networks.  
However, the likelihood for these deaths to be traumatic must be considered.  In 
reporting findings from the National Aboriginal and Torres Strait Islander Health 
Survey 2004–05, Zubrick et al. (52) state 
…grief and loss was the largest single factor to impact on the wellbeing of 
Aboriginal and Torres Strait Islander people.  Many deaths involving infants, 
children, young adults, and men and women in their prime were sudden, 
unexpected and preventable and therefore very traumatic.  
 
In this study, having more people living in the household had a negligible positive 
association with better “Child’s connection” component scores.  However, an opposite 
and stronger effect of this exposure was observed for the “Primary carer’s SEWB 
factors” component scores.  Interestingly, children in the WAACHS living with high 
household occupancy levels were half as likely to have a high risk SDQ Total 
Difficulties score, compared with those living with low occupancy.  Zubrick et al. (12) 
suggest this “may relate to more help being available within the household, greater 
flexibility in managing stresses, and greater buffering of risk exposures”. 
 
It is not possible to infer household crowding (and related stress) from reported 
household size.  The LSIC survey question simply asks for the names of “all the people 
who live in the household” (53), with no clarification about temporary or regular 
visitors, or people who may sleep elsewhere but use the kitchen and bathroom facilities 
of the home.  In contrast to the WAACHS analysis (12), I did not calculate household 
occupancy from the number of bedrooms or number of people who lived in the home.  
The international standard measure for household utilisation also takes into account the 
age, sex and relationship status (couples or singles) of occupants (54).  However, as 
Memmot et al. (54) note, it is important to distinguish between high density of 
household occupants and household crowding.  They argue that crowding is a 
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perception of spatial inadequacy, influenced by a range of factors including the physical 
setting, an individual’s experience and expectations, their relationship to other 
occupants, and the occupants’ activities and behaviour.  Crowding is an experience that 
is culturally defined and, for some families and communities, “[high] density may be an 
expression of proper intimacy with kin and others, which in fact reduces stress” (54).  
However, in the present study, the effects of the number of people in the household 
generally mirror those of the number of major life events, possibly reflecting the fact 
that a problem with housing (including the primary carer feeling too crowded where he 
or she lived, and moving house) was a commonly reported major event (Table 11).    
 
Previous cross-sectional studies of Aboriginal and Torres Strait Islander children of 
similar ages have found associations between lower SDQ Total Difficulties scores and 
better general health (49, 51); ear health (12); higher qualification of the primary carer; 
living in an area of less socioeconomic disadvantage (49) or greater geographic isolation 
(12); lower household financial stress (55); having a primary carer who was employed; 
and living in fewer than four (50) or five homes (12).  In the only published 
examination of the determinants of better SDQ Prosocial Behaviours scores in 
Aboriginal and Torres Strait Islander children, Armstrong et al.’s (49) study of the older 
LSIC cohort found negligible positive effects at Wave 3 for the children who lived in a 
relatively socioeconomically advantaged area at Wave 2.   However, none of these 
factors, occurring in early life, were significant at school entry in this longitudinal study.  
Zubrick et al. (12) note that the lack of association in the WAACHS between carer 
education and SDQ Total Difficulties scores is also inconsistent with findings from a 
large study of the general Australian population.  The authors suggest that, for 
Aboriginal and Torres Strait Islander families, the benefits of improved education are 
attenuated by the effects of “life stress, poor family functioning and carer health”.   
 
CHALLENGES IN MEASURING SOCIAL AND EMOTIONAL WELLBEING 
In developing a conceptual framework for SEWB, I quickly discovered that I could not 
operationalise this outcome using only the SDQ Total Difficulties subscale, the most 
commonly used measure of Aboriginal and Torres Strait Islander child mental health in 
large studies.  By including the strengths-based SDQ Prosocial Behaviours subscale as 
an outcome measure I, as did Goldfield et al. (26), have challenged the common 
assumption that child mental health is the same as the absence of mental illness.  These 
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authors argue for a dual continuum model in which mental health is seen as correlated 
to, but distinct from, mental disorder.  However, measuring only these two states fails to 
capture the Indigenous concept of SEWB.  For operationalising SEWB, perhaps what is 
needed is a ‘triple continuum model’, which includes a domain of relational health of 
community, culture, spirituality and country.  I could not achieve this using the 
‘connection variables’ available for this sample of LSIC children, which prima facie 
cannot quantify a concept that encompasses a rich web of relationships between 
flourishing individuals, families, language, culture, spirituality and country. 
 
Taylor (56) names the intersection between Indigenous culture and government 
reporting frameworks the ‘recognition space’ (Figure 23).  This space is  
…where policy makers and Indigenous people can seek to build meaningful 
engagement and measurement.  This is the area that allows for a necessarily 
reductionist translation of Indigenous people’s own perceptions of their well-
being into measurable indices sought by government.  What is captured in 
this space is obviously far from the totality of Indigenous understandings of 
well-being.  
 
 
Figure 23  The ‘recognition space’ for indicators of Indigenous wellbeing (56). 
 
We may feel that by choosing standard measures we are ensuring objectivity.  However, 
Prout (57) warns that reducing Indigenous notions to narrow conventional indicators is 
a political exercise.  In so doing, this “invisibilises many of the positive, enduring and 
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protective factors, associated with Indigenous ways of life which are not amenable to 
this kind of analysis and reporting” (57).  Our own values and worldviews also 
influence our interpretation of these indicators, and may be in conflict with Indigenous 
perceptions of wellbeing.  Furthermore, Prout argues, by using non-Indigenous 
populations as the reference group we are assuming that equity based on these flawed 
indicators is the ambition for Indigenous populations. 
 
Walter and Andersen (58) suggest that power should be returned to communities by 
framing research through lenses of Indigenous values, ways of being and of knowing.  
A recent project auspiced by the Kimberley Institute aimed to develop culturally 
relevant measures of wellbeing for the Yawuru people, who live in and around Broome 
(59).  In this qualitative project, Yawuru men and women described their concept of 
wellbeing and selected relevant indicators to develop gender-specific and collective 
wellbeing frameworks.  The community specific indicators for collective wellbeing 
derived from the study (Table 25) highlight the complexity of the wellbeing concept and 
contrast with the much narrower constructs measured by the SDQ scales (Table 25).    
 
Table 25 Examples of activities and states for Yawuru men and women that contribute to 
Yawuru’s experience of wellbeing (59). 
Wellbeing themes Potential indicators  
Family, identity and 
relatedness 
 Sharing your fish or kill with family and friends 
 Seeing and spending time with family 
Community  Participating in community cultural events 
 Being able to have a say or have control over what happens in my 
community 
Connection to country  Looking after country 
 Eating bush tucker, eating fish that was caught in season and meat 
that was hunted in season 
Connection to culture 
 Speaking and understanding the Yawuru language 
 Participation in law and ceremonies 
Safety and respect  Feel respected and show respect to Indigenous groups in my 
community 
 Feel respected and show respect to family and friends 
Standard of living  Adequate housing conditions 
 Having a secure income stream including a diversity of sources of 
income 
Rights and recognition 
 Environment free from pollutants and hazards 
 Feel recognised and proud to be Native Title holders 
Health 
 Healthy body to enjoy life 
 Minimise ill health from too much alcohol or drugs 
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STRENGTHS OF THIS STUDY 
As far as possible, and recognising the constraints of my own worldview and social 
position, I have attempted to use an Indigenous quantitative methodology for this study.  
Walter (58) defines this methodology as one in which “the practices and processes of 
research are conceived and framed through an Indigenous standpoint”.  I was fortunate 
to have access to the LSIC data—data which was collected using protocols that 
exemplify this methodology (58).  I have also taken advantage of the power of the 
longitudinal design of the LSIC, and explored the determinants of the SDQ Prosocial 
Behaviours score which has been largely neglected thus far.   
 
LIMITATIONS OF THIS STUDY 
The non-random purposive sampling technique used for the LSIC means generalisation 
to all Aboriginal and Torres Strait Islander children requires caution.  Because of 
exclusions for absence of SDQ scores at Waves 5 or 6, I may have underestimated the 
effects of low birthweight, primary carer employment, remote living and maternal 
smoking.  For the same reason, and based on the findings of previous studies, the SDQ 
scores for the sample may have been more favourable than for the whole cohort.  
Similarly, missing exposure data reduced sample size for the regression models, 
possibly lessening the effect of factors significant in univariable analyses. 
 
Little of the variation in outcomes is explained by the regression models presented here.  
This means either there is a great deal of random variation in the outcome measures 
chosen, or there are other factors that I did not include or consider that determine these 
outcomes.  I was constrained in my selection of both outcome and exposure variables by 
the Waves in which certain questions were asked by the LSIC team.  Because no 
clinical measurements or record reviews are conducted for LSIC, there may be 
measurement error for questions about the child’s health and birthweight.   
 
The results may have been influenced by decisions about categorising variables.  For 
example, I placed the categories of the primary carer’s highest qualification on an 
ordinal scale, with a VET qualification placed higher than completing Year 12 
education only.  The non-linear relationship of this variable with outcome measures 
suggest this was an inappropriate order—probably reflecting the fact that school 
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attainment is not usually a prerequisite for enrolment in VET courses.  Other studies 
have dichotomised the Total Difficulties score, using screening cut-offs for risk of 
clinically-significant emotional and behavioural problems (12, 50), but I aimed to 
explore factors associated with better SDQ scores so the approach used was appropriate.  
Dichotomising continuous variables also reduces their precision, and the effect sizes 
estimated will be smaller than for the continuous variables from which they are derived 
(60).    
 
The construct validity of the SDQ has been established for Aboriginal children in urban 
NSW (61), but not for Aboriginal children elsewhere in Australia, nor for Torres Strait 
Islander children.  It is unknown whether better SDQ scores lead to better school 
performance or completion rates for Aboriginal and Torres Strait Islander children.  
However, in a large British study of seven year old children, Hartas (62) found a strong 
association between higher SDQ Total Difficulties score and below average teacher-
rated listening, reading and writing skills.  A similar effect was found for reading and 
spelling in another large study in the United Kingdom (63).  Linkage of the LSIC data 
with data from the National Assessment Program–Literacy and Numeracy (NAPLAN) 
assessments will shed light on this for the current context (28).   
 
IMPLICATIONS 
Because of modest effect sizes and poor explanatory power of the regression models, 
my study provides little guidance to policy makers working in maternal and child health 
on interventions to promote SEWB in children before school.  Generally, the 
prominence of life events and household occupancy lend weight to the social 
determinants theory of SEWB (9) and adds justification for holistic, trans-portfolio 
approaches.  The results also provide support for social and emotional screening early in 
life to prevent mental health problems later, and for the benefit in prosocial behaviours 
from promotion of physical health.   
 
Measuring SEWB for Aboriginal and Torres Strait Islander children for the purposes of 
policy development, program planning or evaluation is not straightforward.  If 
mainstream measures of mental health are used to plan and evaluate programs, then 
their limitations must be acknowledged.  Communities should be supported to develop 
their own measures of wellbeing.  This presents a challenge: striking a balance between 
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the need to privilege Indigenous ontologies and epistemologies, and the governments’ 
requirement to demonstrate investment accountability using indicators that can be 
applied throughout jurisdictions cost-effectively. 
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CHAPTER 4 – EVALUATION OF AUSTRALIA’S 
ENHANCED INVASIVE PNEUMOCOCCAL 
DISEASE SURVEILLANCE PROGRAM 
 
 
 
 
 
 
Truth is ever to be found in simplicity, and not in the multiplicity and 
confusion of things.  
 
Isaac Newton 
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Prologue 
My interest in pneumococcal diseases stems from working as a research nurse on 
middle ear disease projects in the Northern Territory, including a program monitoring 
pneumococcal carriage in children.  When I discovered that the national Invasive 
Pneumococcal Disease (IPD) surveillance program had never been evaluated, I took the 
opportunity to contribute to improving a system that has such relevance for the health of 
Aboriginal and Torres Strait Islander children.  
 
MY ROLE 
I approached Rhonda Owen and Cindy Toms at the Office of Health Protection (OHP) 
for permission to conduct the evaluation.  Cindy’s support and guidance early in the 
project proved very valuable, and she facilitated access to the Enhanced IPD 
Surveillance Working Group (EIPDSWG).  With regular review from my academic 
supervisor, I  
 developed the questionnaires for consultation with the Working Group members 
and OHP data managers (Appendix 4.2), conducted the phone interviews and 
collated and analysed the data 
 prepared the ethics application 
 developed the stakeholder survey (Appendix 4.3) and analysed the results 
 analysed the surveillance data for completeness, quality and timeliness 
 wrote the interim report for comment from the EIPDSWG (Appendix 4.4) 
 wrote the final report and the article for submission to Communicable Diseases 
Intelligence (Appendix 4.1). 
 
LESSONS LEARNT 
I already knew that response rates to surveys can be very low, but I was disappointed 
that only 28 people responded to the stakeholder survey.  I made a particular effort to 
ensure appropriate contacts in vaccine companies were sent the link to the survey, and 
this was rewarded.  However, I could have made greater attempts to liaise with 
professional organisations and networks to ensure a better response from laboratories 
and medical doctors. 
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I proposed a capture-recapture analysis using hospitalisation data to assess the 
sensitivity of the program and applied to data custodians for estimates of data and 
linkage costs, but OHP did not have the resources to cover this.   In hindsight, I think 
such an analysis would have added little to the evaluation, and a simpler approach was 
probably better.   
 
I vastly expanded my understanding of Streptococcus pneumoniae and pneumococcal 
diseases.  Insightful discussions with Working Group members and OHP staff brought 
home the realities of running a national surveillance program.  Initially, I had not 
appreciated the difficulties in collating data collected using the different jurisdictions’ 
systems.  I was reminded that variations and inconsistencies also occur in systems 
because they are run by people, who are (thankfully) not standardised, but diverse and 
idiosyncratic.   
 
PUBLIC HEALTH IMPACT 
This was the first evaluation of the program.  The EIPDSWG has taken action to 
address most of its recommendations. 
 
ACKNOWLEDGEMENTS 
The members of the Working Group were very generous with their time and expertise 
during interviews and when providing comments on the draft evaluation report.  I was 
impressed with their level of commitment to the program, which is reflected in its 
success.  I am particularly grateful to Heather Cook, EIPDSWG secretary, and Cindy 
Toms and Mark Trungove at OHP, who provided useful advice and support.   I would 
like to thank the stakeholders who responded to the evaluation survey; and Nick Pascual, 
who provided comments on the evaluation report and article. 
 
I’m also grateful to my fellow scholar, Amy Burroughs, who told me “don't overthink 
things – the best recommendations for system improvements are probably the most 
simple” and “you don't have to solve all the issues, just highlight them”.   
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Executive summary  
 
Introduction 
Australia’s Enhanced Invasive Pneumococcal Disease Surveillance Program is a part of 
the National Notifiable Diseases Surveillance System (NNDSS), and is coordinated by 
the Enhanced Invasive Pneumococcal Disease Surveillance Working Group 
(EIPDSWG).  Invasive Pneumococcal Disease (IPD) is caused when the bacterium 
Streptococcus pneumoniae invades a normally sterile site, leading to bacteraemic 
pneumonia, bacteraemia without focus, or meningitis.  It has been a notifiable condition 
in Australia since 2001, and passive surveillance
5
 is conducted in all States and 
Territories (‘the jurisdictions’).  Pneumococcal vaccination is funded under the National 
Immunisation Program (NIP) for all infants and for other high risk population groups.  
This is the first evaluation of the surveillance program.  The purpose of the evaluation is 
to: 
 assess the need for enhanced surveillance of IPD in Australia; 
 evaluate the program’s performance; 
 identify ways in which surveillance may be improved; and 
 make recommendations to the EIPDSWG. 
 
Methods 
I assessed the public health importance of IPD; described the program operation; and 
collected evidence regarding usefulness and performance against a number of attributes.  
I used a range of methods, including literature and document reviews; key informant 
interviews; an online stakeholder survey; and descriptive analyses of a subset of 
surveillance data.  An interim summary of the findings and recommendations was 
presented to the EIPDSWG for correction and comment. 
 
Findings 
Invasive pneumococcal disease remains a disease of public health importance in 
Australia.  It is relatively uncommon, and incidence rates have reduced by around 20% 
since 2003, remaining relatively unchanged for the past four years.  However, disease 
                                                 
 
5
 Passive surveillance consists of regular reporting of disease data by all institutions that see 
cases or test specimens, and are part of a reporting network. There is no active search for cases. 
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can be severe.  The case fatality rate for invasive pneumococcal pneumonia is just under 
20%; for pneumococcal meningitis is up to 37%, and serious disabilities in meningitis 
survivors are common.  Despite the positive impact of targeted vaccination programs, 
significant disparities in the incidence of IPD persist, with relatively higher rates among 
those aged under five and over 65 years, and among Aboriginal and Torres Strait 
Islander people.  Costs of IPD treatment and pneumococcal vaccination are substantial.  
Continued enhanced surveillance of IPD is vital to detect changes in serotype and 
resistance profiles, and to inform and evaluate vaccination and treatment strategies. The 
published surveillance program objectives broadly reflect these goals, but have not been 
endorsed by the EIPDSWG.   
 
The program is complex, with variation in notification processes, follow-up, data entry 
and transmission from the jurisdictions to the NNDSS.  The case definition for IPD 
involves laboratory confirmation (Box A), requiring the participation of a large number 
of public and private diagnostic laboratories, as well as four public health reference 
laboratories and the communicable disease branches in each jurisdiction (Figure A).   
Box A The case definition for a confirmed case of invasive pneumococcal 
disease (IPD), Australia, 2017.  Only confirmed cases are notified.  
 Isolation of S. pneumoniae from a normally sterile site by 
culture 
OR 
 Detection of S. pneumoniae from a normally sterile site by 
nucleic acid testing 
 
While data are collected for all notified cases, some jurisdictions do not routinely collect 
data on Indigenous status, vaccination history or enhanced data (including risk factors) 
for cases aged between five and 50 years.  Furthermore, data collection in some 
jurisdictions is hampered by the absence of accessible electronic health records.  
Summaries of surveillance data are published in regular IPD reports and NNDSS 
Annual Reports, and selected variables of the IPD dataset from 2009 to 2015 are 
publically available on the Australian Government Department of Health website.   
The program is useful for monitoring the effectiveness of the national infant 
pneumococcal vaccination program from 2005.  Surveillance data provided evidence of 
replacement of vaccine serotypes with a consequent change in the recommended 
vaccine for infants in 2011.  However, the program is less useful for evaluating the 
effectiveness of targeted vaccination programs in other high- risk groups, due to 
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Figure A Simple representation of the operation of Australia’s Enhanced Invasive 
Pneumococcal Disease Surveillance Program, 2017. 
 
missing vaccination and risk factor data for cases aged over five years.  There are 
inconsistencies between risk factor categories in jurisdictional data collection forms, the 
national dataset, and The Australian Immunisation Handbook 10
th
 Edition.  
Antimicrobial resistance (AMR) data collected during IPD surveillance has been 
requested by the Antimicrobial Use and Resistance in Australia (AURA) project for 
monitoring S. pneumoniae resistance.  Currently, the surveillance data have only 
moderate utility for this purpose, because reference laboratories are not funded to test 
susceptibility to the full panel of antimicrobials, and because problems with data entry 
and transmission in some jurisdictions has led to missing data on sensitivity to first-line 
antimicrobials.  Other stakeholders indicated that the public IPD dataset would be more 
useful if it included data in greater detail from 2001 onwards.  The EIPDSWG has 
proven a useful forum for rapid communication between jurisdictions and detection of 
outbreaks. 
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The quality and completeness of the surveillance data for cases aged under five years of 
age is excellent, but some issues were identified (Table A).  A key factor in the success 
of this program has been the engagement with the diagnostic laboratory networks 
during the planning and implementation phases.  Ongoing work is required to ensure the 
commitment of laboratories to forward IPD isolates to the reference laboratories for 
serotyping and AMR testing. 
 
Table A Issues affecting quality and completeness of data in Australia’s Enhanced Invasive 
Pneumococcal Disease Surveillance Program, 2017. 
Issue Data fields affected 
Jurisdictions affected 
all  some  
Cases aged 5-50 years 
not routinely followed up  
Vaccination history*    
Risk factors   
Clinical category   
Difficulty accessing 
medical records 
Vaccination history*   
Mortality   
Risk factors    
Clinical category   
Testing not performed Sensitivity to full panel of 
antimicrobials 
  
Serotype (non-culture specimens only)   
Data entry/transmission Sensitivity to first-line antimicrobials   
Data field missing from 
national data collection 
form 
Hospitalisation   
Data entry errors/  
illogical data 
Date fields   
Serotype/ Laboratory method   
*For cases aged over seven years prior to October 2016 only. The whole-of-life Australian 
Immunisation Register was introduced in 2016 to record all vaccinations administered under 
the NIP and most privately-funded vaccines. 
 
The sensitivity of the program for detecting cases of IPD is unknown, but EIPDSWG 
members and stakeholders felt that it was acceptable.  When a specimen was not sought 
(eg in milder illness), could not be obtained, or was obtained post-mortem, cases are not 
notified.  It is unlikely that false positives are a burden to the dataset. The median time 
between onset of disease and receipt of notification by the jurisdictions (six days), and 
between notification and publication of data summaries in Quarterly Reports (three 
months), was acceptable.  However, there is significant delay of transmission of 
enhanced data from the NNDSS to the National Centre for Immunisation Research and 
Surveillance (up to 10 months) due to data quality checks.   
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Over 15 years, the program has been flexible enough to accommodate changes in IPD 
epidemiology and available vaccines, and to continue to provide relevant data to 
stakeholders.  However, the program needs to accommodate trends in laboratory 
methods.  In particular, the increase in the proportion of cases confirmed by polymerase 
chain reaction (PCR) only will reduce the program’s ability to attain high completeness 
for serotype and AMR data fields.  Predicted moves to whole-genome sequencing for 
pneumococcal disease diagnosis and surveillance must be managed.  Steps must be 
taken to ensure the succession of EIPDSWG members who, through their passion for 
IPD prevention, have ensured the stability and longevity of the program.  Although 
complex, the IPD surveillance program is a highly useful, flexible and stable system 
that is acceptable to users and stakeholders.   
  
 139 
 
Recommendations to the EIPDSWG 
Priority Recommendations 
 Collect complete surveillance data for all cases in all jurisdictions.  If resource 
constraints preclude this in some jurisdictions, consider prospectively following-up 
a random sample of cases aged five to 50 years. 
 Ensure researchers and vaccine developers can access the data at the level of 
detail they require in the public dataset, while maintaining the privacy of cases. 
This includes 
 finer stratification of age-groups for cases aged less than five years 
 data from 2001 onwards 
 all available serotype data 
 data on vaccine failures. 
 Improve the completeness and quality of antimicrobial resistance (AMR) data by 
 addressing issues with data transmission in some jurisdictions 
 agreeing on the standards for reference laboratory AMR testing 
 advocating for funding for reference laboratories to undertake this 
testing for every case. 
Other Recommendations 
 Review the program objectives to 
ensure they reflect the EIPDSWG’s 
aspirations for the program. 
 Harmonise notification processes, 
data collection forms and data 
transmission from the jurisdictions to 
the NNDSS. This should include 
standardising risk factor data domains 
to ensure they reflect groups at high 
risk of IPD, as identified in the 
Australian Immunisation Handbook 
10th Edition. 
 Advocate for all jurisdictions to 
implement exclusively electronic 
laboratory notification systems, 
ensuring that these collect data 
consistent with the NNDSS data 
fields.   
 Support jurisdictions to modify their 
databases to prevent entering non-
logical data, and to conduct post-
entry logic checks, where these are 
not already in place.   
 Working with relevant partners, plan 
for the shift to whole genome 
sequencing by overseeing the 
development of quality standards for 
IPD sequencing and bioinformatics, 
and by auspicing pilot 
implementation studies.   
 Work with the Public Health 
Laboratory Network to enhance 
engagement and communication 
with diagnostic laboratories to 
ensure their full participation. This 
should include a review and 
promotion of the guidelines for 
forwarding samples to reference 
laboratories. 
 Implement succession planning 
interventions to ensure there is depth 
of capacity within the EIPDSWG, 
reference laboratories and 
jurisdictions to maintain the program 
at the current high standard. 
  
 140 
 
Introduction   
Invasive pneumococcal disease (IPD) is caused when the respiratory pathogen 
Streptococcus pneumoniae invades a normally sterile site (4). This Gram-positive 
bacterium is transmitted person-to-person via respiratory droplets and colonises the 
nasopharynx of many children within the first year of life, with carriage peaking at 
around 55% at three years of age and declining to less than 10% in adulthood (5).  
Determinants of colonisation include overcrowding, childcare attendance, and exposure 
to tobacco smoke (6). 
 
Local spread of the pathogen can cause non-invasive infections such as otitis media, 
sinusitis and non-bacteraemic pneumonia (7), often in the presence of viral infections (8, 
9).  In susceptible people, organisms may migrate to the bloodstream and cerebrospinal 
fluid (CSF), leading to invasive disease (2).  The most common types of IPD are 
bacteraemic pneumonia, bacteraemia without focus, and meningitis (8).  Other sterile 
sites less commonly infected include the joints, bones, peritoneum, and pericardium (2).  
Over 90 serotypes of S. pneumoniae have been identified, although not all cause disease, 
and some are more likely than others to be associated with IPD and poorer outcomes 
following infection (10).  IPD cases tend to be sporadic and epidemics—occurring 
mainly in institutions (11) and disadvantaged populations, including in Aboriginal 
and/or Torres Strait Islander communities (12, 13)—are now rare. 
 
IPD has been a notifiable condition nationally since 2001, and enhanced passive 
surveillance is conducted in all jurisdictions (14).  This surveillance is a part of the 
National Notifiable Diseases Surveillance System (NNDSS) and is coordinated by 
the Enhanced Invasive Pneumococcal Disease Surveillance Working Group 
(EIPDSWG), a subcommittee of the Communicable Diseases Network Australia 
(CDNA) (15).  Although the NNDSS as a whole was evaluated in 2004 (1), an 
evaluation focused on the IPD Surveillance Program has not been conducted.  The 
purpose of this evaluation is to: 
 assess the need for continued surveillance of IPD in Australia; 
 determine whether the stated program objectives are appropriate, and the 
extent to which they are being met; 
 identify ways in which surveillance may be improved; and 
 make recommendations to the EIPDSWG. 
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Methods  
 
For this evaluation, I followed the framework outlined in the Centers for Disease 
Control and Prevention’s Updated Guidelines for Evaluating Public Health 
Surveillance Systems (16). My objectives were to describe how the program 
functions and collect credible evidence to evaluate  
 the usefulness of the program; and 
 its performance against the attributes of simplicity, flexibility, data quality, 
acceptability, sensitivity, predictive value positive, representativeness, 
timeliness and stability.   
 
I used literature and document review, key informant interviews, and descriptive 
analyses of surveillance data (Table 1), along with an analysis of the attributes listed 
above.  
 
LITERATURE AND DOCUMENT REVIEW 
To review the public health importance of IPD, the usefulness of the surveillance 
system and advances in laboratory methods, I conducted a literature search of the 
SCOPUS, PubMed and Google Scholar databases using the terms “invasive 
pneumococcal disease”, “Australia”, “epidemiology”, “surveillance”, “whole genome 
sequencing” and “culture-independent diagnostic tests”.  I also scanned the reference 
lists of all review articles and primary studies.  I inspected IPD-related content available 
on the Australian Government Department of Health website, notification forms and 
procedures published by the jurisdictions, the EIPDSWG’s Explanatory notes for 
completion of NNDSS Invasive Pneumococcal Disease Enhanced Surveillance data 
collection form, and the data notes and caveats for the IPD public dataset and NNDSS 
data.  I also examined the revision history for the dataset field specifications, to 
determine how these have been changed in response to changes in IPD epidemiology, 
vaccines and laboratory methods.   
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Table 1 Summary of methods used for the evaluation of Australia’s Enhanced IPD Surveillance Program, 2016 (16). 
Task Rationale/ Description 
Method 
Literature 
review 
Working 
Group 
consultation 
Stakeholder 
survey 
Surveillance 
data 
analysis 
Program 
document 
review 
Describe the public health 
importance of the disease 
Establish an ongoing need for surveillance      
Describe the program & its 
objectives 
Indicate how the surveillance data are collected and used for 
public health action  
     
Focus the evaluation design Ensure that time and resources are used efficiently      
Gather evidence of performance:      
Usefulness Contribution to prevention and control of IPD      
Simplicity Simplicity of structure and ease of operation      
Flexibility 
Ability to adapt to changing information needs or operating 
conditions 
     
Data Completeness & 
Quality 
The completeness and validity of the data collected      
Acceptability 
Willingness of persons and organisations to participate in the 
surveillance system 
     
Sensitivity 
Proportion of incident cases detected and the ability of the 
system to detect outbreaks 
     
Predictive Value Positive Proportion of notified cases that truly have IPD      
Representativeness 
Ability to accurately describe the occurrence of IPD over time 
and its distribution in the population by place and person 
     
Timeliness 
Time between steps in the system, production of useful data 
and timeliness for public health intervention 
     
Stability 
Ability to collect, manage and provide data properly without 
failure; and the ability to be operational when it is needed 
     
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COLLECTION OF DATA FROM KEY INFORMANTS 
I consulted with members of the EIPDSWG and Office of Health Protection (OHP) 
data managers at the Australian Government Department of Health between 16 June 
and 11 August 2016.  The EIPDSWG membership consists of representatives from 
communicable disease control units in all states and territories, the Vaccine 
Preventable Diseases section of OHP, National Centre for Immunisation Research 
and Surveillance (NCIRS) and from the four reference laboratories in Sydney, 
Melbourne, Perth and Brisbane.  Interviews were by phone or face-to-face.   I asked 
interviewees to confirm the relevance of the program’s published objectives, to 
describe the operation of the program in their jurisdiction, to assess the program’s 
performance and make suggestions for improvement. I also asked them to suggest 
questions to include in the stakeholder survey.  The interview data collection tool is 
included in Appendix 4.2.  
 
I emailed a link to an anonymous online survey to individuals and groups identified 
as surveillance stakeholders (Table 2).  The survey was open between 12 October 
and 14 November 2016, and was tailored to the affiliation indicated by the 
respondent.  Stakeholders were asked to assess the usefulness and performance of 
the program, to rate and describe their experience of notifying cases or using 
surveillance data (if applicable), and to make suggestions for improvement. The 
stakeholder survey is included in Appendix 4.3.   
 
DESCRIPTIVE ANALYSIS OF SURVEILLANCE DATA 
I analysed selected fields of the IPD surveillance dataset from 1 July 2013 to 30 June 
2016 (‘the study period’) to assess data completeness and quality.  I looked for patterns 
of data coded as: 
 ‘blank’ 
 ‘unknown’ 
 ‘not stated’ 
 ‘Followed up – information not available’ and ‘Not followed up’ (vaccine fields) 
 ‘not typed’ and ‘not referred’ (serotype field). 
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Table 2 Stakeholder groups and their interest in the IPD surveillance program. 
Stakeholder Group Interest in the IPD Surveillance Program 
Australian Technical Advisory 
Group on Immunisation 
(ATAGI) 
Advises the Minister for Health on vaccines and 
advises the Pharmaceutical Benefits Advisory 
Committee on the strength of evidence for 
existing, new and emerging vaccines (17) 
Pneumococcal vaccine 
manufacturers (Pfizer, 
Seqirus, GlaxoSmithKline) 
Use serotype data to monitor vaccine failure and 
develop new multivalent vaccines for the 
Australian market 
Antimicrobial Resistance 
(AMR) Coordination Unit, 
Australian Commission on 
Safety and Quality in Health 
Care  
Undertaking the Antimicrobial Use and 
Resistance in Australia (AURA) Project 
(development of an antimicrobial resistance 
surveillance system)  
Infectious Diseases Physicians, 
Paediatricians and other 
medical officers 
Make diagnoses of IPD and may notify, may use 
antimicrobial resistance data to guide treatment 
decisions 
Department of Prime Minister 
and Cabinet 
Responsible for some areas of Aboriginal and 
Torres Strait Islander health policy 
Commonwealth, state and 
territory health departments 
Conduct surveillance and responsible for 
vaccination policy and programs 
Public and private laboratories Notify IPD cases 
Researchers and academics 
active in field of 
pneumococcal disease 
Use data to explore changes in pneumococcal 
disease epidemiology and vaccine effectiveness 
 
 
To assess the timeliness of the system over the study period, I calculated mean and 
median days between onset date, specimen date, date the notification was made and the 
date the notification was received by the jurisdiction.  Jajosky and Groseclose (18) 
recommend assessing a system’s ability to detect outbreaks in a timely manner by 
calculating the percentage of cases that are reported within one and two incubation 
periods of  the disease, surrogate measures for the period of communicability.   The 
incubation period for IPD ranges from one to seven days (19), so I calculated the 
proportion of case notified within seven and 14 days from disease onset.  Cases with 
missing or invalid date values were excluded from the timeliness analysis.   
 
ETHICAL REVIEW 
The stakeholder survey and surveillance data analysis were reviewed and approved by 
the Australian National University Human Research Ethics Committee (Protocol: 
2016/583). 
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Findings 
In this section I present the results of analysis of data from all sources, together with a 
discussion of their significance and the relevant recommendations.  A summary of the 
conclusions and recommendations is given in the next section. 
 
I conducted twenty interviews with EIPDSWG members and OHP data managers.  All 
jurisdictions and reference laboratories were represented.  On average, members had 
seven years of experience on the Working Group, and six were founder members.  
There were 28 responses to the stakeholder survey.  Most respondents were researchers 
or from diagnostic laboratories, and five nominated more than one affiliation (Table 3).  
None of the respondents indicated an affiliation with ATAGI or the Antimicrobial 
Resistance (AMR) Coordination Unit. 
 
Table 3 Affiliation of stakeholder survey respondents. 
Group Number of respondents* 
Researcher or academic 11 (39%) 
Diagnostic laboratory (public or private) 7 (25%) 
Vaccine manufacturer 4 (14%) 
State/territory policy and programs 4 (14%) 
NCIRS 3 (11%) 
Infectious Disease Physician 2 (7%) 
Paediatrician 1 (4%) 
Public Health Practitioner 1 (4%) 
Total 28  
* Five respondents indicated more than one affiliation (two researchers/academics and NCIRS; one 
researcher/academic and paediatrician; one researcher/academic and public health practitioner; one 
researcher/academic and State/Territory policy and programs)  
 
THE PUBLIC HEALTH IMPORTANCE OF INVASIVE PNEUMOCOCCAL DISEASE IN 
AUSTRALIA 
RELATIONSHIP TO NON-INVASIVE PNEUMOCOCCAL DISEASE   
The surveillance case definition excludes non-invasive infections. Therefore data from 
the surveillance program does not capture the true burden of all pneumococcal diseases.  
It has been estimated that for every bacteraemic pneumonia that is reported, three non-
bacteraemic infections occur (10).  Isolation of the organism in cases of non-
bacteraemic pneumonia is difficult (2), however S. pneumoniae may account for around 
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15% of all community-acquired pneumonia in Australian adults (20).  Pneumococcal 
pneumonia is recognised as a complication of both seasonal and pandemic influenza, 
and was associated with critical illness during the 2009 influenza A (H1N1) pandemic 
(10).    
 
Over 520,000 hospital discharges coded for pneumonia in the 2006-07 year were 
identified in one study (21) , while another estimated the average annual rate of initial 
general practitioner (GP) visits for pneumonia over the period 2006 to 2009 at 
approximately 800 per 100,000 population (22).   
 
The most common non-invasive manifestation of pneumococcal disease in children is 
acute otitis media (AOM), with S. pneumoniae implicated in 28 to 55% of cases (23).   
Otitis media (OM) ranges from effusion behind the eardrum, to suppurative infection 
with or without perforation (AOM) with ear discharge that may become chronic (24).  
Estimates of annual episodes of all forms of OM in Australia range from 1.17 million 
(25) to 2.40 million (26).  Most OM is mild and self-limiting (27).  However, OM 
complications include mastoiditis, meningitis, brain abscess and permanent hearing loss 
(28).  
 
FREQUENCY 
When national notification came into full effect in 2002, IPD notification rates were 
11.5 per 100,000 population (29). Rates dropped markedly to 7.0 per 100,000 
population in 2006 following the introduction of a universal seven-valent pneumococcal 
conjugate vaccine (7vPCV) program for infants in 2005 (30). Since then, rates have 
been generally stable (Figure 1) (31, 32), with an increase in 2011 which can be largely 
attributed to an outbreak of disease due to Serotype 1 (33). The 13-valent pneumococcal 
conjugate vaccine (13vPCV) replaced the 7vPCV in 2011 (34).  Approximately 1,500 
cases were reported in 2015, representing a notification rate of 6.7 per 100,000 (15).  
Notifications of IPD are highest during the winter months (15). The burden of IPD is 
borne predominantly by those aged under five years and over 65 years (Figure 2), and 
rates have declined in both these age groups since 2002 (14). 
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Figure 24 Notified cases and rates of IPD, Australia, 2002 to 2016 (32, 35). 
  
 
 
Figure 25 Notification rates of IPD, Australia, 2014, by age group and sex (31). 
 
 
0
2
4
6
8
10
12
14
0
500
1000
1500
2000
2500
3000
3500
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
R
at
es
 p
er
 1
0
0
,0
0
 p
o
p
u
la
ti
o
n
/y
ea
r 
N
o
ti
fi
ed
 c
as
es
 
Diagnosis year 
Notified cases
Rates
 148 
 
Risk factors for developing IPD following colonisation are shown in Table 4. The 
combination of diabetes, chronic heart disease and chronic obstructive pulmonary 
disease in people over age 19 years places them in the highest category of risk (36).  In 
Australia, common risk factors in 2009 and 2010 for notified cases aged less than five 
years included prematurity (<37 weeks gestation), childcare attendance and 
immunocompromise (14).  Common risk factors for cases aged 65 years or older and 
Aboriginal and Torres Strait Islander cases aged 50 years or older included chronic 
illness and immunocompromise (14).   
 
Table 4 Conditions associated with an increased risk of IPD in children and adults, by severity 
of risk (23). 
Highest 
Increased 
Risk 
Functional or anatomical asplenia 
Immunocompromising conditions: 
 congenital or acquired immune deficiency 
 immunosuppressive or radiation therapy   
 haematological and other malignancies 
 solid organ  or haematopoietic stem cell transplant 
 HIV (including AIDS) 
 chronic renal failure, or relapsing or persistent nephrotic 
syndrome 
Cerebrospinal fluid leak 
Cochlear implants 
Intracranial shunts 
Increased 
Risk 
Chronic cardiac disease: 
 cyanotic heart disease or cardiac failure in children 
 excluding hypertension only (in adults) 
Chronic lung disease: 
 chronic lung disease in preterm infants 
 cystic fibrosis 
 severe asthma in adults  
Diabetes and other metabolic diseases 
Autoimmune conditions (eg systemic lupus erythematosus, 
rheumatoid arthritis and multiple sclerosis) 
Down syndrome 
Alcoholism 
Chronic liver disease 
Preterm birth at <28 weeks gestation 
Tobacco smoking 
 
SEVERITY 
Invasive pneumococcal pneumonia has a 30-day mortality of 17-19% (37, 38). Cases 
may present first with symptoms of meningitis, sepsis, pericarditis or peritonitis (39).  A 
common complication is pleural effusion with empyema; less common are lung abscess, 
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necrotising pneumonia and acute respiratory distress syndrome; and haemolytic uraemic 
syndrome is rare (2). 
 
Bacteraemia without focus accounts for around 70% of IPD in children (23).  Signs and 
symptoms in the absence of focal disease are usually non-specific, and may include 
fever, lethargy and irritability, with febrile convulsions occurring in some children (40).  
Complications include the development of focal infection, sepsis and septic shock (40). 
 
Mortality from pneumococcal meningitis in developed countries ranges from 16 to 37%  
(41).  It usually occurs after pneumococcal bacteraemia (2), and presents with 
symptoms and signs including headache, irritability, fever, lethargy, vomiting, neck 
stiffness, seizures and coma (41).  Cerebrovascular complications, including stroke and 
venous thrombosis, are common (41).  Serious neurological sequelae are common, and 
include cognitive and motor deficits in around 25% of cases and hearing loss in around 
32% (2).  Severe lifelong sequelae occur in nearly 10% of infant meningitis and 
moderate sequelae in an additional 14% (42).  
 
In 2015, 83 deaths from IPD were reported
6
, although mortality data was provided for 
less than two thirds of notified cases (14).  There were 3,615 hospitalisations for IPD 
meningitis and bacteraemia only from 2005 to 2010, which is an annual rate of 18.9 per 
100,000 population for Aboriginal and Torres Strait Islander people, and 3.2 for others 
(43).  
 
 
PREVENTABILITY 
The 23-valent pneumococcal polysaccharide vaccine (23vPPV) contains 
polysaccharides from the serotypes causing the majority of IPD in Australian adults 
(23).  It induces a significant antibody response in adults, but is poor at generating an 
immune response in young children and immunocompromised adults, and has little 
effect on nasopharyngeal carriage as it does not induce an immune memory response (6).  
The 23vPPV has been available and recommended for people with specified high risk 
medical conditions since before 1991 (23).  Pneumococcal conjugate vaccines contain 
                                                 
 
6
 deaths within the first two weeks of diagnosis 
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fewer serotypes but are immunogenic in young children and induce an immune memory 
(23). Introduction of pneumococcal conjugate vaccination programs in infants also leads 
to a decrease in IPD and pneumococcal carriage in unvaccinated people (44).  The 
7vPCV was funded by the NIP for all infants at two, four and six months of age from 
2005 and was replaced by the 13vPCV in 2011 (34).  This change was made in response 
to an increase in non-7vPCV serotypes observed in notified cases.  The 10-valent 
pneumococcal conjugate vaccine was funded for all children in the NT aged two, four, 
six and 18 months from 2009 and replaced by 13vPCV in 2011 (34).  Current 
pneumococcal vaccination practice in Australia, and the serotypes targeted by vaccines 
are shown in Table 5.  In July 2016, the Pharmaceutical Benefits Advisory Committee 
recommended a change in the schedule to a single 13vPCV dose for pneumococcal 
vaccine naïve non-Indigenous adults aged 65 years and over and pneumococcal vaccine 
naïve Aboriginal and/or Torres Strait Islander adults aged 50 years and over (45), 
although this has not yet been implemented.    
 
Table 5 Pneumococcal vaccines, recommendations and serotypes targeted, 2016 (23). 
Vaccine type Recommendation 
Serotypes targeted 
by the vaccine 
13-valent 
pneumococcal 
conjugate 
vaccine 
(13vPCV) 
 Infants at 2, 4 and 6 months of age 
 Aboriginal and/or Torres Strait Islander 
children at 12-18 months of age living in NT, 
QLD, SA and WA 
 Adults with a medical condition(s) associated 
with the highest increased risk of IPD (see 
Table 4) 
1, 3, 4, 5, 6A, 6B, 7F, 
9V, 14, 18C, 19A, 19F 
and 23F. 
23-valent 
pneumococcal 
polysaccharide 
vaccine 
(23vPPV) 
 Aboriginal and/or Torres Strait Islander 
people  aged ≥50 years 
 Adults aged ≥65 years 
 Children aged >5 to <18 years with chronic 
medical condition(s) associated with 
increased risk of IPD (see Table 4) 
 Adults with a condition(s) associated with an 
increased risk of IPD (see Table 4) 
1, 2, 3, 4, 5, 6B, 7F, 8, 
9N, 9V, 10A, 11A, 
12F, 14, 15B, 17F, 
18C, 19F, 19A, 20, 
22F, 23F and 33F. 
 
Invasive pneumococcal disease notifications have decreased since the introduction of 
pneumococcal conjugate vaccines, but there has been an associated increase in the 
proportion of serotypes not covered by the 7vPCV (Figure 3) (15).  There were also 
marked reductions in all-cause pneumonia hospitalisations for children (38% for 
children aged <2 years; 28% for children aged 2 to 4 years) in the 30 months following 
the introduction of the 7vPCV program (21).  A recent study estimated that over the five 
year period of the 7vPCV program, 162 IPD deaths, 5 783 IPD hospitalisations and 60 
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cases of moderate or severe disability from meningitis were averted (46).  The program 
also prevented nearly 12 000 myringotomies with ventilation tube insertion, and over 22 
000 hospitalisations and 5 100 deaths from non-invasive community-acquired 
pneumonia (46).  The trend of lower rates of notifications has shown a decline since the 
introduction of the 13vPCVin 2011 (47).  Data from 2014 indicates that 60-70% of IPD 
in age groups targeted by the 23vPPV program is caused by serotypes included in this 
vaccine (15).  Ongoing surveillance of IPD is vital to detect serotype replacement and 
emergence of disease-causing serotypes, and to identify and evaluate vaccination 
programs (43).  
 
 
 
 
Figure 26 Notifications of invasive pneumococcal disease, Australia, 2002 to 2016, year and 
quarter, by vaccine serotype group (32).  
 
Tertiary prevention for IPD includes antimicrobial treatment, general supportive care 
and intensive care (2).  Surveillance data indicates that the rate of resistance to penicillin 
and ceftriaxone/cefotaxime increased to 16% in 2010, with resistance mainly evident in 
serotypes 19A (the serotype that accounted for the highest number of deaths) and 19F 
(14).   Continued surveillance will provide data on prevalence of resistant serotypes in 
the population, and inform treatment choices for invasive and non-invasive disease.   
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COST 
The estimated costs (to the health care system) and quality-adjusted life years (QALYs) 
lost for each case of pneumococcal disease in children aged under 5 years in 2011 are 
shown in Table 6 (42).  The estimated cost of treating pneumococcal pneumonia and 
invasive bacteraemia and meningitis in people aged 65 years and over was $56.9 
million in 2012 (48). The annual average general practitioner-related cost of all-cause 
pneumonia over 2006 to 2009 in all age groups were approximately $20 million per 
year (22).  Treatment costs for OM in 2008 were estimated to be between $100 million 
and $400 million (26).  The net cost to the NIP of the 13vPCV program was estimated 
at less than $10 million in 2015 (49).  The cost of the 23vPPV to the Pharmaceutical 
Benefits Scheme was $611,310 in 2011 (50).    
 
Table 6 Estimated costs and QALY loss for each case of pneumococcal disease in children aged 
under 5 years, 2011 (42).  This table includes non-invasive pneumonia and otitis media (OM). 
Parameter  Cost/Loss 
per case  
Cost Hospitalisation  
Meningitis  $10 132  
Bacteraemia  $8 666  
Pneumonia* $3 788 
OM $1 641 
Hearing loss (meningitis)  
Hearing aid/s (every 5 years):  
21–64 years (private)  $2 000  
Others ages (public)  $500  
Fitting (every 5 years)  $500  
Maintenance (per year)  $137  
Cochlear implant  $27 505  
Moderate disability   
5–17 years  $9 540  
18+ years  –  
Severe disability   
5–17 years  $23 353  
18+ years  $82 500  
QALY 
loss 
Hospitalisation  
Meningitis  0.0232  
Bacteraemia  0.0079  
Pneumonia* 0.006 
OM 0.009 
Outpatient cases   
Pneumonia* 0.004 
OM 0.005 
Moderate disability (per year)  0.09  
Severe disability (per year)  0.54  
*Includes non-bacteraemic pneumonia 
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DISPARITIES 
In 2014, the incidence rate of notification for Aboriginal and Torres Strait Islander 
people was around six times higher than for other Australians (Figure 4) (14).  There 
was an 87% reduction in notifications of IPD caused by 7vPCV serotypes between 2001 
(when the 7vPCV program among Aboriginal and Torres Strait Islander children began) 
and 2010 (43).  However, the reduction was not as steep as for other children, due to a 
lower proportion of IPD caused by 7vPCV types before vaccine introduction (43).  
Prevalence of OM among Aboriginal children is 42%, the highest rate in the Asia-
Pacific (25).   
 
 
Figure 27 Notifications and notification rates of invasive pneumococcal disease, Australia, 2005 
to 2014, by year and Indigenous status (31). 
 
 
PUBLIC AND POLITICAL INTEREST 
As a disease with limited outbreak potential, IPD is unlikely to generate the public and 
political interest garnered by some other communicable diseases.  However, in 2008 the 
Council of Australian Governments agreed to six targets to address Aboriginal and 
Torres Strait Islander disadvantage, including closing the gap in life expectancy by 2031 
and halving the gap in mortality rates for children under five by 2018 (51).  Given the 
disparity in pneumococcal disease burden between Aboriginal and Torres Strait 
Islanders and other Australians, addressing this disease is important politically and 
ethically.   
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CONCLUSION  
IPD is a severe disease with high rates of mortality, incidence of disability in survivors 
and costs to the health system.  Non-invasive pneumococcal disease, while less severe, 
has high incidence.  Vulnerable groups—particularly the very young, elderly and 
Aboriginal and Torres Strait Islander people—are over-represented in pneumococcal 
disease incidence.  The World Health Organization recommends routine surveillance of 
IPD, on the grounds of the disease’s severity and the availability of vaccines (52).  
 
While significant gains in pneumococcal disease incidence have been made as result of 
vaccination programs, these have not been shared equally among all groups at risk, and 
the emergence of serotype replacement and antimicrobial resistance continues to 
threaten primary and tertiary prevention strategies.  Continued national surveillance of 
this disease of public health importance will inform the development and evaluation of 
vaccination programs and contribute to closing the gap on Aboriginal and Torres Strait 
Islander disadvantage. 
 
 
PROGRAM OPERATION  
In this section, I present the findings related to the surveillance program operation, 
including the surveillance case definition, management and flow of data, and the human 
resources required to operate the program.  This provides the context in which to 
discuss the objectives of surveillance.   
 
The legislative basis for the collection of data required for the functioning of the IPD 
surveillance program and the other systems in the NNDSS is provided by the public 
health legislation of each state and territory (53).  States and territories voluntarily 
forward these data to the Australian Government Department of Health for the purpose 
of surveillance.  The exchange of this information, including personal information, 
between jurisdictions and the Commonwealth is authorised by the National Health 
Security Act 2007.   The National Health Security Agreement supports this legislation, 
and is a policy and administrative arrangement that outlines the operational procedures 
and mandatory data (unique record number, notifying State or Territory, disease code, 
and date of receipt of notification) to be provided to the Australian Government (54).  
Under this agreement, “additional data may be provided as defined in the NNDSS Core 
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and Enhanced Datafield Specifications”.  Governance of the enhanced data fields is the 
responsibility of the EIPDSWG, which meets by teleconference quarterly and 
 assures data quality, for example through the development and review of 
explanatory notes for all fields of the national IPD dataset  
 provides a network for a coordinated response to changes in IPD 
epidemiology, the NIP and laboratory methods. 
 
 
SURVEILLANCE CASE DEFINITION 
The national case definition for a confirmed case of IPD is  
 Isolation of S. pneumoniae from a normally sterile site by culture 
or 
 Detection of S. pneumoniae from a normally sterile site by nucleic acid testing 
(4). 
 
Only confirmed cases are notified. This case definition has not essentially changed since 
2001 (55), although the method of detection was explicitly articulated later, in 2004 (56). 
 
 
DATA MANAGEMENT, FLOW AND REPORTING 
Data collection for the program is integrated into the systems set in place for the 
NNDSS.  The components of the program are described in Table 7.  Dataset fields for 
core and enhanced data are specified and have undergone several revisions since 2001.  
Enhanced data collection is supported by detailed explanatory notes which define 
dataset fields, indicate acceptable data sources, and provide explanations or examples 
for each field (57).  Figure 5 illustrates how surveillance data flows through the system.   
 
Laboratories and pathologists are required by law to notify cases of IPD in all 
jurisdictions.  All medical practitioners are required to notify cases in SA, Victoria, NT 
and ACT.  Each jurisdiction uses a different form for notification. Most notifications are 
received by the state or territory Communicable Diseases branch passively from the 
primary diagnostic laboratories (public or private).  Occasionally notifications are 
received directly from a medical practitioner.  Some primary diagnostic laboratories do 
not have the ability to perform nucleic acid testing (polymerase chain reaction, PCR), so 
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must forward these samples to a secondary laboratory.  Isolates are forwarded to a 
reference laboratory for serotyping using the Quellung reaction (for culture-positive 
specimens) or, in around 5% of cases, molecular typing (for PCR-positive specimens) 
(35).   Serotype data are usually received by the jurisdictions from the reference 
laboratories some weeks after the initial notification, and are cross-checked against the 
notification data.  While susceptibility to first-line antimicrobials is assessed by the 
diagnostic laboratory, susceptibility to the full panel of antimicrobials is only routinely 
conducted on suitable specimens from Queensland and NT.   
 
While data are collected for all notified cases, Victoria and NSW—the jurisdictions 
with the largest populations— do not routinely collect data on Indigenous status, 
vaccination history or enhanced data (including risk factors) for cases aged between five 
and 50 years.  In 2015, this subgroup consisted of 29% and 25% of notifications in 
Victoria and NSW respectively, which is over 13% of cases nationally.  Routine 
collection of enhanced data on these age groups in Queensland is not universal, and 
varies by local public health unit (PHU).  If cases were admitted to a public hospital, the 
epidemiologist collects enhanced data from the integrated electronic inpatient medical 
record.  In smaller jurisdictions (eg ACT and NT) all follow-up and enhanced data 
collection is conducted by the Public Health Nurse (PHN), surveillance officer or 
epidemiologist in the Communicable Diseases Branch.  In larger jurisdictions, case 
follow-up is delegated to officers in the local PHU.  Direct access to clinical data varies 
widely between jurisdictions and PHUs.  For example, in the NT, the PHN has access to 
all electronic hospital, laboratory and (all-ages) vaccination data, and quite often 
contacts the case or their family directly to obtain data.  In contrast, public health 
officers in Victoria must request copies of hospital discharge summaries and GP 
vaccination records, and only have electronic access to childhood vaccination data via 
the Australian Childhood Immunisation Register
7
 (ACIR).  In all jurisdictions, entered 
data are checked for errors and missing data by the epidemiologist or PHN.   
 
Deidentified data are automatically transmitted daily to the NNDSS.  The exceptions are 
in WA, Tasmania and ACT, where all data are sent manually and the enhanced data are 
transmitted quarterly or annually rather than daily.  Extra transmissions are made on 
                                                 
 
7
 The Australian Immunisation Register was introduced in October 2016. 
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request.  Core data are collated into a fortnightly report for the CDNA, and published on 
the Department of Health website (58).  Every quarter, the NNDSS data officer emails a 
spreadsheet of line-listed cases back to the jurisdictional officer for checking.  Once 
checked, the core data are collated into a quarterly report for review and public release 
(59).   
 
Complete core data and enhanced data are sent to NCIRS approximately monthly and 
annually, respectively.  These data form the basis of NCIRS’ advice to ATAGI 
regarding vaccines to be included in the NIP. The EIPDSWG also aims to publish an 
annual report, but the latest combines the 2011 and 2012 reports (35).  Annual IPD data 
are included in the NNDSS annual reports, most recently 2014 (60).  Every year, the 
EIPDSWG sends a report to all laboratories, outlining the epidemiological status of IPD 
nationally and in the laboratory’s jurisdiction.  Selected surveillance data from 2009 to 
2014 are available publicly on the Department of Health’s website (59).  
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Table 7 Components of Australia’s Enhanced IPD Surveillance Program, 2016.  
Component Description 
Population under surveillance (14) 
Core data 
All Australian residents 
 Indigenous status & vaccination history are not routinely collected for cases aged 5 -49 years in 
NSW & Victoria 
Enhanced data  All ages ACT, NT, TAS, SA & WA 
 Under 5 years & 50 years and 
over 
QLD* (61), Victoria† (62) & NSW 
Who is required to 
notify 
 Laboratories: all jurisdictions 
 Medical practitioners: NT‡ , SA, VIC, ACT 
 Authorised Nurse Practitioners & hospitals: ACT 
Data collected  
Core data  State/Territory 
 Notification ID 
 Disease code 
 Organism code and Name 
 Serogroup subtype  
 Confirmation status 
 Laboratory diagnosis method 
 Vaccination history (status, validation and doses) 
 Resident postcode and location 
 Dates of onset, specimen collection, notification made 
and notification received 
 Date of birth 
 Age at onset 
 Sex 
 Indigenous status 
 Died 
 Outbreak reference 
 How the notified case was 
identified 
 Place of acquisition 
 Hospitalised 
 Date of last vaccination 
 Details of up to five vaccinations 
* Follow-up of enhanced data in Queensland varies between Public Health Units.  Since 2014, the epidemiologist has been able to follow up all cases admitted to 
public hospitals through the integrated electronic health record system. (61) 
† Prior to 30 June, 2012, Victoria followed up the collection of enhanced data on all ages. Between 1 July 2012 and 31 December 2012, and from 2014 
to the present, Victoria only followed up the collection of enhanced data in the under 5 years and the 50 years and over age groups (62, 63).  
 
‡ In the NT, medical practitioners are required to notify cases, but IPD is not included in the doctors’ notification form (64). 
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Component Description 
Data collected  
Enhanced data  Risk factors 
 Gestational age 
 Clinical category of IPD (bacteraemia, meningitis, pneumonia, or other) 
 Date died 
 The specimen from which the organism was obtained 
 Susceptibility to first-line antimicrobials 
 Susceptibility to full panel of antimicrobials 
Data sources  
Core data (except 
serotype   and 
vaccination history) 
 Primary public and private laboratories 
 Clinicians: general practitioners, hospital medical officers, infection control nurses and/or 
discharge summaries 
Serotype data (and 
full panel 
susceptibility in QLD 
and NT only) 
Reference laboratories: 
 Microbiological Diagnostic Unit Public Health Laboratory, University of Melbourne (VIC, TAS & 
SA cases) 
 NSW Health Pathology (NSW & ACT cases) 
 Pathwest Laboratory Medicine (WA cases) 
 Queensland Health Forensic & Scientific Services (QLD & NT cases) 
Vaccination history  Australian Immunisation Register (prior to October 2016: Australian Childhood Immunisation 
Register for cases under 7 years of age only) 
 clinical record, general practitioner or the case/family 
 NT: Northern Territory Immunisation Register (NTIR) – all adults and children 
 QLD: Vaccination Information and Vaccination Administration System (VIVAS) – for children up 
to age 10 years, adult refugees, and 23vPPV for Indigenous adults (65) 
Other enhanced data   Obtained from clinicians by jurisdictional surveillance officers or local public health  officers 
  In some jurisdictions, officers have direct access to electronic clinical records, and/or contact 
cases or their families directly 
 160 
 
Component Description 
Data Management 
systems (entry, transfer, 
storage etc) 
 Notifications and reference laboratory data are received by jurisdictions via online reporting, 
fax, post, or (less commonly) phone calls  
 Various methods of data entry, including  
o hand-written notification/case report forms or laboratory log entries, later transcribed 
into web-based databases or spreadsheets 
o direct data entry into databases or spreadsheets  
 Predominantly, core data are automatically transmitted to NNDSS nightly. Enhanced data are 
transmitted daily or quarterly.  Some jurisdictions manually email a spreadsheet of core and 
enhanced data quarterly. 
 Each quarter, a spreadsheet of cases notified to NNDSS are emailed to each jurisdiction for 
checking, cleaning and further follow-up 
 Data transmitted to NCIRS from NNDSS monthly (core data) and annually (enhanced data)  
Data privacy and 
security systems 
 All electronic databases are backed up on departmental servers 
 Data transmission either automatic or through secure fax or email 
 Only de-identified data transmitted to NNDSS 
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Figure 28 IPD case notification and reporting of surveillance data, 2016. 
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RESOURCES 
Members of EIPDSWG report that 181 staff are involved in IPD surveillance data 
collection nationally, including reference laboratory staff, but all have other duties.  
Reference laboratories stated that testing, data entry and reporting for each case took an 
average of 30 minutes, but sometimes up to an hour.  Members from jurisdictional 
health departments reported a wide variation in estimates of the time spent on data 
collection for each case.  Generally, data collection in jurisdictions with electronic 
access to clinical records takes 90 minutes or less per case, but three to 10 hours per 
case in jurisdictions without electronic access.   
 
The costs of conducting IPD surveillance include those related to reference laboratory 
testing, case follow-up, data entry, reporting, and information technology technical 
support and maintenance. Under the Project Agreement for Vaccine Preventable 
Diseases Surveillance Program the Australian Government will provide the States and 
Territories with $845 000 for reporting of surveillance data on the 15 nationally 
notifiable vaccine-preventable diseases (including IPD) during the 2016-17 financial 
year (66).  This includes payments to the Northern Territory for provision of secretariat 
services to the EIPDSWG.    
 
PROGRAM OBJECTIVES 
There are five objectives for the surveillance program published on the Department of 
Health’s website  (Table 8) (53).  These have not been endorsed by the EIPDSWG.  I 
asked EIPDSWG members comment on each objective and indicate whether they were 
still relevant and being achieved.   
 
Overall, EIPDSWG members thought that the objectives were appropriate, although not 
all were currently being met.  Members thought that surveillance was capturing as high 
a proportion of cases as was possible (Objective 1), but that it was still important to 
strive for 100% sensitivity.  Although enhanced data are not currently collected for all 
age groups in some jurisdictions, 90% of members thought that they should be 
(Objective 2).  As it is important to gain a national picture of IPD epidemiology, 
inclusion of IPD surveillance within the NNDSS is still appropriate (Objective 3).  
There was consensus that the epidemiological impact of conjugate vaccination must be 
measurable using data collected by the program (Objective 4), and some members 
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suggested that polysaccharide vaccination should be included in this objective.  
However, the capacity to achieve this objective is limited by missing vaccination, 
serotype and AMR data.  The former is due to the difficulty in collecting vaccination 
data on adults, while the latter relates to laboratory methods. Many EIPDSWG members 
felt that the wording of Objective 5 was unhelpful and did not reflect the likelihood that 
deaths associated with IPD vaccine failure or AMR may have multiple causes, 
particularly for the elderly.  Again, achievement of this objective has been hampered by 
missing vaccination and AMR data, and also by problems with mortality data that will 
be discussed in later sections.   
 
Sixty per cent of members thought that there was no need for further objectives to be 
added.  Suggestions for additional objectives centred on the need for the program to 
report high quality data that would allow other organisations to  
 monitor epidemiology (including the types of presentations and risk factors)  
 develop vaccination policy and write the Australian Immunisation Handbook 
 estimate the economic burden of IPD.   
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Table 8 EIPDSWG members’ assessment of the stated objectives of the surveillance program, 2016. 
Objective (53) 
Proportion of 
EIPDSWG members 
who thought this 
objective was… 
Selected Respondent Comments 
(Key:  J – state or territory health department;  L – reference laboratory;  O/N – OHP  or NCIRS) 
…relevant …being 
met 
1. To record every case of 
IPD occurring in 
Australia 
100% 80% Not sure that we are hearing about every case – particularly the less severe ones.  I think we are doing it for 
all the severe cases.  This is an aspirational objective, but still appropriate – J  
Out of all the diseases, this is the most likely to capture all cases – O/N 
We’re meeting this to a large extent, as most cases in Australia are hospitalised – O/N 
I feel that the reference lab is getting 95% of cases for serotyping  - L 
2. To collect detailed 
information on each 
case of IPD as set out in 
the NNDSS Invasive 
Pneumococcal 
Infection Enhanced 
Surveillance Form 
90% 40% Antibiotic susceptibility is incomplete, and we’re missing some age groups in some jurisdictions, but in terms 
of reflecting the higher risk groups and targeted populations, we have it covered – O/N 
Data managers work hard, but it’s hard to get the original data from clinicians and[diagnostic] labs – O/N  
I think it has been a pragmatic policy decision of the [EIPDSWG] not to follow up every case.  Those not 
followed up are a smallish number of relatively healthy adults – O/N  
All fields are relevant for all cases – O/N 
It’s disappointing that we can’t do it in the biggest jurisdiction for a big group that are at risk of disease and 
death and is our largest Indigenous population.  And there are so few cases they could be doing it all as they 
have per-capita resources – J 
We have seen serotype completeness drop for the over five- and under fifty-year-olds. These are often the 
most interesting cases – quite a few deaths, but we are often missing serotype, Indigenous status and 
comorbidities for these cases – J  
Ideally, in Victoria and NSW we would take a random sample of the over five- and under 50-year-olds – L  
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Objective (53) 
Proportion of 
EIPDSWG members 
who thought this 
objective was… 
Selected Respondent Comments 
(Key:  J – state or territory health department;  L – reference laboratory;  O/N – OHP  or NCIRS) 
…relevant …being 
met 
3. To collate nationally 
this information in the 
NNDSS dataset for 
enhanced IPD 
surveillance 
95% 80% It absolutely has to be national, especially for serotypes, as they differ geographically.  I see a lot of things 
published with data from bigger cities and results are extrapolated to all of Australia.  Life’s not like that! – J  
The NNDSS is the most appropriate place to collate it – O/N  
It’s not necessary for all the enhanced data to be collated and reported nationally as a part of NNDSS.  For 
example, we may only need serogroups rather than serotypes - L 
4. To measure the impact 
of conjugate 
pneumococcal 
vaccination on the 
rates and types of 
pneumococcal disease, 
the prevalence of 
circulating 
pneumococcal 
serotypes and levels of 
antibiotic resistance 
100% 40% This is one of the uses of the data, not an objective of the system. These assessments are mostly done as 
separate projects by OHP or NCIRS – O/N  
This is the main aim.  We are not getting full [antibiotic] susceptibility data, but we should – L 
We have issues now with PCR-positive cases.  It’s selective as to which ones are being serotyped: only certain 
labs send samples for PCR serotyping, usually the under 5s, those with low suspicion of IPD and a small 
amount of genetic material will not be typed - L 
We have uniform collection practices for rates and types of disease and for serotypes, but it’s not the best for 
levels of antibiotic resistance.  We don’t use a common reference lab so we don’t have the uniform data we 
hoped for – J  
We probably should include the polysaccharide vaccine in the objective, or as a separate objective – J  
5. To assess whether 
cases or deaths in 
children under 5 years 
and adults over 65 
years are due to IPD 
vaccine failure or 
antibiotic resistance 
85% 40% [This objective] should include high risk and high comorbidity groups so we can adjust the NIP to target 
people with risk factors and provide more evidence for modifying risk factors – J  
Unless we follow up later, we may not know if someone has died. We could do a study linking data from the 
NNDSS and the mortality database – J  
Vaccination and susceptibility data are often missing – L  
We need an ‘all-of-life’ vaccination register – L  
It should be ‘associated with’, not ‘due to’ – J  
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Table 9  Examples of additional objectives for the Enhanced IPD surveillance program 
suggested by EIPDSWG members, 2016.   
Selected Respondent Comments 
(Key:  J – state or territory health department;  L – reference laboratory;  O/N – OHP  or 
NCIRS) 
 
Possibly one about data feeding into vaccination policy and clinical guidelines, like the 
[Immunisation] Handbook – O/N  
 
Should be an objective about regular reporting and provision of data for transparency…and 
include one about measuring the impact of polysaccharide vaccination – J  
 
Something to do with ‘characterising the type of presentations’ caused by the pathogen.  For 
example, there is a new type of meningococcal in Australia with an atypical presentation.  It 
would be good to be able to pick this up to warn people.  So, there seems to be an increase in 
empyema cases in certain [IPD] serotypes, but there’s not enough data to be sure – L  
 
We need to think about whether we want to understand better the rates of hospital 
admissions and length of stay—so, healthcare costs.  This could be used to build a business 
case for funding surveillance – L  
 
 
Recommendation 1 
Review the program objectives to ensure they reflect the EIPDSWG’s aspirations for the 
program. 
 
 
PROGRAM PERFORMANCE  
In this section I assess the performance of the program and make recommendations for 
improvement for each of the attributes listed in Table 1.  Recommendations may apply 
to more than one attribute. 
 
USEFULNESS 
Over 90% of respondents in EIPDSWG interviews and the stakeholder survey indicated 
that the program was very or extremely useful (Figure 6).  Those who indicated that the 
program was moderately useful were representatives from reference laboratories, who 
reported that the discussions held at EIPDSWG meetings were not usually relevant to 
them.  Table 10 lists some of the comments made by respondents about the usefulness 
of the program. 
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Figure 29 EIPDSWG member and stakeholder ratings of the overall usefulness of the enhanced 
IPD surveillance program, 2016.  
 
 
 
Table 10 Examples of comments on the usefulness of the enhanced IPD surveillance program 
from EIPDSWG members and stakeholders, 2016.   
Selected Respondent Comments 
(Key:  J – state or territory health department;  V – vaccine manufacturer;  O/N – OHP  or 
NCIRS) 
 
The surveillance has been used to guide child and adult vaccination programs.  We 
have the evidence to take to ATAGI to inform a change. – J  
 
Publically available surveillance information is essential to inform the development 
of new vaccines and for the evaluation of the performance of current vaccines – V  
 
There is a 10 month delay in the dump of enhanced data from NNDSS to NCIRS.  
There is a reason why it takes so long—all the checking and confirmation is time 
consuming—but it reduces the utility of the system for us (OHP/NCIRS). – O/N  
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Figure 30 Purposes for which EIPDSWG interview and stakeholder survey respondents 
reported using various sources of IPD surveillance data, Australia, 2016. (*Only two 
stakeholder survey respondents indicated they had requested line-listed data from OHP).   
 
Usefulness for evaluating and informing vaccination policy and programs 
The complete national dataset (including dates of birth and residential location) is only 
available for analysis within OHP and by NCIRS.  It is clear that this national 
surveillance data has provided evidence for effective changes to the infant conjugate 
vaccination program.  However, the program has less utility for evaluating the impact of 
the targeted 23vPPV program, as less than three quarters of cases aged over 50 years 
had complete vaccination data over the study period (data not shown).  A lack of data 
for cases aged over five years also hinders the estimation of the herd effects of 
childhood vaccination, and thus economic evaluations (46).  
   
It is difficult to assess the impact of the NIP on other high-risk population groups 
targeted by immunisation programs.  This is because of lack of adult vaccination data, 
and inconsistencies between the risk groups listed in the Australian Immunisation 
Handbook 10
th
 Edition (23) and categorisation of ‘risk factor’ data in the national 
enhanced IPD dataset (67)—and there are further variations between these and the risk 
factor data collected in Victoria (68) and Queensland (69) (Table 11).  In other 
jurisdictions, notification forms allow at most a free-text field for ‘clinical comments’ or 
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‘risk factors’, and detailed risk factor data are sought by PHNs, public health officers or 
epidemiologists and entered directly into their database. The explanatory notes for the 
national dataset do provide excellent guidance as to the types of conditions to be 
included in each domain.  However, grouping of risk factors (eg into ‘chronic 
conditions’) and the fact that data on the specific type of condition is held at the state 
and territory level (if at all) means that it may be difficult to extract useful risk factor 
data from the dataset.  For example, while it would be simple to assess changes in IPD 
epidemiology and the impact of vaccination programs on people with functional and 
anatomical asplenia, it would be difficult to do the same for people with cochlear 
implants, intracranial shunts, Type 2 diabetes, or for transplant recipients (Table 11).  
Notable inconsistencies also exist for exposure to smoke and excessive alcohol use.  
 
 
Usefulness of the public dataset 
Several EIPDSWG members indicated that the provision of surveillance data in the 
public dataset had reduced the requests to OHP for data and felt that this dataset 
contained everything stakeholders required for their purposes.  Nearly half of survey 
respondents indicated that they had used the IPD public dataset, including all who were 
affiliated with pharmaceutical companies.  Most stakeholders reported that serotype (92% 
of respondents), demographic data (92%) and vaccination history (75%) were the most 
useful data fields in the public dataset.  Overall, they found the data caveats and 
interpretation notes useful for understanding these data fields.  
 
Vaccine developers and researchers identified currently unavailable surveillance data 
that they would find useful for their work (Table 12).  To adequately assess the impact 
of the NIP, stakeholders wanted access to data from before 2009.  Two respondents 
from vaccine manufacturers emphasised their need for finer stratification for children 
aged under five years to reflect the timings of 13vPCV immunisation in the NIP.  
Currently, the age of cases included in the public dataset is provided in five year age 
groups to prevent re-identification of cases.  However, it is notable that quarterly reports 
published since March 2016, and the annual report for 2011-2012 have provided age in 
months (for cases aged under one year) and years (for cases aged one year to under five 
years) as well as Indigenous status, serotype, clinical category and risk factor data.  One 
respondent suggested age stratification bands of zero to six months, seven to 23 months 
and two to five years for the public dataset.   
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Table 11 Risk factors for IPD infection (and therefore groups targeted for vaccination) compared with data domains for Victorian and Queensland IPD data 
collection forms and the national enhanced IPD surveillance dataset, 2016. 
Risk factors for infection (red=highest 
increased risk; blue=increased risk) (23) 
Victorian IPD notification form (68) Queensland IPD case report form (69) 
National dataset risk factor data domains 
(57, 67) 
Functional or anatomical asplenia Anatomical or functional asplenia Anatomical or functional asplenia Anatomic or functional asplenia 
Immunosuppressive or radiation 
therapy   
Immunosuppressive therapy   
 Immunocompromised; specify 
Immunocompromised (eg transplant*, 
HIV, lymphoma, multiple myeloma, 
nephrotic syndrome, HTLV-1, IgA 
deficiency, chronic pancytopaenia, active 
SLE, other autoimmune disease, recent or 
current immunosuppressive therapy,)  
 
*included in dataset field specifications, but 
not in the explanatory notes 
Haematological and other malignancies 
Multiple myeloma 
Other cancer 
Solid organ  or haematopoietic stem cell 
transplant 
Organ transplantation 
HIV (including AIDS) HIV infection 
Relapsing or persistent nephrotic 
syndrome 
Nephrotic syndrome  
Autoimmune conditions (eg systemic 
lupus erythematosus, rheumatoid 
arthritis and multiple sclerosis) 
Other immuno-compromising condition 
(including chronic pancytopaenia, IgA 
deficiency, active SLE, other 
autoimmune disease) 
Congenital or acquired immune 
deficiency, including symptomatic IgG 
subclass or isolated IgA deficiency 
Cochlear implants - - - 
Intracranial shunts - - - 
Chronic renal failure 
Chronic renal failure  
 
 
 
Chronic disease; specify 
 
 
 
Chronic illness, including 
 chronic renal failure with reduced 
function  
 CSF leak 
 
 cardiac disease (ischaemic heart disease 
but not uncomplicated hypertension) 
 
Cerebrospinal fluid leak CSF leak 
Chronic cardiac disease: 
 particularly cyanotic heart disease or 
cardiac failure in children 
 excluding hypertension only (adults) 
Cardiac disease (but not uncomplicated 
hypertension) 
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Risk factors for infection (red=highest 
increased risk; blue=increased risk) (23) 
Victorian IPD notification form (68) Queensland IPD case report form (69) 
National dataset risk factor data domains 
(57, 67) 
Chronic lung disease, including: 
 chronic lung disease in preterm 
infants 
 cystic fibrosis 
 severe asthma in adults  
Bronchiectasis 
Emphysema 
Chronic airway limitation (due to 
scarring/severe asthma requiring 
hospitalisation or chronic treatment) 
 
 
 
 
 
Chronic disease; specify 
 pulmonary disease (bronchiectasis, 
emphysema and other chronic airway 
limitations due to scarring, or severe 
asthma requiring hospitalisations/ 
regular treatment in the last 12 months) 
  chronic liver disease with reduced 
function 
 diabetes (types 1 & 2) 
 carcinoma not recorded under 
immunocompromised 
 Chronic or recurrent infections (eg 
chronic otitis media, pancreatitis) 
 any chronic condition that impairs 
physical functioning (eg cerebral palsy, 
significant dementia or other 
neurological deficit, malnutrition) 
Chronic liver disease 
Other chronic conditions impairing 
physical functioning (eg cerebral palsy, 
neurological deficit, malnutrition) 
- 
Chronic or recurrent infections (incl 
pancreatitis, chronic otitis media) 
Diabetes or other metabolic disease Diabetes (Type 1 or 2) 
Chronic disease [as above] 
Metabolic abnormalities (case <15 
years old only) 
Down syndrome  Congenital or chromosomal abnormality 
Congenital or chromosomal 
abnormality 
Congenital or chromosomal abnormality 
Preterm birth at <28 weeks gestation Gestational age Premature (<37 weeks gestation) 
Premature (<37 weeks gestation); specify 
gestational age 
 
 
Tobacco smoking 
Smoking status (current, ex, never) Smoking status (current, ex, never) 
Risk factors not identified elsewhere: 
 excessive alcohol consumption 
 smoke exposure (smoker or ex-smoker; 
passive household exposure to smoke 
even if a person smokes outside only) 
 exposure to campfire/cooking 
smoke >1 per week at time of illness  
 History of previous pneumonia 
Smoker in household 
Smoker in household (case <15 years 
old only) 
Alcoholism Alcohol-related problems Alcohol excess 
- 
Attended grouped care outside home 
for >4 hrs within 4 weeks of onset 
Childcare attendee 
Attended grouped childcare (>4 hrs 
cumulative) within the preceding 4 weeks 
- Previous diagnosis of IPD Previous episode of IPD Previous episode of IPD 
 172 
 
 
Table 12 Extant surveillance data (not currently available in the public dataset) that vaccine 
manufacturers and researchers who responded to the stakeholder survey would find useful, 
2016.  
Vaccine manufacturers Researchers/Academics 
 Finer age stratification for <5 years 
 Serotype data for WA 
 ACT data (combined with NSW) 
 Pre-2009 data 
 Data updated quarterly 
 Vaccine failures 
 Timing of vaccinations 
 Clinical risk factors  
 Deaths 
 Specimen site (if not in the clinical 
category) 
 Pre-2009 data  
 
Individual identification of vaccine failures would also be useful.  These data are 
collected by jurisdictions for discussion at EIPDSWG meetings and included in the 
Quarterly reports, but are not explicitly included in the NNDSS (57).   One stakeholder, 
who is involved in research, indicated that data on other vaccines received by the cases 
would be useful.  This respondent may have been interested in the role of influenza 
vaccination on the risk of IPD (9, 70, 71).   
 
Usefulness for monitoring antimicrobial resistance (AMR) 
Qualitative susceptibility to first-line antimicrobials used in clinical management of 
IPD (penicillin and cefotaxime/ceftriaxone) is routinely tested by diagnostic 
laboratories.  However, completeness of this field for cases diagnosed by culture 
over the study period was low, at 78% nationally— a result largely due to 
completeness of only 3% in Western Australia (Figure 8).  This is due to problems 
with transmission of data from the primary laboratories, and the Western Australian 
database not containing a data field for minimum inhibitory concentration.  
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Figure 31 Proportion (%) of notified IPD cases diagnosed by culture for which qualitative 
susceptibility to first-line antimicrobials (penicillin and cefotaxime/ceftriaxone) is reported, by 
State or Territory of residence, Australia, 1 July 2013 - 30 June 2016. 
 
The surveillance program was set up to also collect quantitative susceptibility to the 
full panel of 14 antimicrobials (including penicillin and cefotaxime) tested under 
standard conditions in a reference laboratory.  However, reference laboratories do 
not receive funding from the Australian Government for this, as they do for 
serotype testing (72).  There is reference laboratory susceptibility data in the IPD 
dataset for only 7% of cases nationally over the study period (data not shown), and 
these include information for, at most, four antimicrobials.  The method of 
susceptibility testing and the panel of antimicrobials tested are not uniform across 
the four reference laboratories.  Some laboratories do test samples and forward the 
data to the jurisdictions, but these data are not necessarily routinely entered for 
transmission to the NNDSS. 
 
The Australian Group on Antimicrobial Resistance (AGAR) conducted six surveys of 
AMR in S. pneumoniae in invasive and non-invasive infections between 1989 and 
2007 (73), assessing quantitative susceptibility to up to eight antimicrobials in 20 
laboratories.  These surveys demonstrated steadily increasing rates of AMR, 
including an increase in multi-resistant strains.  However, the group is not planning 
to conduct further surveys (74).   
 
 
0
10
20
30
40
50
60
70
80
90
100
ACT NSW NT QLD SA TAS VIC WA Total
%
 o
f 
ca
se
s 
State or Territory 
 174 
 
According to the World Health Organization, AMR  
…threatens the very core of modern medicine and the sustainability of an 
effective, global public health response to the enduring threat from infectious 
diseases …Without harmonized and immediate action on a global scale, the 
world is heading towards a post-antibiotic era in which common infections 
could once again kill. (75) 
 
Under the implementation plan for Australia’s First National Antimicrobial 
Resistance Strategy 2015 – 2019, the Australian Government has made a 
commitment to “minimise the development and spread of antimicrobial resistance and 
ensure the continued availability of effective antimicrobials” (76).  One objective 
included in this plan is to develop nationally coordinated surveillance of AMR.  
Monitoring of AMR is additionally important for S. pneumoniae to allow 
comprehensive evaluation of immunisation programs.  This is because vaccination 
can reduce circulation of resistant serotypes (eg as seen the reduction in IPD caused 
by serotype 19A following the introduction of the 13vPCV (35)), and also by 
reducing the need for antimicrobial prescribing for both invasive and non-invasive 
disease (73).  This topic is one that has been discussed at EIPDSWG meetings and 
arose repeatedly in interviews for this evaluation. For example 
…we need a consensus on how this will be approached.  Is the clinical 
management susceptibility data adequate?—and what is its quality?—or will 
we move to reference labs?  This has funding implications…  
 
Surveillance data has been requested by the AURA project for monitoring S. 
pneumoniae resistance.  Establishing a parallel system for monitoring AMR would 
capture data about non-invasive disease, but would lack the richness of the 
enhanced data provided by the IPD surveillance program.  Therefore, it is essential 
that reference laboratory AMR surveillance is conducted as a part of the existing 
enhanced IPD surveillance program. 
 
Usefulness for informing clinical practice 
Providing reliable data to inform clinical decision-making is not a direct objective of the 
program, but there is evidence that the IPD data is used this way.  For example, an 
EIPDSWG member representing a reference laboratory reported:  
I direct people to the data and reports frequently.  For example, a clinician 
had a patient with an unusual serotype.  They wanted to know how common 
it was, I could direct them to the online reports and dataset.  Also, 
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paediatricians want to know about AMR trends to inform their treatment 
decisions – (Reference laboratory) 
 
One survey respondent, who identified themselves as a paediatrician and 
researcher/academic made the following suggestion for additional reporting from 
surveillance data: 
Provide an easy to access website that you can access on your phone to 
review IPD condition frequency, serotype distribution, and antibiotic 
resistance profile of IPD in your region.  Ideally, this should allow the user 
to access results according to different time frames and according to 
different age groups at the bedside.  It would be most helpful if this was part 
of a larger database that allow access to this information for all important 
invasive infections rather than just limited to IPD. 
 
 
Usefulness of the Working Group as a communication network 
Several interviewees noted the importance of the working group as a means of rapid 
communication between jurisdictions, for example: 
Queensland saw breakthrough cases of 19A after PCV13 6-8 months before 
other jurisdictions.  The Working Group forum allowed us to keep others on 
the look-out 
 
Another EIPDSWG member noted 
I've been on five committees over the years and this one is the most 
productive—a big focus on high quality and accurate data.  
 
However, one member stated the Working Group would function better if members met 
face-to-face once a year, and another thought that there was opportunity for more 
collaborative projects involving all members.   
 
 
Recommendation 2 
Collect complete surveillance data for all cases in all jurisdictions.  If resource 
constraints preclude this in some jurisdictions, consider following-up of a random 
sample of cases aged five to 50 years in these jurisdictions.  
 
This is a priority recommendation 
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Recommendation 3 
Ensure researchers and vaccine developers can access the data at the level of detail they 
require in the public dataset, while maintaining the privacy of cases. This includes 
 finer stratification of age-groups for cases aged less than five years 
 data from 2001 onwards 
 all available serotype data 
 data on vaccine failures. 
 
This is a priority recommendation 
 
 
Recommendation 4 
Harmonise notification processes, data collection forms and data transmission from the 
jurisdictions to the NNDSS. This should include standardising risk factor data domains to 
ensure they reflect groups at high risk of IPD, as identified in the Australian 
Immunisation Handbook 10th Edition. 
 
 
Recommendation 5 
Improve the completeness and quality of antimicrobial resistance (AMR) data by 
 investigating the poor completeness for first-line AMR data from Western 
Australia 
 agreeing on the standards for reference laboratory AMR testing 
 advocating for funding for reference laboratories to collect these data for 
every case 
 
This is a priority recommendation 
 
 
 
SIMPLICITY 
One EIPDSWG member described the program as “a fine system – not the easiest 
to use…and intricate…but not too bad for a complex disease”.  Confirmation of 
IPD cases is more straightforward than for some other notifiable conditions (for 
example, Hepatitis B), and of the five stakeholder survey respondents who 
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indicated that they had notified a case of IPD, three described the process as 
‘extremely easy’ and the remainder described it as ‘somewhat easy’.  However, the 
surveillance program is not a simple system.  This is largely due to the collection of 
enhanced data.  The flow of data is complicated (Figure 5), and this is compounded 
by the fact that data collection systems are not harmonised across jurisdictions.   
 
The two stakeholder survey respondents who had requested line-listed surveillance 
data described the request process as ‘somewhat difficult’ and ‘neither easy nor 
difficult’, but did not elaborate.  This process is currently under review by OHP.  
 
 
DATA COMPLETENESS AND QUALITY  
Results of the completeness of AMR data is presented under the findings related to 
usefulness in Section 3.3.1 
 
Serotype and Vaccination History 
In the 2014 Project Agreement for Vaccine Preventable Diseases Surveillance Program 
(66), the Commonwealth of Australia agreed to provide a financial contribution to the 
states and territories for the reporting of surveillance data on nationally notifiable 
vaccine preventable diseases.  The Agreement specifies performance indicators against 
which the jurisdictions must report annually.  I do not have access to these reports, but 
have assessed performance against the indicators relevant to IPD using surveillance data 
collected during the evaluation study period (1 July 2013 to 30 June 2016). 
 
The first indicator is that “the Serogroup Subtype field is completed (where lab [sic] 
diagnosis method allows) for…cases younger than 5 years or older than 50 years for 
equal to or greater than 80% of notified cases” (66).  As shown in Figure 9, all the 
jurisdictions other than South Australia (64% serotype data for age less than five years) 
are achieving above this target.   
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Figure 32 Proportion (%) of notified IPD cases in age groups targeted for vaccination for whom 
serotype data is complete, by State and Territory, Australia, July 2013 to 30 June 2016. This 
does not include for cases for which the isolate could not be tested. The red line (at 80%) 
indicates the performance target specified in the Project Agreement for Vaccine Preventable 
Diseases Surveillance Program (66). 
 
Availability of serotype data for all ages is also markedly lower in South Australia 
compared with other jurisdictions (Table 13).  Working group interviewees perceived 
this to be a problem of South Australian diagnostic laboratories not forwarding a large 
proportion of PCR-positive isolates to the reference laboratory for typing, because they 
do not think there is sufficient genetic material.  Among cases aged under five years in 
South Australia over 37% of diagnoses are made by PCR alone, compared with 0.4% in 
cases aged over 50 years.  This is the likely cause of the poor performance of this state 
against the above target.   
 
The second indicator is “vaccination information is completed for children aged less 
than 7 years…for equal to or greater than 95% of notified cases where their vaccination 
status is recorded on the Australian Childhood Immunisation Register” (66).  Nationally, 
this target is not being reached, due to only 87% completeness in NSW, the state with 
30% of cases in this age group (Figure 10).  This state also achieved only 91% 
completeness for cases aged less than five years.  All other jurisdictions have met this 
target over the study period. Upon further investigation, this appears to be a problem of 
transmission of data to the NNDSS.  
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Table 13 Proportion (%) of all notified IPD cases for which serotype data is provided, by State 
and Territory, Australia, 1 July 2013 - 30 June 2016. 
State or 
Territory 
* 
Serotype 
data 
available 
(%) 
Isolate not 
typable, not 
viable or 
result 
pending (%) 
Typing not 
attempted 
(PCR) (%) 
Untyped (%) 
Not referred 
for typing (%) 
ACT 100.0 0 0 0 0 
NSW 94.0 0 0 0.5 6.0 
NT 98.0 0.7 0 0 1.0 
QLD 94.0 0.3 3.0 0.8 2.0 
SA 84.0 4.0 3.0 0 9.0 
TAS 94.0 0.8 0.8 0 5.0 
VIC 97.0 2.0 0 0.7 0.7 
WA 98.0 1.0 0.5 0.4 0 
Australia 94.0 1.0 0.7 0.5 3.0 
* Row totals may not sum to 100% due to rounding 
 
 
 
Figure 33 Proportion (%) of notified IPD cases aged under 7 years for whom vaccination data 
are complete, by State and Territory, Australia, July 2013 to 30 June 2016. This does not 
include cases whose data was sought but was not available.  The red line (at 95%) indicates the 
performance target specified in the Project Agreement for Vaccine Preventable Diseases 
Surveillance Program (66). 
 
When the vaccination completeness data for all ages is examined, there is a much 
greater variation between jurisdictions (Figure 11).  In 2016, the ACIR was 
expanded to become the whole-of-life Australian Immunisation Register (AIR) for 
all NIP and most privately-funded vaccines (77).  As a result, I would expect a 
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marked improvement in the completeness of vaccination fields in the future.   
However, the degree of improvement in NSW, Victoria and Queensland would 
depend upon the commitment of these jurisdictions to follow-up every case.  
 
 
Figure 34 Proportion (%) of all notified IPD cases for which vaccination history data are 
provided, by State and Territory, Australia, 1 July 2013 - 30 June 2016. 
 
Hospitalisation and mortality  
Hospitalisation and mortality are the only measures of severity and cost burden of 
IPD cases collected in the surveillance dataset.  Hospitalisation (which includes 
admission to an emergency department for more than four hours) is one of the least 
complete fields in the enhanced IPD dataset (Figure 12A).  Only ACT and Western 
Australia provide data for this field.  The hospitalisation status of a case was 
ratified as a core data field of the NNDSS in March 2016, and included in the IPD 
data collection form in April 2016, so it was not routinely collected before this date.   
 
Deaths from IPD are defined as “those due to a current invasive pneumococcal 
infection even if the case has a pre-existing terminal condition or other co-
morbidities that contributed to their death” (57).  The EIPDSWG provides a 
flowchart with clear guidance for recording IPD deaths (57).  Although mortality is 
recorded in over 90% of notified cases nationally (Figure 12B), IPD deaths may be 
misclassified, particularly if they occur many weeks after the notification was 
received, were not hospitalised, or died after discharge.  Again, access to electronic 
0
10
20
30
40
50
60
70
80
90
100
ACT NSW NT QLD SA TAS VIC WA Total
%
 o
f 
ca
se
s 
State or Territory 
Vaccination
history recorded
Data sought but
not available
Data not sought
No data provided
 181 
 
records would improve the completeness and accuracy of death data, as noted by 
one EIPDSWG member who represented a jurisdiction: 
…perhaps getting access to all digital medical records will allow us to 
systematically follow-up cases to find out who has died from their IPD. We 
don't have the resources to keep ringing up, and staff change in hospitals, 
making it difficult. 
 
 
 
Figure 35 Proportion (%) of all notified IPD cases for which (A) hospitalised and (B) mortality 
data are provided, by State and Territory, Australia, 1 July 2013 - 30 June 2016. 
 
Indigenous Status  
In 2004, the year that recommendations were made in the Improving Indigenous 
Identification in Communicable Disease Reporting Systems report (78), Indigenous 
status was recorded in slightly under 80% of IPD cases nationally. Over the 
evaluation period, recording of Indigenous status was higher at 90% (Figure 13).  
This is an excellent result when compared with NNDSS data as a whole, which had 
only 45% completeness for this field in 2014 (31).  Reporting in the ACT improved 
dramatically (6% in 2004 versus 100% in the evaluation study period), but 
worsened in Victoria (93% versus 77%).  Further improvements in completeness 
and quality of this data field can be expected with continued promotion and 
implementation in hospitals, GP practices and diagnostic laboratories of the 
National Best Practice Guidelines for Collecting Indigenous Status in Health Data 
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Sets (79).  In a small study in one PHU in NSW, staff were able to increase the 
completeness for this field to 99% in IPD cases by referring to the electronic 
hospital admissions database (80).  This process took less than five minutes per 
case.  
 
 
Figure 36 Proportion (%) of notified IPD cases for which Indigenous status data were provided 
in 2004 (56) and the period 1 July 2013 - 30 June 2016, by State and Territory, Australia.  
Completeness data for all diseases recorded in the NNDSS in 2014 is provided for comparison 
(31). 
 
 
Clinical data 
The completeness of the clinical category and risk factor data fields over the study 
period is shown in Figure 14.  Cases for which clinical category data are missing 
include those coded as ‘Other’ (neither bacteraemia, meningitis, nor pneumonia), but 
with no further details.  Nationally, completeness was 86% for clinical category and 74% 
for risk factor data.  The poorest performance was in jurisdictions where all age groups 
are not routinely followed-up and where surveillance staff do not have access to 
electronic medical records.     
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Figure 37 Proportion (%) of notified IPD cases for which data on clinical category and risk factor 
data is provided, Australia, 1 July 2013 - 30 June 2016. 
 
It is clear that enhanced data collection for IPD surveillance would be greatly improved 
through access to a single electronic health record. Integrated state-wide electronic 
medical inpatient record systems are being implemented across public (but not private) 
hospitals in NSW (81) and Queensland (82). Unfortunately, although electronic records 
systems are being rolled out in Victorian hospitals, these systems are not integrated 
across the state, so the access to enhanced data will vary across PHUs. Currently, only 
Queensland has an exclusively electronic laboratory notification system.  All private 
and public laboratories participate in this system and there is a governance structure to 
ensure notifications are made to standard.  Two other jurisdictions have electronic 
notification systems, but they also receive notifications by fax and mail, and in one 
jurisdiction the data from the electronic form must be manually entered into the 
surveillance database.   
 
 
Data Quality 
Overall members of the EIPDSWG reported that the quality of data had improved over 
the last few years, to the point where the data is now highly reliable.  This is particularly 
the case since OHP has been sending extracts from the NNDSS back to the jurisdictions 
for checking prior to the preparation of the quarterly report.  Logic checking of NNDSS 
entries has also helped. 
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In analysing the surveillance data, I encountered a number of errors in the chronology of 
dates, and also logical inconsistencies between ‘laboratory diagnosis method’ and 
‘serotype’.  These errors (in date and other field types) could be avoided by ensuring 
jurisdictional databases have controls that prevent entering non-logical data, and by 
conducting post-entry logic checks at the jurisdictional level, when data verification is 
easiest.   
 
Recommendation 6 
Advocate for all jurisdictions to implement exclusively electronic laboratory notification 
systems, ensuring that these systems collect data consistent with the NNDSS data fields.  
 
 
Recommendation 7 
Support jurisdictions to update their databases to prevent entering non-logical data and 
to conduct post-entry logic checks, where these are not already in place.   
 
 
FLEXIBILITY 
EIPDSWG members almost universally agreed that the program is flexible enough 
to accommodate changes in IPD epidemiology and available vaccines.  Most 
stakeholders also thought the program could do this very or extremely well.  
Examination of the core and enhanced data fields revision history indicates multiple 
changes to both datasets since 2001, including changes to reflect the introduction of 
the 13vPCV and the identification of new serotypes.  Representatives from the 
jurisdictions and OHP data managers indicated that, technically, it was easy to alter 
dataset fields or domains, although the bureaucratic process to obtain permission 
may be lengthy. 
 
In contrast, both EIPDSWG members and stakeholders had less confidence in the 
program’s ability to adapt to changes in laboratory methods.  The proportion of 
notified cases confirmed by PCR only has increased from 0.1% in 2001 and 2002 to 
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6.8% in the 2015-16 financial year.  This has likely resulted in a slight increase in 
sensitivity and decrease in specificity, as presence of the pathogen’s genetic 
material does not necessarily indicate disease.  Also, isolates obtained for PCR are 
less useful than cultures for determining serotype and AMR.  Data on laboratory 
methods are reported in the IPD annual reports, but not the quarterly reports or 
public dataset.   
 
Several EIPDSWG members foreshadowed the emergence of whole-genome 
sequencing (WGS) for diagnostic and surveillance purposes.  In a study in Canada, 
public health laboratories assessed the utility of WGS for routine pneumococcal 
surveillance by testing a random sample of surveillance isolates collected over a 
four year period (83).  Overall, the researchers demonstrated 95% sensitivity and 
100% specificity of genomic prediction of susceptibility to erythromycin, 
clindamycin, chloramphenicol and tetracycline; and a 98% success rate for 
predicting sequence type.  In a similar study in the US, the Active Bacterial Core 
surveillance (ABCs) team subjected over 80% of S. pneumoniae surveillance 
isolates collected in 2015 to WGS using a bioinformatics tool, or “pipeline”, to 
predict antimicrobial phenotypes (84).  The authors concluded that  
the capability of our WGS pipeline to accurately and reliably 
predict antimicrobial testing results for currently recovered IPD 
isolates to six different β-lactam antibiotics, erythromycin, 
clindamycin, cotrimoxazole, tetracycline and chloramphenicol. In 
addition, the pipeline detected rare instances of fluoroquinolone-
resistance and [rifampicin]-resistance. This sampling of recent 
national surveillance IPD isolates gives an accurate assessment of 
the pipeline's reliability for detecting and measuring individual 
resistance phenotypes, and for determining the frequencies of 
different resistance mechanisms. WGS-based methodology is an 
effective substitute for [broth dilution testing] that also serves for 
concurrent determination of other critical pneumococcal strain 
features. As technical advancements continue, WGS technology 
may be employed in future clinical settings for deducing key 
pathogen parameters relevant to patient care. The high 
concordance of WGS-based predictions with pneumococcal 
antimicrobial phenotypes is compatible with this goal. 
 
The move towards WGS for diagnosis and surveillance appears inevitable and will 
lead to profound advances in the understanding of communicable disease 
epidemiology (85) and enhance outbreak detection (86, 87).  The speed of change 
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in next-generation sequencing indicates that WGS may soon be comparable to 
conventional laboratory methods in terms of time and cost (85, 88).  However, the 
shift to WGS is not without its challenges, and will require clear guidelines, robust 
protocols and standard operating procedures not only for sample preparation and 
sequencing (wet laboratory), but also for the computational assessment (dry 
laboratory) of the results. The interpretation of billions of sequence reads is by no 
means trivial, and improvements in the availability of 'user-friendly' software and 
enhancements in computer and data storage infrastructure will be of paramount 
importance for the realization of the potential of these technologies.(89) 
 
The European Centre for Disease Prevention and Control expects that, in the next 
five years, it will have standards and systems in place to allow WGS to replace all 
other typing methods used for microbial surveillance across the European Union 
(88).  Following this lead, now is the time for the EIPDWG to initiate work with 
OHP, the Public Health Laboratory Network, and other relevant parties to plan for 
such a change in Australia, ensuring that standards and formats allow data to be 
shared and synthesised internationally.  The EIPDSWG may also wish to initiate or 
auspice pilot implementation studies of WGS using Australian IPD surveillance 
data. 
 
Recommendation 8 
Working with relevant partners, plan for the shift towards whole genome sequencing by 
overseeing the development of quality standards for IPD sequencing and bioinformatics, 
and by auspicing pilot implementation studies.   
 
 
ACCEPTABILITY 
From the interviews with EIPDSWG members, it is clear that the program is highly 
acceptable. As one interviewee noted 
Because of the buy-in of the Working Group who are passionate (especially 
in the NT), this leads to a commitment to collecting useful data to inform 
decisions.   Overall, all parties want to collect the info—it's not like pulling 
teeth to get it (OHP/NCIRS). 
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As a system reliant upon laboratory diagnosis, the success of this program has also been 
largely a result of engagement with diagnostic laboratory networks during the planning 
and early implementation phases in 2000 and 2001.  However, one representative of a 
reference laboratory gave the following warning: 
We hear more and more from our colleagues in primary labs that they have 
more and more work to do and they feel it is not their business to do 
surveillance...the increase in work is leading to missing data/missing 
isolates/missing cases. The weight of gathering the info is shifting from 
reference lab to public health unit to collect. 
 
Ongoing work is required to ensure the commitment of laboratories to forward isolates 
to the reference laboratories for serotyping and AMR testing.  This is particularly the 
case for South Australia, where many PCR-positive isolates are not forwarded.  The 
EIPDSWG and the Public Health Laboratory Network have published guidelines for 
collection, storage, and transport of PCR-positive specimens (90).  However, these 
guidelines are verbose and would benefit from a review.  A simple, colourful flowchart, 
highlighting the value of serotype data and distributed to laboratories through an 
appropriate method may assist.  Direct engagement with laboratory networks may also 
be required.   
 
Although the EIPDSWG provides an annual report, tailored by jurisdiction, to all 
laboratories, only one of the six survey respondents from diagnostic laboratories was 
certain that they had ever received such a report.  Respondents indicated that they would 
like to receive summary reports, with serotype data reported at the national and regional 
level.  One respondent emphasised that they would like the serotyping method to be 
reported in both the laboratory summary and in the public dataset.   
 
 
Recommendation 9 
Work with the Public Health Laboratory Network to enhance engagement and 
communication with diagnostic laboratories to ensure their full participation in the 
program. This should include a review and promotion of the guidelines for forwarding 
samples to the reference laboratories. 
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SENSITIVITY 
Sensitivity refers to the proportion of cases of disease detected by the program. 
Eighty percent of EIPDSWG members thought that the sensitivity of the program 
was excellent, with the remainder rating it as good.  They felt that the severity of 
the disease meant that most cases were detected.  Stakeholders’ ratings were 
slightly less favourable, with most rating the sensitivity as good.   
 
According to the objectives of the program, it should identify every case of IPD in 
Australia (sensitivity of 100%).  The true sensitivity of the program could only be 
estimated through methods such as a capture-recapture analysis.  The factors 
affecting the ability of the system to capture every case (shown in Figure 15) are 
generally outside of the control of the EIPDSWG.  As IPD is usually not a mild 
disease, there will be only a small proportion of true IPD cases who do not present 
for health care.  However, obtaining specimens from sterile sites is not 
straightforward, and in some cases (e.g. meningitis with raised intracranial pressure) 
may be contraindicated (2).  As one EIPDSWG member noted, “clinical 
management should always determine whether or not a specimen is collected”. 
Blood culture methods may detect S. pneumoniae in as few as 10% to 20% of 
pneumococcal pneumonia cases (91).  Failure to detect or isolate S. pneumoniae may 
be due to the sporadic nature of bloodstream invasion, poor handling of the 
specimen, and prior administration of antimicrobial treatment (3). The availability 
of PCR, the results of which are unaffected by antimicrobial treatment, has 
improved sensitivity, although serotyping from PCRs is less sensitive.  According 
the one EIPDSWG member, some cases are missed by surveillance “because the 
clinician and primary laboratory forget that certain sites should be sterile, like 
pleural fluid or the brain”.  
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Some EIPDSWG members suggested that the case definition could be broadened to 
include detection of S. pneumoniae antigen in urine.  Urinary antigen testing is 
increasingly used in clinical practice due to the ease of obtaining a sample and 
because (as for PCR) administration of presumptive antimicrobials will not affect 
the result. The EIPDSWG has previously referred this question to the Public Health 
Laboratory Network.   
 
The sensitivity of a surveillance system also refers to its ability to detect an 
outbreak.  This is discussed below.  As enhanced data on clinical category of IPD is 
collected, the program’s sensitivity to changes in IPD epidemiology in terms o f 
types of clinical presentation is reasonably high.  However, as discussed above, 
missing data for cases aged five to 50 years reduces its sensitivity.  
 
REPRESENTATIVENESS 
As the true sensitivity of the program is unknown, it is difficult to determine if there is 
any pattern to missed cases that would reduce the program’s ability to accurately 
describe the occurrence of IPD over time and its distribution in the population by place 
and person.  However, it is clear that there is relatively lower completeness for cases 
 Case does not present (mild illness) 
 Case dies prior to seeking care 
 Specimen not obtained (not ordered, 
contraindicated or not able to be 
obtained) 
 Poor specimen quality 
 Poor storage or transportation 
 Specimen obtained after 
commencement of antibiotic 
treatment 
 Intermittent bloodstream invasion by 
bacterium 
 False negative test result 
Case of IPD 
Case presents to hospital or GP 
Sterile site specimen obtained 
S. pneumoniae isolated  
or detected 
Laboratory makes notification 
 Laboratory does not make 
notification  
Factor 
Figure 38 Factors affecting sensitivity of the IPD surveillance Program (1-3) 
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aged between five and 50 years of vaccination history, Indigenous status, and enhanced 
data fields (including risk factors), compared with other cases.   
 
PREDICTIVE VALUE POSITIVE 
The predictive value positive of the surveillance program is the proportion of 
notified cases that truly have IPD.  As only laboratory-confirmed (not suspected) 
cases are notified, it is rare for non-IPD cases to be notified, and so it is likely that 
the PVP is high.  EIPDSWG members representing jurisdictions reported that the 
handful of notified cases that turn out not to be IPD are mainly due to  
 laboratories or clinicians notifying detection or isolation of S. pneumoniae 
from  
o a non-sterile site (eg sputum, bronchial washings, ear swabs) 
o urinary antigen testing 
o post-mortem collection; or 
 rarely, the reference laboratory identifies the isolate as a bacterium other than S. 
pneumoniae, despite a positive culture in the diagnostic laboratory.  
Post-mortem cases are sometimes included, following review by the EIPDSWG.  
 
TIMELINESS  
The median time between the onset of disease and receipt of notification by the 
jurisdiction was six days nationally (Figure 16).   Fortnightly lists of new cases are 
produced for the CDNA and published within a week on the Department of Health’s 
website (92).  The median time to publication of a year’s IPD surveillance data in an 
annual report is four years (93), but was as long as seven years for 2009 data (14).  Both 
EIPDSWG members and stakeholders indicated that the introduction of the quarterly 
reports has improved the timeliness of publically-available data.  Over the study period 
75% of quarterly reports were published three months after the end of the reported 
quarter, with the remainder published six months after.  However, survey respondents 
representing vaccine developers indicated that the quarterly reports—although timely—
did not have the level of detail they required.  They wished to have access to the data 
behind the figures and aggregated tables in these reports.  For these respondents, the 
annual reports and public dataset were not updated frequently enough to be of use.   
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Two-thirds of stakeholders and 90% of EIPDSWG members thought that the national 
data are analysed and reported frequently enough to inform prevention programs and 
policy.  However, it appears that ensuring the high quality of enhanced data has come at 
some cost to timeliness, with one EIPDSWG member noting that: 
There is a 10 month delay in the dump of enhanced data from NNDSS to 
NCIRS.  There is a reason why it takes so long—all the checking and 
confirmation is time consuming—but it reduces the utility of the system 
(OHP/NCIRS). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EIPDSWG interviews revealed that delays in obtaining and verifying data are due to  
 lack of access to electronic clinical records; 
 delays in the production of hospital discharge summaries; 
 absence of an ‘all-of-life’ vaccination register; 
 batching of serotype testing and reporting by reference laboratories; 
 diagnostic labs requiring prompting to forward isolates for typing (particularly 
for cases confirmed by PCR); and 
True onset date 
Specimen date 
Notification date 
Notification received date 
Date reported in NNDSS Fortnightly Report 
Date of publication of Quarterly Report 
6  
days* 
2 days 
max 
7 days 
max  
14 days 
Date reported to NNDSS 
3  
months 
3 days 
0 days 
Figure 39 Median intervals between elements of case notification (1 July 2013 to 30 June 2016) 
and reporting (2001 – 2016) in Australia’s enhanced IPD surveillance program. 
* This interval does not equal the sum of the sub-intervals, due to missing data in date fields 
Date of publication of Annual Report 
4 years 
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 data cleaning and checking. 
 
The detection of outbreaks of IPD is not an objective of IPD surveillance, and less than 
a quarter of stakeholders thought the program was capable of this.  In contrast, three 
quarters of EIPSWG members thought that through the communication network of the 
EIPDSWG, surveillance was timely enough for jurisdictions to detect an outbreak.  
Several interviewees pointed to the experience of the multi-jurisdictional serotype 1 
outbreak from 2010 to 2012 as an example:  
An outbreak was identified in the NT using [jurisdictional] data. When we 
looked at data obtained through the Working Group we could see that the 
outbreak started some time earlier in WA. 
 
Nationally, 54% of cases with available and valid date data are notified within seven 
days and 80% within 14 days.   However, it must be noted that it usually takes several 
weeks after notification for the jurisdictions to receive data on serotype for a case, 
making early identification of linked cases unlikely.   One EIPDSWG member indicated 
that South Australia would have difficulty identifying linked cases due to this 
jurisdiction’s difficulty in obtaining serotype data.  Another indicated that they would 
find it helpful if the Working Group developed guidelines about what to do in case of a 
suspected outbreak. 
   
 
STABILITY 
Forty percent of EIPDSWG interviewees rated the stability of the program as ‘excellent’, 
and half rated it as ‘good’.  None indicated that there had been any significant periods 
during which the program could not function.  The exception was one reference 
laboratory which became overwhelmed during the 2009 H1N1 influenza pandemic, and 
was unable to type about 20% of cases.  These favourable responses reflect the fact that 
the program has operated for over 15 years without major problems, and that the 
NNDSS is a stable system.  Again, the utility of the EIPDSWG as a governance and 
communication mechanism has been important in this regard.  However, some members 
indicated they were concerned about the program’s ability to function at the current 
level when long-term members left.  They suggested that the high quality of enhanced 
data was heavily reliant upon the involvement of passionate members of EIPDSWG 
who have been a “driving force”.  Some jurisdictions and the OHP indicated there 
would be problems in data collection and quality if key public health staff left their 
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positions with no succession plan.  One jurisdiction reported that they had already 
addressed this issue: 
It used to be just one person in [jurisdiction] looking after IPD data, now it 
is spread across a few people. We often do training sessions on how to use 
the [data collection] form and using the metadata 
 
Some interviewees felt that the program was somewhat vulnerable to changes in 
funding priorities from the Australian Government, for example 
It takes a lot of manpower to collect detailed information on not many cases.  
It may look to some as if [the program] has little bang for buck and is a good 
candidate for cost-savings (OHP/NCIRS).  
  
One member suggested that more work needed to be done to quantify the economic 
costs arising from IPD hospitalisations and deaths in order to demonstrate the “business 
case” for continued enhanced surveillance.  To this end, it is important that useful IPD 
surveillance data, including high quality hospitalisation and death data, be readily 
available for such work. 
 
Recommendation 10 
Implement succession planning interventions to ensure there is depth of capacity within 
the EIPDSWG, reference laboratories and jurisdictions to maintain the program at the 
current high standard. 
 
Conclusion 
This evaluation verifies that the enhanced IPD surveillance program is one of 
Australia’s most useful and stable disease surveillance systems.  Nonetheless, the 
program is not performing to its full potential, particularly in terms of data collection for 
cases aged between five and 50 years to inform targeted vaccination programs, AMR 
monitoring, and providing easily accessible and useful surveillance data.  The declining 
number of cases, the increasing availability of vaccination data for all ages on the AIR, 
and the continued move towards electronic medical records should put complete data 
collection for all cases within the reach of all jurisdictions.  Ongoing work is required of 
the EIPDSWG to ensure complete AMR testing; to harmonise notification, data entry 
and transmission processes; and to plan for the shift to whole-genome sequencing.   
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CHAPTER 5 – NEW DIRECTIONS: MOTHERS 
AND BABIES SERVICES: AN EVALUATION OF 
THE PROGRAM USING AUSTRALIAN EARLY 
DEVELOPMENT CENSUS DATA 2009 - 2015 
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We have a catchy mantra of ‘Closing the Gap’, which in many 
ways suggests that as blackfullas we are here; other Australians 
are there; with a big gap in the middle that leaves us blackfullas 
with some catching up to do if we are to be as good as the 
average Australian.  When in fact the truth is reflected in the less 
catchy notion of ‘shifting the bell curve to the right’, a notion that 
reminds us all that many Aboriginal people are as exceptional as 
our fellow Australians. 
Dr Chris Sarra 
 
 
 
 
 
 
Artwork: Making Two Worlds Work Project, developed by Mungabareena Aboriginal 
Corporation and Women’s Health Goulburn North East, 2008. www.whealth.com.au/mtww  
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ABBREVIATIONS 
 
AEDC Australian Early Development Census 
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DISCLAIMER 
This report uses data from the Australian Early Development Census 
(AEDC). The AEDC is funded by the Australian Government 
Department of Education and Training. The findings and views 
reported are those of the author and should not be attributed to the 
Department or the Australian Government. 
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Prologue 
The New Directions: Mothers and Babies Services (NDMBS) program is a key 
responsibility of my Section at the Department of Health.  Although it has been in 
operation since 2008, it has not been evaluated for effectiveness.  This was the first 
project commenced during my field placement, but the last completed.  The main reason 
for this was that the geographical locations in which NDMBS had already been 
delivered was uncertain as a result of an amalgamation of the program into a broader 
primary health care program.  This information took many months and much effort by 
staff in the Section to obtain.  While these data were gathered, the project aims changed 
from informing the expansion of the NDMBS to new locations, to baseline analysis for 
later evaluation, and finally an evaluation of the program outcomes after release of the 
2015 Australian Early Development Census (AEDC) data in 2016. 
 
MY ROLE 
For this project I 
 developed the data analysis plan  
 developed the program logic model for NDMBS 
 drafted the ethics application 
 conducted the analysis 
 drafted the report for the Department of Health, and the accompanying technical 
summary 
 wrote the Minute to obtain clearance for publication from the Branch Manager 
 presented the evaluation findings to the Indigenous Health Division forum. 
My academic supervisor, David Harley, provided ongoing feedback and guidance.    
 
LESSONS LEARNT 
In developing the program’s logic model, I gained a deeper understanding of program 
planning and evaluation.  I learnt about the difficulty that funding agencies face in 
balancing the need to implement programs quickly, with minimal burden to the funded 
organisations, and the need to collect useful data from those organisations.  I also learnt 
the value of keeping a detailed record of commands used in a data analysis.  My 
methods were questioned by the AEDC data team, and by checking my annotated Stata 
do files, I was able to quickly justify my analysis.  
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PUBLIC HEALTH IMPACT 
This was the first outcome evaluation of a $278 million national program.  Its 
usefulness was hindered by problems with allocation to exposure groups, as it was 
difficult to determine the geographical reach of the NDMBS program accurately and 
with a high enough resolution.  However, in the report and presentation to the Division, 
I aimed to highlight the need for development of logic models during program planning, 
and to ensure that appropriate data is collected to facilitate later evaluation.  Several 
staff members from within the Indigenous Health Division have since approached me to 
discuss logic models and evaluation for other programs.   
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Summary of findings and recommendations  
 
New Directions: Mothers and Babies Services (NDMBS) aims to increase access to 
antenatal, postnatal and child and maternal services for Aboriginal and Torres Strait 
Islander families to ensure children are healthy and ready to learn when they start school.  
Over $224 million was invested in NDMBS from 2007-08 to 2014-15.  A further 
$53.96 million has been committed for 2015-16 to 2017-18 to expand the program to a 
further 51 sites.  
 
In this first evaluation of the program, we assessed the effect of NDMBS investment 
between 2007 and 2015 on school readiness of Aboriginal and Torres Strait Islander 
children.  Using data from the Australian Early Development Census (AEDC) collected 
in 2009 and 2015, we analysed whether measures of early development in the first year 
of school improved for children who lived in an area serviced by an NDMBS-funded 
organisation, compared with children who did not.   
 
Overall, the results show improvements in areas that were serviced by NDMBS-funded 
organisations.  However, comparisons with non-NDMBS areas suggest that the 
contribution of the NDMBS program to these improvements have been modest on a 
national scale.  At most, only two percentage points of the improvement in early child 
development indicators could be attributed to living in an area serviced by an NDMBS-
funded organisation.  In some indicators, improvements in NDMBS-serviced areas were 
exceeded by the improvements in the rest of Australia.   
 
As the program has targeted areas of highest need, it is possible that child development 
indicators in these areas may have worsened in the absence of investment.  Problems 
with maternal and child health staff recruitment and retention in remote areas may also 
have limited the effectiveness of the NDMBS.   
 
The AEDC indicators relate only to the school readiness of children, not to the ability of 
schools to engage children in high quality teaching and learning.  The accuracy of this 
evaluation was reduced by the limitations of using population-level outcome indicators, 
and by the low geographical resolution of the data.   
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Recommendations  
1. Enhance support for NDMBS-funded organisations that deliver services in 
remote and very remote areas.  Focus should be on strategies that develop 
the remote maternal and child health workforce, particularly Aboriginal 
and/or Torres Strait Islander Workers/Health Practitioners and Aboriginal 
and Torres Strait Islander midwives and nurses. 
 
2. Require organisations that receive NDMBS funding to regularly report the 
postcodes of children and families who receive services to allow future 
evaluations of effectiveness.   
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Introduction   
New Directions: Mothers and Babies Services (NDMBS) is part of the Australian 
Government’s commitment to close the gap in infant mortality rates between Aboriginal 
and Torres Strait Islander and non-Indigenous Australian children (Figure 1). The 
program is based on international and Australian research that indicates the importance 
in investing in the early years for children and their families. The objective of NDMBS 
is to increase access to antenatal, postnatal and child and maternal services for 
Aboriginal and Torres Strait Islander families.  The areas serviced by organisations that 
received funding to deliver New Directions Mothers and Babies Services between 2007 
and 2015 is shown in Figure 2, and listed in Appendix 5.1.   
 
NDMBS is a child and maternal health care program that supports Aboriginal and 
Torres Strait Islander families and early childhood development to support children to 
be healthy and ready to learn when they start school, through providing access to 
services in five priority areas: 
1. antenatal and postnatal care; 
2. standard information about baby care; 
3. practical advice and assistance with breastfeeding, nutrition and parenting; 
4. monitoring of developmental milestones, immunisation status and infections; 
and 
5. health checks and referrals to treatment for Aboriginal and Torres Strait Islander 
children before starting school. 
The program is flexible to local needs and provides access to a range of child and 
maternal health functions as part of a broader primary healthcare service. 
 
Over $224 million was invested in NDMBS from 2007 to 2015.  A further $53.96 
million has been committed for expanding the program in 2015to 2018.  Three 
assessments of the program have already been completed:  
 a performance audit conducted by the Australian National Audit Office (ANAO) 
in 2011-12 (1); 
 a Descriptive Analysis commissioned by the Department of Health (“the 
Department”) in 2013 (2); and 
  an assessment of the program conducted by the Australian Institute of Health 
and Welfare (AIHW) in 2014 (3).   
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The performance audit concluded that the Department had been effective in establishing 
and implementing the program, but more performance data needed to be collected by 
the program in order to monitor and evaluate its effectiveness.  The Descriptive 
Analysis consisted of a review of the funded organisations’ NDMBS action plans, a 
survey of 64% of funded organisations, and interviews with staff at 17% of 
organisations.  Services reported they were mostly using the NDMBS funding to 
employ midwives, child and family health nurses, and Aboriginal and/or Torres Strait 
Islander Health Workers/Health Practitioners to provide care in clinic and home settings.  
Overall, organisations were providing services consistent with the program’s priority 
areas, and there had been increased activity as a result of the program.    However, 
organisations were challenged by difficulties in recruiting and retaining staff, lack of 
patient transport, limited funding, and difficulties related to remote service delivery.  
Only one quarter of the organisations indicated they had capacity to meet demand for 
maternal and child health services.  
 
The AIHW assessment used national Key Performance Indicator (nKPI) data from 2012 
and 2013 that is collected from primary health care organisations funded by the 
Australian government.  The data used included measures of outcome (proportion of 
normal birthweight children, and proportion of women who attended their first antenatal 
visit before 13 weeks gestation) and processes-of-care (completeness of birthweight 
data; immunisation coverage at one, two and five years of age; and child and women’s 
health check coverage).  The change in these measures over a six or twelve month 
period in organisations that received NDMBS funding was compared with the change in 
organisations that did not.  Organisations funded by NDMBS improved to a greater 
degree in five of the eight measures, but no tests of statistical significance were 
performed.   
 
In this analysis, we aimed to evaluate the effect of NDMBS investment between 2007 
and 2015 on school readiness, and to make recommendations to the Department.  
Specifically, we wished to determine if indicators derived from the Australian Early 
Development Census (AEDC) improved for Aboriginal and Torres Strait Islander 
children who lived in NDMBS-serviced areas, compared with children who did not.  
This report is accompanied by a technical summary (Appendix 5.2). 
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Figure 40 Program logic for the New Directions: Mothers and Babies Services (NDMBS) program. 
Overarching Goal 
 
Equality of health status and life 
expectancy between  
Aboriginal and Torres Strait Islander 
people and non-Indigenous 
Australians by 2031 
Inputs 
• $90.3 million from 2007-08 to 
2011-12 
• $133.8 million  from 2011-12 to 
2014-15 
• $53.96 million from 2015-16 to 
2017-18 
Activities 
• Antenatal checks and care 
• Postnatal checks and care 
• Child health checks and care to age 4  
years 
•Maternal, infant and child 
immunisations 
• Parenting, breastfeeding, and healthy 
lifestyle support for families 
• Partnerships with birthing 
centres/hospitals 
• Partnerships with playgroups, daycare  
centres and pre-schools 
Outputs 
• Number of maternal and child health 
staff employed 
• Number of visiting services purchased 
• Number of  families receiving services 
• Number of antenatal clinics held 
• Number of immunisations 
• Number of child health checks 
• Number of  health checks for carers 
Outcomes 
•Increased proportion of women receiving 
antenatal checks before 20 weeks 
•Increased number of antenatal checks per 
pregnancy 
•Reduced maternal smoking, alcohol and 
substance use 
•Increased proportion of healthy birthweight 
babies 
•Increased proportion of children fully 
immunised at 12 and 24 months 
•Decreased rate of avoidable hospitalisations 
•Decreased rate of ear and hearing health 
problems 
New Directions: Mothers and Babies Services 
Impacts 
Reduced  
infant mortality 
Children are 
healthy and ready 
for school 
Children have the 
same health 
outcomes as non-
Indigenous 
children 
Children have the 
same educational 
and employment 
outcomes as non-
Indigenous 
children 
214 
 
 
Figure 41 Indigenous Areas (IAREs) serviced by organisations that received funding to deliver New Directions Mothers and Babies Services (NDMBS), 2007-2015. 
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Methods  
CHILD DEVELOPMENT MEASURES 
We used data from the Australian Early Development Census (AEDC, previously the 
Australian Early Development Index), which is a population measure of early childhood 
development (4).  It is often used as a measure of school readiness.  It covers five 
domains of child development: physical health and wellbeing; social competence; 
emotional maturity; language and cognitive skills; and communication and general 
knowledge.  All five of these domains have been found to predict National Assessment 
Program – Literacy and Numeracy (NAPLAN) outcomes at Years 3, 5 and 7 (5).  
Children who start school with good early development will generally maintain superior 
educational trajectories compared with children who have poor early development, 
regardless of their socio-economic status (6). 
 
Scores for AEDC domains are calculated for each Australian child during the first year 
of full-time school, based on teacher responses to 96 developmental questions.  If the 
teacher of an Aboriginal and Torres Strait Islander child is not of Indigenous descent, 
the questions are completed in consultation with an Indigenous cultural consultant, 
where available.  The census was taken in 2009, 2012 and 2015, and the dataset 
includes over 96.5% of all children registered to start school in those years.  While 
AEDC data is collected for each child, data is aggregated at a community level based on 
the communities where children live.  
 
Results from the AEDC are reported as proportions of children regarded as ‘on track’, 
‘developmentally at risk’ and ‘developmentally vulnerable’ in each domain (Table 1), 
Summary indicators reported are the proportion of children vulnerable in one or more 
domain, and vulnerable in two or more domains.  Results are also reported using the 
Multiple Strengths Indicator (MSI, Table 2).  Unlike the vulnerability summary 
indicators, which are based on the challenges children face when they start school, the 
MSI combines information from all five domains to summarise the strengths they have 
developed (7).  As these summary indicators are capturing different information about 
child development, communities may have both a high proportion of children with 
developmental vulnerabilities and a high proportion of children with well-developed or 
highly-developed strengths.   
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Table 1 Characteristics of children considered ‘developmentally on track’, or ‘developmentally 
vulnerable’ for each of the four AEDC domains (4). 
Domain Children developmentally on track Children developmentally vulnerable 
Physical 
health & 
wellbeing  
Almost never have problems that 
interfere with their ability to 
physically cope with the school 
day. These children are generally 
independent, have excellent motor 
skills, and have energy levels that 
can get them through the school 
day. 
Experience a number of challenges that 
interfere with their ability to physically cope 
with the school day. This may include being 
dressed inappropriately, frequently late, 
hungry or tired. Children are usually clumsy 
and may have fading energy levels. 
Social 
competence 
Almost never have problems 
getting along, working, or playing 
with other children; is respectful to 
adults, is self-confident, and is able 
to follow class routines; and is 
capable of helping others. 
Experience a number of challenges with poor 
overall social skills. For example children who 
do not get along with other children on a 
regular basis, do not accept responsibility for 
their own actions and have difficulties 
following rules and class routines. Children 
may be disrespectful of adults, children, and 
others’ property; have low self-confidence 
and self-control, do not adjust well to change; 
and are usually unable to work 
independently. 
Emotional 
maturity 
Almost never show aggressive, 
anxious, or impulsive behaviour. 
Children will have good 
concentration and will often help 
other children.  
Experience a number of challenges related to 
emotional regulation. For example problems 
managing aggressive behaviour being prone 
to disobedience and/or is easily distracted, 
inattentive, and impulsive. Children will 
usually not help others and are sometimes 
upset when left by their caregiver.  
Language & 
cognitive 
skills (school-
based) 
Children will be interested in 
books, reading and writing, and 
basic mathematics; capable of 
reading and writing simple 
sentences and complex words. Will 
be able to count and recognise 
numbers and shapes. 
Experience a number of challenges in 
reading/writing and with numbers; unable to 
read and write simple words, will be 
uninterested in trying, and often unable to 
attach sounds to letters. Children will have 
difficulty remembering things, counting to 20, 
and recognising and comparing numbers; and 
usually not interested in numbers. 
Communicati
on skills & 
general 
knowledge 
Children will have excellent 
communication skills, can tell a 
story and communicate easily with 
both children and adults, and have 
no problems with articulation. 
Children will have poor communication skills 
and articulation; have limited command of 
English (or the language of instruction), have 
difficulties talking to others, understanding, 
and being understood; and have poor 
general knowledge. 
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Table 2 Characteristics of children in each Multiple Strengths Indicator (MSI) category (7). 
Category Characteristics 
Emerging strengths 
Children may be meeting developmental expectations when they start school 
but they do not demonstrate a high number of strengths. Children in this 
category range from those with strengths in none of the 39 MSI items, to 
children with strengths in about half of the MSI items.  
Well-developed 
strengths 
Children are showing strengths in 50-70% of the following skills: relating to 
peers and teachers, self-control, curiosity about the world, working 
independently, reading and writing simple words, communicating effectively 
with peers and teachers, and storytelling.  
Highly developed 
strengths 
Children have strengths in most of the 39 MSI items. These children are likely 
to be on track on all five AEDC domains, and show strengths in their social and 
emotional, literacy and communication skills.  
 
DATA ANALYSIS 
We used data for all Aboriginal and Torres Strait Islander children who did not have 
special needs, were aged over three years, and who had available geographical data 
from the 2009 and 2015 censuses (Figure 3).  As the NDMBS program rolled out in 
2007, most of the children in the 2009 census were too old to receive NDMBS services, 
so these data were used as the baseline for the evaluation.  Follow-up data was taken 
from the 2015 AEDC.  Most children in this census were born in 2010, so NDMBS 
services were available throughout their antenatal and early childhood periods.  We 
divided the data from both census years into two groups: all children living in areas that 
were serviced by a NDMBS-funded organisation, and all other children.  Children were 
allocated to either group based upon the Indigenous Area (IARE) they lived in at the 
time of the census.  Indigenous Areas generally have a minimum of 250 Aboriginal and 
Torres Strait Islander residents (8).  We calculated the percentage point change in child 
development indicators between 2009 and 2012 for both groups nationally and by state 
and territory.  Each of these calculations excluded children who did not have a valid 
score for the indicator.   
 
As the NDMBS program has been targeted at areas of high need for maternal and child 
health services, we expected that children in these areas would have relatively poorer 
development indicators.  However, if the NDMBS program has been effective, we 
would expect to see a greater improvement in these areas between 2009 and 2015, 
compared with areas that did not receive NDMBS investment.   
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Figure 42 Method for evaluation of New Directions: Mothers and Babies Services from 2007 to 2015 using AEDC data. 
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Results 
DESCRIPTION OF CHILDREN INCLUDED IN THE EVALUATION 
In 2009 and 2015, there were 12 459 and 16 197 Aboriginal and Torres Strait Islander 
children who were eligible for this study and for whom census data were available.  Just 
over 45% of these children lived in IAREs serviced by organisations that received 
NDMBS funding between 2007 and 2015.  The age and sex of this group of children did 
not differ from other Aboriginal and Torres Strait Islander children, and their 
distribution across areas of relative socio-economic disadvantage was similar (Table 3).  
A greater proportion of children who lived in non-NDMBS areas were in remote or very 
remote areas, had a language background other than English
8
, and spoke English as a 
second language.  While 86% of all Aboriginal and Torres Strait Islander children were 
assessed in the AEDC by a non-Indigenous teacher, a greater proportion of assessments 
of children living in non-NDMBS areas were completed with the assistance of an 
Indigenous cultural consultant.   
 
Two-thirds of children in the NDMBS-serviced areas lived in New South Wales or 
Queensland in 2009 (Figure 4).  All of the IAREs in the ACT were serviced by a 
NDMBS-funded organisation, so no comparison could be made in this jurisdiction.    
 
 
 
 
 
 
 
 
 
 
 
                                                 
 
8
 Children who speak a language other than English in the home or whose parent(s)/guardian(s) speak a 
language other than English in the home. 
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Table 3 Characteristics of children included in the analysis (Aboriginal and Torres Strait Islander 
children in the first year of school), by NDMBS service areas, 2009.   
Characteristic 
Area received 
NDMBS 
(5 674 
children) 
Area did not 
receive 
NDMBS 
(6 785 
children) 
All Aboriginal & 
Torres Strait 
Islander 
children (12 459 
children) 
Mean age (years) 5.5 5.5 5.5 
Female 2 889 (51%) 3 369 (50%) 6 258 (50%) 
Language background other 
than English1 
1 405 (24%) 1 966 (29%) 3 371 (27%) 
English as a second 
language 
1 132 (20%) 1 658 (24%) 2 790 (22%) 
Lived in least socio-
economic disadvantage 
area 
364   (7%) 335   (5%) 699 (6%) 
Lived in most socio-
economic disadvantage 
area  
2 685 (48%) 3 106 (46%) 5 791 (47%) 
Remote or very remote 
location 
1 345 (24%) 2 058 (30%) 3 403 (27%) 
Indigenous teacher 763 (14%) 951 (14%) 1 714 (14%) 
Non-Indigenous teacher 
who was assisted by an 
Indigenous cultural 
consultant 
1 440 (29%) 2 151 (37%) 3 591 (33%) 
Attended a preschool 
program  
3 266 (69%) 4 196 (72%) 7 462 (71%) 
 
 
 
Figure 43 State or territory of residence of Aboriginal and Torres Strait Islander children living 
in NDMBS-serviced areas, 2009. 
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DEVELOPMENTAL DOMAINS 
In the NDMBS-serviced areas, the proportion of children who were on-track in each 
AEDC domain increased between 2009 and 2015.  Over 60% of children in these areas 
were on track in each domain in 2015.  There were remarkable improvements in the 
‘language and cognitive skills’ domain (Figure 5 and Table 4).  However, reductions in 
developmental vulnerability in other domains were much smaller or negligible.      
 
Overall, the improvements observed in the NDMBS-serviced areas were also observed 
in the rest of Australia (Table 4 and Figure 6). The greatest relative improvements in 
early child development that could be attributed to the NDMBS program were in the 
proportion of children on-track in the ‘emotional maturity’ domain, and the proportion 
of children vulnerable in the ‘physical health and wellbeing’ domain.  However, these 
differences were small.  In some indicators—in the ‘communication & general 
knowledge’ domain, for example—improvements in NDMBS-serviced areas were 
exceeded by the improvements in the rest of Australia.  
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Figure 44 Proportion of Aboriginal and Torres Strait Islander children living in areas serviced by New Directions Mothers and Babies Services (Wave 1), in each 
AEDC domain category, 2009 and 2015.  Hatched bars indicate that the change between 2009 and 2015 was within the margin of error.    
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Table 4 Change in proportion of Aboriginal and Torres Strait Islander children on-track and vulnerable in each developmental domain, from 2009 to 2015, by 
NDMBS service area.  A negative change in the vulnerable categories indicates an improvement. 
NDMBS 
services 
 
Physical health & 
wellbeing 
Social competence Emotional maturity 
Language & cognitive 
skills (school-based) 
Communication & 
general knowledge 
 
On-track Vulnerable On track Vulnerable On track Vulnerable On track Vulnerable On-track Vulnerable 
Yes 
2009 (%) 60.0 22.5 59.0 19.6 60.1 16.5 49.0 27.4 56.2 21.0 
2015 (%) 62.9 20.0 60.4 19.9 64.2 16.1 65.1 18.9 60.2 18.8 
change (%) 2.9 -2.5 1.4 0.3* 4.1 -0.3* 16.1 -8.5 4.0 -2.1 
No  
2009 (%) 60.1 22.4 56.9 21.5 58.9 18.1 45.6 31.3 53.8 23.2 
2015 (%) 61.8 22.0 58.1 21.0 61.0 17.5 60.9 21.2 59.0 19.8 
change (%) 1.7 -0.5* 1.2 -0.5* 2.1 -0.6* 15.3 -10.1 5.2 -3.4 
Difference in change (%)  1.2 -2.0 0.2 0.8 2.0 0.3 0.8 1.6 -1.3 1.3 
          * The change between 2009 and 2015 was within the margin of error.  
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Figure 45  Change in the proportion of Aboriginal and Torres Strait Islander children in AEDC domain categories, NDMBS-serviced areas versus non-NDMBS areas, 
2009-2015.  A negative change in the vulnerable categories indicates an improvement.  Hatched bars indicate that the change was within the margin of error. 
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SUMMARY INDICATORS – AUSTRALIA 
There were substantial improvements in the summary indicators for children in 
NDMBS-serviced areas from 2009 to 2015 (Table 5, Figure 7 and Figure 8), 
particularly in the proportion of children who had highly-developed strengths.  However, 
these changes were similar to the improvements observed in all Aboriginal and Torres 
Strait Islander children over this period (Table 5 and Figure 9), with less than one 
percentage point difference between the groups on each indicator.  
 
 
Table 5 Change in summary early child development indicator categories for Aboriginal and 
Torres Strait Islander children, from 2009 to 2015, by NDMBS service area.  A negative change 
in the vulnerable and ‘emerging strengths’ categories indicates an improvement.   
NDMBS services 
Vulnerable 
in 1 or 
more 
domains 
Vulnerable 
in 2 or 
more 
domains 
 Multiple Strengths Indicator 
 Highly-
developed 
strengths 
Well-
developed 
strengths 
Emerging 
strengths 
Yes 
2009 (%) 46.9% 29.0%  30.6% 24.9% 44.5% 
2015 (%) 40.8% 25.2%  38.6% 23.5% 37.9% 
change (%) -6.1% -3.8%  8.0% -1.4% -6.6% 
No  
2009 (%) 49.7% 31.8%  27.8% 25.0% 47.2% 
2015 (%) 43.2% 27.1%  34.8% 23.7% 41.5% 
change (%) -6.5% -4.7%  7.0% -1.3% -5.7% 
Difference in change (%)  0.4% 0.9%  0.9% -0.1% -0.9% 
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Figure 46 Proportion of Aboriginal and Torres Strait Islander children who were vulnerable in 
one or more, or two or more domains, 2009 and 2015, by NDMBS service area.   
 
 
 
 
Figure 47 Proportion of Aboriginal and Torres Strait Islander children who were in Multiple 
Strengths Indicator categories, 2009 and 2015, by NDMBS service area.   
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Figure 48  Change in summary early child development indicator categories for Aboriginal and Torres Strait Islander children, from 2009 to 2015, by 
NDMBS service area.  A negative change in the vulnerable and ‘emerging strengths’ categories indicates an improvement.  
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SUMMARY INDICATORS – STATE AND TERRITORY 
Notable improvements in summary indicators in NDMBS areas were observed in New 
South Wales and Queensland (Table 6 and Figure 10).  Western Australia experienced 
more modest improvements overall, and an increase in the proportion of children who 
were vulnerable in two or more domains.  The changes observed in the other States and 
Territories were within the margin of error for the vulnerability indicators.  
 
 
Table 6 Change in summary child development indicators, NDMBS-serviced areas only, 2009-
2015, by State and Territory. 
 
State/Territory 
Number of 
children in 
2009 
Percentage point change 
Highly 
developed 
strengths 
Emerging 
Strengths# 
Vulnerable 
in ≥1 
domains# 
Vulnerable 
in ≥2 
domains# 
NSW 2 136 7.8% -5.7% -4.3% -2.6% 
VIC 203 5.2% -7.3% -2.1%* -3.1%* 
QLD 1 626 8.8% -8.8% -7.5% -5.1% 
SA 108 0.5% -4.5% 0.8%* -3.5%* 
WA 675 3.8% -0.9% -1.1%* 4.1% 
TAS 228 5.0% -2.0% -4.8%* -4.6% 
NT 595 1.4% 0.7% -1.9%* 1.4%* 
ACT 101 -3.6% 2.7% 2.9%* 6.1%* 
Australia 5 672 8.0% -6.6% -6.1% -3.8% 
*The changes observed in these indicators were within the margin of error. 
#
 As these are indicators of deficit, a negative change represents an improvement.  
 
 
New Directions investment appears to have had a positive but modest effect upon 
children with emerging strengths or who were developmentally vulnerable in New 
South Wales and Queensland (Table 7 and Figure 11).  However, children in areas of 
Western Australia serviced by a NDMBS-funded organisation had substantially lesser 
improvements in all summary indicators, compared with children living in other parts of 
the State.  The effects in other jurisdictions were undetectable due to small numbers of 
children in the analysis.     
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Table 7 Difference in the change in summary child development indicators, NDMBS-serviced 
areas versus non-NDMBS areas, 2009-2015, by State and Territory.   
State/Territory 
Percentage point difference in change 
Highly 
developed 
strengths 
Emerging 
strengths# 
Vulnerable 
in ≥1 
domains# 
Vulnerable 
in ≥2 
domains# 
NSW 0.6% -3.8% 1.1% -1.0% 
VIC* 3.8% -8.3% 0.6%* 1.6%* 
QLD -0.2% -3.2% -1.0% -2.2% 
SA -0.8% 0.2% 3.9%* -1.5%* 
WA -1.7% 5.4% 5.5%* 11.1% 
TAS -15.6% 8.7% 0.3%* 1.9% 
NT -3.1% 6.6% 15.5%* 10.0%* 
Australia -0.1% -0.9% 0.4% 0.9% 
* The changes observed in these indicators were within the margin of error 
#
 As these are indicators of deficit, a negative difference represents a greater 
improvement in the NDMBS-serviced areas.  
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Figure 49  Change in summary indicators for child development indicators in NDMBS-serviced areas from 2009-2015, by State and Territory. *The changes 
observed in these jurisdictions were within the margin of error. # As these are indicators of deficit, a negative change represents an improvement. 
-10%
-8%
-6%
-4%
-2%
0%
2%
4%
6%
8%
10%
NSW VIC* QLD SA* WA TAS* NT* ACT* Australia
P
er
ce
n
ta
ge
 p
o
in
t 
ch
an
ge
 f
ro
m
 2
0
0
9
-2
0
1
5
 
Highly-developed
strengths
Emerging strengths#
Vulnerable in ≥1 
domains# 
Vulnerable in ≥2 
domains# 
 231 
 
 
Figure 50  Difference in the change in summary early childhood indicators between NDMBS-serviced areas and non-NDMBS areas, 2009-2015, by State and 
Territory.   *The changes observed in these jurisdictions were within the margin of error.  # As these are indicators of deficit, a negative change represents a 
greater improvement in NDMBS-serviced areas. 
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Discussion 
Overall, population measures of early child development indicate improvements in 
areas that were serviced by NDMBS-funded organisations.  However, comparisons with 
non-NDMBS areas suggest that the contribution of the NDMBS program to these 
improvements have been modest on a national scale.  In this first ‘before and after’ 
evaluation of the program, we have been unable to demonstrate a substantial effect on 
the school readiness of Aboriginal and Torres Strait Islander children resulting from 
NDMBS investment.  However, as the program has targeted areas of highest need, it is 
possible that child development indicators in these areas may have worsened in the 
absence of investment. 
 
The largest comparative improvements in early child development were in the 
‘emotional maturity’ and ‘physical health and wellbeing’ domains.  The AIHW 
assessment of the program, which lacked baseline data, found that there was a 13.8 
percentage point greater improvement over 12 months in the proportion of NDMBS-
funded organisations that completed health checks for more than half of all children 
aged four years, compared with non-NDMBS organisations (10).  The quality of these 
health checks cannot be assessed, but they may have resulted in prevention of, or early 
intervention in, physical illness or problems with emotional development.  Relative 
improvements observed in the proportion of organisations with more than half of 
children fully immunised at ages one, two and five years may also help explain the 
improvements in the ‘physical health and wellbeing’ domain found in the present 
evaluation.  Hospitalisation for infection in the first five years of life has been found to 
marginally increase the likelihood of a child being developmentally vulnerable in all 
AEDC domains (11). 
 
While greater gains have been made in NDMBS areas in Queensland and NSW, this is 
not the case in Western Australia and the Northern Territory.  In 2015, 57% of Western 
Australian and 98% of NT children living in NDMBS areas were also in remote or very 
remote areas, in contrast to under 1% of children in NSW and under 12% in Queensland.  
It is plausible that remoteness has led to less favourable outcomes in WA and NT.  In 
the 2013 Descriptive Analysis, NDMBS-funded organisations indicated that the 
recruitment and retention of qualified staff was their greatest challenge, and that this 
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problem was “amplified in rural and remote areas” (12).  In particular, services had 
difficulty in recruiting suitably qualified Aboriginal and Torres Strait Islander staff.   A 
systematic review conducted in 2010 identified the following three evidence-based 
strategies for developing and maintaining a skilled and qualified rural and remote health 
workforce to improve Aboriginal and Torres Strait Islander health outcomes: 
 promote rural and remote Aboriginal and Torres Strait Islander health practice to 
health students; 
  provide additional support, such as training, improved cultural competence, and 
peer mentoring to the existing health workforce; and 
 develop and support the Aboriginal and Torres Strait Islander health workforce 
at a local level (13). 
 
In spite of the differences in language backgrounds between the two groups, the large 
improvements observed in NDMBS areas in the ‘communication skills and general 
knowledge’ domain were exceeded by improvements in non-NDMBS areas.  Preschool 
attendance has been implicated in improved English proficiency at the time of starting 
school in children from linguistically diverse backgrounds (14).  However, while a 
slightly larger proportion of children in the non-NDMBS group had attended a 
preschool program in 2009 (72% versus 69% in NDMBS-areas, Table 1), this gap had 
closed by 2015 (83% versus 84%).   
 
Substantially fewer 2009 AEDC assessments of Aboriginal and Torres Strait Islander 
children who had a non-Indigenous teacher were completed with the assistance of a 
cultural consultant in NDMBS areas (Table 1).  However, this disparity was essentially 
reversed by 2015 (34% of children in NDMBS areas versus 31% in non-NDMBS areas).  
Assuming that a non-Indigenous teacher would assess a child more favourably with 
consultation, the small observed improvements relative to non-NDMBS areas may have 
been inflated.    
 
LIMITATIONS OF THE STUDY DESIGN AND ANALYSIS 
The AEDC is just one measure of school readiness related to characteristics of the child. 
It does not measure the ability of schools to engage children in high quality teaching 
and learning (9).  It is also influenced by factors outside the scope of the NDMBS, such 
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as access to appropriate preschool programs, and the availability of Aboriginal and 
Torres Strait Islander school staff who can facilitate transition to school.  
 
We followed up the same IAREs over time, not the same children.  Therefore, we were 
unable to measure or control for child-related factors that may have confounded the 
results.  We cannot be certain that any maternal and child health services received by 
the children in the NDMBS group in the 2015 Census were funded by the NDMBS 
program.  Aboriginal and Torres Strait Islander families may seek health care outside 
NDMBS-funded services, where these are available.  Many may also have moved in or 
out of the NDMBS-serviced areas.   
 
The accuracy of this evaluation has been significantly hindered by the low resolution of 
available geographical data.  Funding is provided for NDMBS for an organisation, not 
for a geographical area, and organisations are not required to report on the resident 
locations of the children and families they service.  These areas are unlikely to match 
the IARE boundaries.   Funded organisations may have changed the locations of service 
delivery between 2007 and 2015 and were not required to report such changes.    
 
The 2011-12 Audit Report concluded that: 
…the emphasis on minimising performance reporting requirements has had a 
significant impact on the quality of performance data available to assist managers 
and external stakeholders. As a consequence, very few performance indicators and 
targets were developed and there was no agreement to any baseline information 
against which to measure change. This has limited [the Department’s] ability to 
understand the program’s effectiveness and, in particular, the impact and 
contribution it is making to the outcomes of the [National Partnership Agreement on 
Indigenous Early Childhood Development]. This will also constrain the ability of the 
Department to conduct an evaluation of the program... 
 
The nKPI data provides mostly information about processes-of-care rather than 
outcomes, and is not reported by every organisation that offers maternal and child health 
services.  Therefore, we support the conclusion of the AIHW assessment that nKPI data 
cannot be used to evaluate the effectiveness of the NDMBS.  One option that may assist 
future evaluations would be to require NDMBS-funded organisations to report the usual 
resident postcodes of the children and families who have received services funded by 
the program.  This high-resolution data would allow a more accurate evaluation using 
AEDC and NAPLAN data, and allow evaluation using other population-level health 
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indicators.  For example, analysis of data from the National Perinatal Data Collection 
could allow evaluation of NDMBS outcomes such as maternal smoking, antenatal visits 
and neonatal deaths (15); and data from the Australian Immunisation Register would 
allow evaluation of immunisation coverage (16).    
 
Recommendations 
 
1. Enhance support for NDMBS-funded organisations that deliver services in 
remote and very remote areas.  Focus should be on strategies that develop 
the remote maternal and child health workforce, particularly Aboriginal 
and/or Torres Strait Islander Workers/Health Practitioners and Aboriginal 
and Torres Strait Islander midwives and nurses. 
 
2. Require organisations that receive NDMBS funding to regularly report the 
postcodes of children and families who receive services to allow future 
evaluations of effectiveness.   
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CHAPTER 6 –TEACHING EXPERIENCE 
  
  
  
  
  
 No one learns as much about a subject as one who is forced 
to teach it. 
 Peter F. Drucker 
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ABBREVIATIONS 
 LFF Lesson from the field 
LSIC Longitudinal Study of Indigenous Children 
MAE Master of Philosophy (Applied Epidemiology) 
NCEPH National Centre for Epidemiology and Population Health 
PCA Principal component analysis 
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My role and lessons learned 
MAE scholars are required to complete two teaching exercises: participating in teaching 
the first year scholars; and presenting a Lesson from the Field (LFF) to our own MAE 
cohort. 
I worked in a team of four on a session to teach the first year students about 
confounding.  The team was motivated and teleconferenced early on to ensure we would 
be ready in time.  We remembered how tired of lectures we had been by the time the 
second-year students taught us, so we aimed to develop a session that would be 
interactive and get people out of the classroom.  I came up with the idea of a murder skit 
to illustrate the relationship between an exposure, a confounder and an outcome, and we 
developed this idea together.  We then divided up the more formal part of the session 
between us and came together to review the sections.  A few weeks before the course 
block, we received some criticism of our skit and presentation slides from the NCEPH 
lecturer.  I think we all felt a little deflated, and I realised with some embarrassment (as 
an experienced trainer) that we had not written a lesson plan.  Developing a plan 
(Appendix 6.1) did focus our efforts and led to a simpler and clearer session.  The 
presentation slides are shown in Appendix 6.2. 
Due to illness in the family, I was unable to participate in the delivery of the 
confounding teaching session.  However, I did assist in the delivery of the “Outbreak 
Investigation” subject, leading a small group case study discussion.  With such depth 
and breadth of knowledge and experience among scholars, I was a bit daunted by this.  I 
found it easier to take on a facilitator role and draw out the group participants in 
discussion, rather than trying to appear as an expert. 
I developed my LFF on Principal Component Analysis (PCA).  I chose this topic as I 
had spent much time and energy trying to understand the technique in order to use it in 
my epidemiological project (Chapter 3), and I thought other scholars might find it 
useful for their own MAE projects or future work.  I also wanted to share the Stata 
command I had learned for adding metadata to datasets and variables.   
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In developing the self-directed learning package (Appendices 6.4 and 6.5), I wanted to 
describe PCA simply and avoid getting bogged down in technicalities.  I know from my 
experience in training Aboriginal Health Workers that it helps to ‘layer on’ different 
ways of explaining the same concept, so I provided a written explanation, an audio-
visual explanation, as well as storytelling and a case study exercise.  The most time 
consuming part was making a dummy dataset for which PCA would actually work.  An 
important lesson I learnt was to check my work carefully: there was an error in the 
exercise and I had to send out an amended version. 
My MAE colleagues found the exercise challenging, but nonetheless enjoyable and 
useful.  I had several thought-provoking discussions.  I was asked how to interpret the 
results of the Wilcoxon rank-sum test.  This led me to revisit my understanding of what 
is actually tested. While I had thought it was a test of equality of medians, the Wilcoxon 
rank-sum test actually provides a measure of effect size.  After further research, I found 
a user-written Stata command that calculates the estimate and confidence interval for 
the effect size, and I was able to use this in the analysis for my epidemiological project.   
I also took the opportunity to co-supervise a medical school student for their research 
project.  The student chose to analyse factors associated with ear disease in children in 
the Longitudinal Study of Indigenous Children (LSIC).  I was able to share the lessons I 
had learned about using the LSIC data, but also general research skills such as refining 
the research question, choosing the correct method for the question and data, and 
writing for publication.  Working with the student was a challenging but rewarding 
experience.  
 
 
